Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3029713	s-mkomp-1	g/l (g/l)	10119	22598	0.00%
3029713	s-mkomp-1	— (—)	2167	4436	100.00%	Distribution not available
3029713	m-komp-1	g/l (g/l)	134	1068	0.00%	Distribution not available
3029713	m-komp-1	— (—)	61	236	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Condition for Implicit Sepsis (Organ dysfunction codes)

2465

7627

2.42

322.23

2.5

2.3

0.79

0.86

g/l

0.33

2090

6543

Examination and observation for other reasons

1835

4012

2.87

319.84

2.3

2.4

0.53

0.87

g/l

3.82

1656

3441

Pain in limb

2233

6606

2.52

317.85

2.3

2.4

0.70

0.93

g/l

1.97

1946

5638

Autoimmune diseases excluding thyroid diseases

2878

7122

2.30

314.70

2.1

2.6

0.70

0.93

g/l

2.47

2531

6059

Dialysis, with operation codes

634

1247

5.66

310.80

4.1

2.1

0.68

0.86

g/l

0.53

573

1071

Metabolic disorders

2650

7241

2.33

309.13

2.7

2.3

0.65

0.97

g/l

4.56

2306

6182

Bacterial Sepsis

1578

5048

2.92

308.28

3.0

2.3

1.08

1.00

g/l

0.24

1328

4242

Autoimmune diseases excluding thyroid diseases, strict definition

2788

6898

2.31

308.06

2.1

2.6

0.71

0.94

g/l

2.22

2452

5861

Multiple myeloma and malignant plasma cell neoplasms

656

521

20.27

307.65

16.1

1.7

6.78

0.78

g/l

34.75

543

442

Renal failure

2196

5041

4.34

307.65

2.7

2.3

0.82

1.12

g/l

2.31

1923

4184

Other and unspecified polyneuropathies, also in other diseases

1051

2302

5.12

307.65

2.2

2.3

0.55

0.98

g/l

3.53

920

1942

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

362

280

21.67

307.65

20.1

1.7

7.03

0.78

g/l

22.66

325

234

Chronic kidney disease

1578

3493

4.97

307.65

2.5

2.3

0.73

1.07

g/l

2.52

1401

2863

Renal tubulo-interstitial diseases

3009

7808

3.08

307.65

2.6

2.3

0.82

0.92

g/l

0.63

2600

6654

Polyarthropathies

2308

5167

3.09

307.65

2.6

2.5

0.78

0.96

g/l

1.25

2033

4433

Bacterial infection, other or unspecified

1929

5805

3.15

307.65

3.4

2.2

1.05

0.95

g/l

0.47

1683

4862

Aplastic and other anaemias

2105

5244

4.11

307.65

2.8

2.3

1.02

1.03

g/l

0.02

1781

4383

Other systemic involvement of connective tissue (FG)

1031

2520

4.34

307.65

1.9

2.6

0.55

1.08

g/l

4.65

893

2114

First line medication for Crohn's disease

3330

6609

2.83

307.65

3.1

1.7

0.89

0.78

g/l

0.74

2917

5634

ILD medications

3631

6713

3.07

307.65

3.1

1.8

0.86

0.83

g/l

0.13

3171

5714

Inflammatory bowel disease treatment related agents

3386

7689

2.57

307.65

2.2

2.5

0.76

0.90

g/l

1.00

2961

6546

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

866

475

36.41

307.65

7.5

1.2

5.33

0.18

g/l

71.74

686

403

L04AX Other immunosuppressants

1858

6225

3.12

307.65

5.2

1.9

1.19

0.73

g/l

4.17

1617

5359

Implicit Sepsis

2309

7170

2.59

307.65

2.6

2.3

0.84

0.90

g/l

0.26

1938

6120

Heart failure, not strict

2453

6679

2.63

307.65

2.6

2.4

0.66

1.04

g/l

5.25

2119

5684

ILD medications: prednisolone, methylprednisolone, prednisone

3445

6689

3.01

307.65

2.3

1.8

0.77

0.84

g/l

0.42

3018

5690

General symptoms and signs

2904

6178

2.41

307.65

2.6

2.2

0.75

0.87

g/l

0.89

2537

5285

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1363

873

27.42

307.65

10.5

1.3

5.60

0.26

g/l

81.93

1101

740

Multiple myeloma, excluding all cancers (controls excluding all cancers)

667

490

22.08

307.65

15.9

1.5

6.80

0.50

g/l

40.14

553

412

Other and unspecified anaemias

1997

4907

4.27

307.65

2.8

2.3

1.02

1.03

g/l

0.04

1686

4096

Primary_lymphoid and hematopoietic malignant neoplasms

1521

2761

6.28

307.65

8.6

1.5

3.74

0.51

g/l

44.18

1310

2328

ILD medications: immunosuppressive drugs

2292

5669

4.08

307.65

4.6

1.8

1.00

0.76

g/l

1.79

2020

4851

Polyneuropathies and other disorders of the peripheral nervous system

1131

2645

4.74

307.65

2.5

2.3

0.57

0.97

g/l

3.47

992

2231

Malaise and fatigue

1563

4450

3.04

307.65

2.2

0.89

1.01

g/l

0.46

1311

3739

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3986

7505

4.01

307.65

2.7

2.2

0.89

0.84

g/l

0.35

3440

6415

Oral corticosteroids

3275

7639

2.67

307.65

2.2

2.5

0.75

0.90

g/l

1.21

2862

6500

Other bacterial diseases

3037

7931

2.74

307.65

3.0

2.2

0.96

0.82

g/l

0.96

2633

6756

Multiple myeloma and malignant plasma cell neoplasms

656

487

21.73

307.65

16.1

1.5

6.78

0.51

g/l

38.60

543

410

Primary_lymphoid and hematopoietic malignant neoplasms

1521

2806

6.18

307.65

8.6

1.5

3.74

0.48

g/l

44.86

1310

2356

Other anaemias

2010

4946

4.25

307.65

2.8

2.3

1.03

1.02

g/l

0.02

1698

4128

Tramadol

2336

5751

2.69

307.65

2.4

2.0

0.71

0.87

g/l

1.28

2025

4903

Anaemias

888

588

10.64

307.65

2.7

1.3

0.71

0.27

g/l

2.72

780

524

Multiple myeloma

362

280

21.67

307.65

20.1

1.7

7.03

0.78

g/l

22.66

325

234

Second line medication for Crohn's disease

1884

6340

3.11

307.65

5.1

1.9

1.17

0.73

g/l

4.08

1639

5463

Systemic connective tissue disorders

1402

4116

3.63

307.65

2.0

2.4

0.49

0.97

g/l

6.67

1228

3461

Fever of other and unknown origin

1755

5186

3.26

307.65

4.0

2.2

1.22

0.93

g/l

1.48

1542

4396

Acute renal failure

895

2329

4.17

306.79

2.9

2.2

0.89

0.97

g/l

0.18

771

1932

Pneumonias (Asthma/COPD co-morbidities)

2701

8437

2.27

305.34

3.2

2.1

0.95

0.79

g/l

1.22

2341

7255

All pneumoniae

2711

8459

2.27

304.20

3.2

2.1

0.95

0.78

g/l

1.24

2351

7278

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2514

6838

2.36

302.69

3.2

2.0

0.96

0.78

g/l

1.31

2180

5884

2514

6838

2.36

302.69

3.2

2.0

0.96

0.78

g/l

1.31

2180

5884

Other soft tissue disorders, not elsewhere classified

2509

6733

2.36

300.18

2.5

2.4

0.72

0.92

g/l

1.73

2190

5751

Influenza and pneumonia

2780

8370

2.24

298.75

3.2

2.1

0.96

0.77

g/l

1.52

2399

7219

Pneumonia, organism unspecified

2497

7997

2.32

297.98

3.1

2.1

0.94

0.80

g/l

0.94

2144

6871

Glomerular diseases

808

2017

4.36

293.41

2.9

2.3

0.62

1.00

g/l

1.63

721

1736

Other systemic involvement of connective tissue

1057

3187

3.53

288.92

1.9

2.4

0.56

0.98

g/l

3.62

916

2689

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2628

8498

2.23

283.81

3.2

2.2

0.96

0.79

g/l

1.32

2276

7306

Finngen Rheumatological endpoints

2481

6259

2.31

277.86

2.1

2.5

0.62

0.96

g/l

4.68

2168

5385

Implicit bacterial Sepsis

1382

4590

2.90

268.53

2.8

2.3

0.91

1.03

g/l

0.45

1162

3852

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

487

906

6.19

256.29

3.9

2.3

1.96

1.03

g/l

2.52

401

771

Gout

1052

3061

3.32

256.16

3.3

2.5

1.03

1.18

g/l

0.52

911

2560

Heart failure and antihypertensive medication

881

1543

3.97

255.34

2.1

2.6

0.62

1.10

g/l

2.61

757

1318

Codeine

2359

5910

2.24

243.91

2.3

2.0

0.73

0.85

g/l

0.69

2040

5053

Nephropathy related operations

578

1303

4.90

240.88

4.3

2.3

0.70

0.93

g/l

0.67

523

1122

Infections, IBD-co-morbidities

484

633

5.82

227.54

3.8

2.3

0.79

1.26

g/l

1.11

412

550

Abnormal findings on examination of blood, without diagnosis

1494

5723

2.55

227.53

3.0

2.4

1.35

0.91

g/l

3.27

1286

4860

Osteopathies and chondropathies

1605

6438

2.45

227.06

3.2

2.3

0.98

0.87

g/l

0.54

1327

5500

Opioids

2400

5944

2.16

225.32

2.6

2.0

0.78

0.84

g/l

0.29

2084

5085

Persons encountering health services for specific procedures and health care

2683

8326

2.04

225.26

2.7

2.2

0.89

0.81

g/l

0.43

2369

7099

Disorders of lipoprotein metabolism and other lipidaemias

2269

6745

2.17

223.76

2.4

2.3

0.60

1.03

g/l

6.87

1971

5728

Glomerular disorders in diseases classified elsewhere

544

1244

4.82

222.63

3.1

2.3

0.77

1.02

g/l

0.52

481

1078

Gout, FINNGEN

1052

3709

3.00

220.28

3.3

2.4

1.03

1.12

g/l

0.28

911

3094

Heart failure,strict

1646

5072

2.43

215.52

2.2

2.5

0.71

1.15

g/l

4.60

1424

4233

Other heart diseases

1095

2465

3.01

214.48

2.4

2.1

0.60

0.81

g/l

1.02

958

2166

Reimbursement for rheumatic diseases

1624

7127

2.35

211.64

1.8

2.5

0.62

0.88

g/l

2.44

1441

6049

Unspecified kidney failure

474

1017

5.17

210.12

2.8

2.2

0.82

0.98

g/l

0.34

421

849

Hypertension, essential

1890

4819

2.29

207.43

2.2

2.4

0.65

0.86

g/l

1.44

1663

4146

Autoimmune diseases related-to ILD

2153

9328

2.08

204.52

2.2

2.4

0.69

0.87

g/l

1.50

1891

7966

Other diseases of blood and blood-forming organs, wide

798

2518

3.37

202.97

3.4

2.3

1.29

0.89

g/l

1.65

705

2158

Codeine or tramadol medication

2861

8354

1.93

202.20

2.3

2.4

0.71

0.91

g/l

2.12

2470

7157

Certain infectious and parasitic diseases

2403

5900

2.08

201.78

2.6

2.0

0.83

0.78

g/l

0.27

2109

5031

Oedema, not elsewhere classified

933

3198

3.03

201.69

2.4

2.2

0.59

0.99

g/l

3.67

810

2674

Nutritional anaemias

1443

6030

2.41

198.44

2.1

2.4

0.73

1.06

g/l

2.89

1215

5073

Other and unspecified iron deficiency

1024

3769

2.84

196.40

2.0

2.4

0.64

1.01

g/l

3.25

871

3172

Exposure to unspecified factor

2377

9483

1.98

195.19

2.3

2.4

0.67

0.88

g/l

2.08

2035

8154

Hypertensive diseases (excluding secondary)

1170

2485

2.80

194.67

2.3

2.2

0.62

0.81

g/l

0.82

1054

2177

Iron deficiency anaemia

1242

4996

2.56

194.21

2.1

2.4

0.72

1.01

g/l

2.20

1040

4181

Pain in joint

1499

4218

2.41

191.88

2.1

2.3

0.68

0.89

g/l

1.25

1317

3597

Asthma, unspecified (mode), excluding more controls

1269

3999

2.56

191.69

2.2

2.0

0.87

0.82

g/l

0.14

1102

3444

Diseases of arteries, arterioles and capillaries (FINNGEN)

746

1528

3.56

190.89

2.3

0.55

1.04

g/l

2.63

646

1317

GASTRO-related operations

1795

4034

2.27

187.86

2.3

2.0

0.69

0.78

g/l

0.48

1552

3514

Any gastric operation

1795

4034

2.27

187.86

2.3

2.0

0.69

0.78

g/l

0.48

1552

3514

Pure hypercholesterolaemia

1978

6414

2.12

187.62

2.5

2.4

0.70

1.06

g/l

4.27

1729

5430

Care involving dialysis

389

795

5.46

182.99

2.7

2.2

0.46

1.08

g/l

2.56

349

691

Septicaemia

1201

4736

2.53

182.79

3.0

2.2

1.33

0.99

g/l

1.22

1011

3954

Benign neoplasm of colon, rectum, anus and anal canal

1505

4740

2.34

182.01

2.4

1.5

0.92

0.48

g/l

4.86

1277

4044

Explicit Sepsis

1232

4916

2.49

181.27

3.0

2.3

1.31

0.98

g/l

1.28

1039

4142

Cardiovascular diseases (excluding rheumatic etc)

1231

2771

2.61

180.46

2.3

2.1

0.65

0.73

g/l

0.24

1110

2442

Asthma, excluding more controls

1749

4258

2.23

178.52

2.2

2.0

0.77

0.79

g/l

0.06

1538

3677

Hypertensive diseases

1831

4861

2.17

178.36

2.2

2.4

0.64

0.86

g/l

1.57

1626

4181

Hypertension

1827

4859

2.17

177.09

2.2

2.4

0.63

0.86

g/l

1.60

1622

4179

Dental caries

763

2504

3.15

176.56

3.6

2.2

1.05

0.87

g/l

0.50

674

2164

Ulcer of lower limb, not elsewhere classified

587

1677

3.80

176.24

2.4

2.3

0.57

0.95

g/l

1.74

514

1411

Autoimmune diseases

2609

7146

1.89

171.22

2.1

2.6

0.74

0.93

g/l

1.54

2275

6079

Heart failure, strict

1748

6074

2.14

170.31

2.2

2.6

0.75

1.11

g/l

3.52

1503

5065

Asthma, unspecified (mode)

1300

4429

2.38

169.73

2.2

2.0

0.88

0.82

g/l

0.19

1125

3804

Diseases of oesophagus, stomach and duodenum

2572

8496

1.87

169.32

2.2

2.4

0.69

0.90

g/l

2.24

2184

7324

Used for control exclusion in common control thyroid runs

2465

6599

1.92

169.07

2.1

2.6

0.67

0.94

g/l

2.96

2150

5615

Other arthritis (FG)

835

2985

2.90

168.58

2.4

2.7

0.59

1.05

g/l

4.10

737

2552

Abnormalities of breathing

2064

6186

2.02

168.23

2.4

2.3

0.76

0.85

g/l

0.50

1768

5372

Dyspnoea

2228

9043

1.93

167.29

2.5

2.4

0.74

0.92

g/l

1.53

1894

7737

Diverticular disease of intestine

1953

6512

2.04

167.02

2.6

2.4

0.86

0.98

g/l

0.67

1677

5563

Asthma

1833

4728

2.12

165.21

2.2

2.0

0.78

g/l

0.01

1607

4074

Malignant immunoproliferative diseases

132

26.42

164.71

10.5

1.2

8.01

0.33

g/l

11.20

111

Other specific joint derangements/joint disorders

1648

5230

2.15

163.88

2.0

2.4

0.68

0.85

g/l

1.11

1444

4532

Benign neoplasm: Colon

1339

4565

2.32

161.46

2.4

1.5

0.91

0.50

g/l

4.10

1131

3878

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

121

34.45

161.22

11.2

1.1

9.24

0.15

g/l

12.47

100

Osteoporosis

859

3067

2.82

158.92

2.5

2.2

1.01

0.99

g/l

0.05

674

2564

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

528

1504

3.78

158.84

3.0

1.5

1.43

0.48

g/l

5.70

469

1262

All-cause Heart Failure

1694

5986

2.11

158.40

2.2

2.6

0.75

1.12

g/l

3.53

1455

4989

Dentinal caries

681

2244

3.15

158.13

3.7

2.2

1.01

0.91

g/l

0.24

599

1944

Continuous positive airway pressure

614

1631

3.40

155.44

2.3

2.5

0.90

0.96

g/l

0.10

532

1406

Transplanted organ and tissue status

401

958

4.55

154.67

4.8

2.2

0.85

0.84

g/l

0.01

366

834

Asthma (mode)

1774

4763

2.08

154.24

2.2

2.0

0.76

0.78

g/l

0.06

1559

4106

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

344

488

5.47

151.80

2.4

0.74

1.57

g/l

1.84

309

411

Acute tubulo-interstitial nephritis

1494

6392

2.12

150.80

2.3

0.75

1.00

g/l

1.63

1260

5393

Other septicaemia

1040

4296

2.46

150.17

2.7

2.2

1.20

1.02

g/l

0.54

875

3575

Asthma (only as main-diagnosis), excluding more controls

1523

4258

2.17

150.09

2.2

2.0

0.75

0.79

g/l

0.13

1332

3677

L04AA Selective immunosuppressants

661

2224

3.12

150.01

2.0

2.3

0.34

0.89

g/l

6.30

602

1931

Other heart diseases, wide

2033

6620

1.94

149.53

2.5

2.3

0.72

0.83

g/l

0.72

1765

5747

Gout, idiopatic and unspecified

844

3252

2.74

149.38

2.1

2.5

0.64

1.09

g/l

3.22

736

2737

Erysipelas

1432

6259

2.14

148.44

2.2

0.81

0.91

g/l

0.39

1251

5281

Cardiovascular diseases

1055

2268

2.57

148.17

2.3

2.0

0.54

0.63

g/l

0.33

956

2008

Pain in throat and chest

1925

6103

1.96

146.11

2.4

2.3

0.64

0.86

g/l

2.22

1670

5291

Other specified/unspecified arthritis

747

2722

2.85

145.72

2.3

2.5

0.58

0.96

g/l

2.96

654

2324

Malignant immunoproliferative diseases

132

105

20.74

145.25

10.5

1.9

8.01

0.58

g/l

10.62

111

Polymyalgia rheumatica

536

1638

3.54

144.97

1.9

2.4

0.68

1.13

g/l

1.96

448

1356

Coagulation defects, purpura and other haemorrhagic conditions

614

2025

3.19

144.57

2.5

2.3

0.76

0.92

g/l

0.45

527

1735

Cerebrovascular diseases (FINNGEN)

767

1943

2.91

144.55

2.5

2.2

0.65

0.93

g/l

1.20

671

1684

Fall on same level

2604

8288

1.78

144.19

2.4

0.67

0.90

g/l

2.62

2186

7244

Medical observation and evaluation for suspected diseases and conditions

1629

4061

2.09

140.63

2.4

0.87

0.88

g/l

0.04

1408

3476

Diseases of the skin and subcutaneous tissue

2342

6487

1.84

139.69

2.4

2.3

0.85

g/l

0.00

2037

5538

Covid-19 confirmed case

810

3149

2.67

139.36

3.0

2.2

1.06

0.89

g/l

0.53

686

2694

Other disorders of skin and subcutaneous tissue

1743

8395

1.95

139.14

2.4

0.76

0.96

g/l

1.45

1490

7127

Low back pain

1692

6708

1.98

138.39

2.8

2.2

0.91

0.80

g/l

0.53

1459

5751

Spondylopathies

1988

6456

1.91

138.29

2.7

2.3

0.95

0.85

g/l

0.47

1720

5504

Enlarged lymph nodes

475

1375

3.62

137.83

2.2

0.60

0.89

g/l

1.26

433

1171

Other diseases of intestines

2339

7633

1.81

137.32

2.4

2.3

0.77

0.86

g/l

0.48

2017

6593

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2569

8476

1.76

135.67

2.3

2.4

0.74

0.89

g/l

1.25

2317

7173

Rheumatoid arthritis

899

3350

2.52

135.26

2.0

2.6

0.71

1.02

g/l

1.95

790

2841

Persons encountering health services in other circumstances, wide

2786

8534

1.72

133.99

2.4

0.80

0.89

g/l

0.62

2478

7213

Neurological diseases, wide definition

548

764

3.66

132.40

2.4

2.2

0.68

1.07

g/l

1.07

498

668

Asthma (only as main-diagnosis)

1570

4728

2.04

132.34

2.2

2.0

0.77

0.78

g/l

0.05

1369

4074

Gout, strict definition

633

2247

3.00

131.77

2.1

2.5

0.58

1.12

g/l

3.62

549

1890

L04AD Calcineurin inhibitors

378

971

4.17

131.74

2.8

2.6

0.30

0.96

g/l

3.78

351

855

Complications of surgical and medical care, not elsewhere classified

2285

9395

1.77

131.16

2.4

0.73

0.90

g/l

1.45

1951

8048

Gout, unspecified

690

2568

2.84

131.00

2.2

2.4

0.66

1.03

g/l

1.88

611

2166

Diseases of arteries, arterioles and capillaries

1783

7123

1.92

130.04

2.1

2.6

0.63

1.07

g/l

6.74

1531

5995

Disorders of thyroid, IBD co-morbidities

376

652

4.32

128.84

2.0

2.3

0.42

1.20

g/l

2.91

323

566

Oxycodone

957

4016

2.38

128.53

5.2

2.1

1.58

1.03

g/l

2.55

801

3364

Disturbances of skin sensation

703

2649

2.75

128.49

2.0

2.3

0.48

0.79

g/l

2.06

641

2310

Disorders resulting from impaired renal tubular function

208

333

7.30

128.22

2.4

2.7

0.34

1.64

g/l

3.74

196

299

Diabetic nephropathy, excluding more controls

481

1202

3.55

127.28

1.9

2.2

0.35

0.92

g/l

3.96

429

1009

Headache

1313

5343

2.09

127.22

2.3

2.2

0.71

0.84

g/l

0.75

1148

4566

Symptoms and signs involving cognition, perception, emotional state and behaviour

2236

9000

1.77

126.98

2.1

2.5

0.72

0.90

g/l

1.58

1911

7735

Codes for special purposes

1048

4795

2.24

124.11

3.0

2.2

0.94

0.84

g/l

0.36

897

4139

Symptoms and signs involving the skin and subcutaneous tissue

1624

8655

1.91

123.96

2.3

2.4

0.74

0.87

g/l

0.69

1434

7359

Provisional assignment of new diseases of uncertain etiology

1046

4789

2.24

123.68

3.0

2.2

0.94

0.84

g/l

0.36

896

4133

Non-follicular lymphoma, hilmo, excluding all cancers

381

1034

4.00

123.63

2.7

1.5

1.41

0.54

g/l

3.34

337

877

Dorsalgia

2217

6822

1.79

123.05

2.5

2.2

0.85

0.81

g/l

0.21

1920

5847

Glomerulonephritis

381

1035

3.96

122.95

2.9

2.5

0.32

1.13

g/l

5.39

344

900

COPD/asthma/ILD related infections

2369

6840

1.76

122.70

3.1

2.0

0.94

0.78

g/l

1.08

2066

5886

COPD/asthma related infections

2369

6840

1.76

122.70

3.1

2.0

0.94

0.78

g/l

1.08

2066

5886

Pain, not elsewhere classified

652

2420

2.78

122.44

2.7

2.1

0.81

0.88

g/l

0.17

579

2055

Benign neoplasm of colon, rectum, anus and anal canal

1631

7935

1.90

120.79

2.4

2.5

0.91

1.02

g/l

0.57

1383

6705

Heart failure and bmi 25plus

987

2990

2.36

120.16

2.1

2.7

0.69

1.15

g/l

2.89

841

2439

Abnormalities of gait and mobility

452

1399

3.47

119.67

1.9

2.5

0.52

1.13

g/l

3.63

406

1192

Other pulmonary diagnosis

1790

4775

1.91

119.52

2.6

2.0

0.85

0.79

g/l

0.25

1559

4115

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

728

1314

2.82

118.28

2.4

1.9

0.84

0.77

g/l

0.15

661

1139

Syncope and collapse

1062

4380

2.20

117.75

2.4

2.3

0.70

1.02

g/l

2.14

884

3675

Parasetamol

1685

4532

1.92

116.51

2.3

2.2

0.72

0.90

g/l

1.17

1459

3963

Viral Sepsis

576

2075

2.90

115.59

3.5

2.2

1.06

0.88

g/l

0.38

481

1759

Seropositive rheumatoid arthritis

681

2663

2.64

115.03

2.0

2.7

0.75

1.13

g/l

2.06

600

2241

Implicit viral Sepsis

574

2072

2.90

114.75

3.6

2.2

1.06

0.88

g/l

0.38

479

1756

Atrial fibrillation and flutter

736

1859

2.65

114.48

2.7

2.2

0.66

0.97

g/l

1.26

646

1605

Neoplasms

1449

3933

2.00

113.58

2.9

1.2

1.10

0.19

g/l

14.38

1274

3446

Excluding asthma or asthma-COPD overlap

1765

4775

1.88

112.96

2.5

2.0

0.86

0.79

g/l

0.27

1543

4115

Lymphoid leukaemia

252

538

5.20

112.72

3.0

1.5

1.08

0.46

g/l

1.97

226

457

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

180

286

7.50

112.34

2.2

1.4

0.77

0.51

g/l

0.62

165

240

Chronic lymphocytic leukaemia, helper endpoint

180

286

7.50

112.34

2.2

1.4

0.77

0.51

g/l

0.62

165

240

Other necrotizing vasculopathies (FG)

252

540

5.12

111.78

1.7

2.8

0.19

1.39

g/l

5.98

225

457

Type 2 diabetes, wide definition

1976

7386

1.78

111.65

2.1

2.6

0.63

1.00

g/l

4.73

1700

6281

Preparatory care for dialysis

227

450

5.77

111.61

2.1

3.0

0.30

1.50

g/l

4.82

214

397

Any reimbursement code in KELA

1020

2255

2.30

110.50

2.5

1.6

0.70

0.62

g/l

0.23

922

1953

Other disorders of fluid, electrolyte and acid-base balance

817

3414

2.39

110.35

2.6

2.2

0.78

1.12

g/l

1.54

689

2845

Asthma (diagnoses ohter than nonallergic)

1926

9541

1.75

110.08

2.1

2.4

0.79

0.88

g/l

0.42

1676

8139

COPD differential diagnosis

1748

4763

1.86

109.43

2.5

2.0

0.86

0.78

g/l

0.38

1530

4106

ILD differential diagnosis

1748

4763

1.86

109.42

2.5

2.0

0.86

0.78

g/l

0.38

1530

4106

Depression medications

456

643

3.62

108.99

1.7

1.3

0.55

0.25

g/l

1.30

419

574

Symptoms and signs involving the urinary system

1844

8156

1.78

108.57

2.3

2.5

0.95

0.92

g/l

0.11

1580

6927

Lower back pain or/and sciatica

2277

9534

1.68

107.62

2.6

2.3

0.87

0.84

g/l

0.14

1966

8176

Small fibre neuropathy

171

270

7.54

107.35

2.5

2.6

0.56

1.53

g/l

1.95

152

235

Non-follicular lymphoma

381

1138

3.63

107.14

2.7

2.5

1.41

1.06

g/l

0.71

337

982

Nephrotic syndrome

168

259

7.42

106.87

2.7

2.8

0.25

1.11

g/l

2.81

157

232

Purpura and other haemorrhagic conditions

438

1419

3.27

106.80

2.4

0.82

1.00

g/l

0.35

370

1228

Diseases of pulp and periapical tissues

851

3813

2.29

106.38

3.8

2.2

1.14

0.82

g/l

1.32

723

3280

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

868

2389

2.35

104.84

2.3

2.2

0.73

0.84

g/l

0.37

775

2091

Other dorsopathies, not elsewhere classified

2187

6828

1.71

104.67

2.3

2.2

0.87

0.80

g/l

0.32

1891

5853

Asthma-related infections

1325

6904

1.93

104.45

2.4

0.90

g/l

0.01

1154

5859

Asthma, hospital admission 2, infections

1325

6904

1.93

104.45

2.4

0.90

g/l

0.01

1154

5859

Symptoms and signs involving the circulatory and respiratory systems

2113

6198

1.73

103.88

2.4

2.3

0.78

0.85

g/l

0.34

1842

5383

Other and unspecified dermatitis

1190

6112

1.99

103.44

2.3

2.4

0.69

0.86

g/l

1.14

1032

5194

Chronic periapical parodontitis

577

2207

2.72

102.84

4.5

2.2

1.21

0.93

g/l

0.78

491

1898

Non-ischemic cardiomyopathy

890

3342

2.27

102.80

2.3

2.5

0.86

1.10

g/l

0.94

749

2769

Hypertensive heart and/or renal disease

737

2394

2.47

102.55

2.0

2.6

0.61

1.20

g/l

4.85

642

1974

Adjustment and management of implanted device

600

2358

2.67

101.93

2.6

2.2

0.66

1.07

g/l

2.30

518

1940

Antihypertensive medication - note that there are other indications

1005

2530

2.20

101.38

2.1

2.3

0.55

0.79

g/l

1.34

902

2220

Constipation

2024

8640

1.71

101.30

2.8

2.4

0.86

0.92

g/l

0.26

1688

7414

Endocrine, nutritional and metabolic diseases

1598

4411

1.87

101.18

2.2

2.4

0.51

1.00

g/l

7.68

1401

3822

Other necrotizing vasculopathies

293

767

4.17

100.36

1.9

2.7

0.21

1.23

g/l

6.93

262

660

Soft tissue disorders

2182

6788

1.69

99.54

2.4

0.67

0.91

g/l

2.50

1912

5797

Dermatitis and eczema

2350

9545

1.64

99.15

2.2

2.4

0.75

0.87

g/l

0.87

2044

8168

Diaphragmatic hernia

981

4793

2.11

98.95

2.4

0.82

0.94

g/l

0.37

828

4047

Pain (limb, back, neck, head abdominally)

1629

4491

1.84

98.47

2.3

0.78

0.95

g/l

0.96

1423

3815

Chronic periodontitis

464

1627

3.00

98.26

3.4

2.2

0.83

0.98

g/l

0.35

415

1400

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1570

8266

1.80

98.08

2.5

1.06

0.94

g/l

0.44

1355

6983

Symptoms and signs concerning food and fluid intake

317

882

3.79

97.96

2.0

2.3

0.41

1.00

g/l

2.69

271

741

Chronic lymphocytic leukaemia

180

329

6.49

97.64

2.2

2.7

0.77

1.57

g/l

1.48

165

284

Disorders of mineral metabolism

295

788

4.02

97.62

3.8

2.3

0.87

1.28

g/l

0.75

234

690

Lymphoid leukaemia

252

607

4.59

97.04

3.0

2.7

1.08

1.28

g/l

0.30

226

525

Benign neoplasm: Colon

1367

7367

1.87

96.39

2.4

2.5

0.91

1.03

g/l

0.63

1156

6226

Diseases of the musculoskeletal system and connective tissue

1029

2430

2.15

95.92

2.4

2.2

0.89

0.95

g/l

0.15

919

2088

Other disorders of white blood cells

234

537

4.79

95.62

2.1

2.7

0.47

1.29

g/l

2.96

207

473

Bleeding

1938

8446

1.70

95.59

2.3

2.5

0.96

0.90

g/l

0.22

1652

7194

Extracorporeal dialysis

251

609

4.53

95.49

2.8

2.6

0.51

1.26

g/l

2.73

219

538

Other CVD (FINNGEN)

347

789

3.64

94.93

3.0

2.3

0.61

1.31

g/l

1.98

285

667

Disorders of calcium metabolism

251

613

4.46

94.42

4.2

2.2

1.03

1.20

g/l

0.21

198

535

Asthma-related pneumonia or sepsis

915

4429

2.12

93.94

2.5

2.3

0.92

0.99

g/l

0.17

803

3688

Asthma, hospital admissions 3, pneumonia

915

4429

2.12

93.94

2.5

2.3

0.92

0.99

g/l

0.17

803

3688

Need for other prophylactic measures

228

520

4.80

93.78

2.4

2.6

0.60

1.14

g/l

1.46

219

458

Amyloidosis, other/unspecified

127

169

9.33

93.72

8.6

2.3

1.65

1.49

g/l

0.11

113

145

Asthma-related pneumonia

912

4420

2.12

93.34

2.5

2.3

0.93

0.99

g/l

0.17

800

3679

Cardiac arrhythmias

1202

4118

1.96

93.28

2.5

2.4

0.58

0.84

g/l

1.88

1041

3601

ILD medications: azathioprine

346

1053

3.40

92.58

1.9

1.6

0.41

0.59

g/l

0.76

305

916

Hypothyroidism (congenital or acquired)

376

617

3.55

92.37

2.4

1.3

0.36

0.26

g/l

0.47

343

551

Valvular heart disease excluding rheumatic fever

1161

4407

1.97

92.33

2.5

0.91

1.05

g/l

0.52

985

3738

Dermatitis

1363

7585

1.83

92.16

2.3

2.4

0.71

0.89

g/l

1.26

1178

6453

367

1165

3.29

92.07

2.3

0.63

0.95

g/l

0.76

324

1000

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1889

6636

1.71

91.71

3.9

1.5

1.35

0.42

g/l

16.07

1648

5723

Rheumatoid arthritis, including avohilmo

981

4923

2.05

91.70

2.0

2.5

0.74

0.92

g/l

0.91

866

4154

Malignant neoplasm, wide definition for exclusion

1889

6636

1.71

91.70

3.9

1.5

1.34

0.42

g/l

16.03

1648

5723

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1889

6636

1.71

91.68

3.9

1.5

1.34

0.42

g/l

16.03

1648

5723

Atrial fibrillation and flutter with reimbursement

627

1606

2.57

91.37

2.8

2.3

0.80

1.08

g/l

0.83

538

1386

Hypothyroidism, levothyroxine purchases

373

617

3.53

90.80

2.4

1.3

0.36

0.26

g/l

0.43

340

551

Hypothyroidism and >3 levothyroxin purchases

373

617

3.53

90.80

2.4

1.3

0.36

0.26

g/l

0.43

340

551

Non-rheumatic valve diseases

1154

4396

1.96

90.55

2.5

0.92

1.05

g/l

0.49

979

3727

Diabetic nephropathy

484

1793

2.82

90.34

1.9

2.2

0.35

0.86

g/l

4.19

431

1523

Hyperlipidaemia, other/unspecified

997

4793

2.02

89.26

2.5

2.4

0.77

1.11

g/l

1.91

837

4020

Osteoporosis with pathological fracture (FG)

248

626

4.29

89.09

1.8

2.4

0.51

1.05

g/l

1.64

193

511

Arthropathies

1821

5440

1.72

88.93

2.1

2.4

0.65

0.91

g/l

2.14

1595

4695

Diarrhoea and gastroenteritis of presumed infectious origin

1485

7745

1.77

88.65

2.8

2.2

0.72

0.87

g/l

0.99

1285

6612

Genitourinary diseases

1228

3200

1.95

88.18

2.2

2.3

0.66

1.00

g/l

2.43

1096

2770

Haemorrhage from respiratory passages

875

3955

2.11

87.47

2.4

1.11

1.07

g/l

0.10

739

3346

Malignant neoplasm

1927

6921

1.68

87.39

4.2

1.5

1.42

0.44

g/l

16.10

1668

5966

Chronic gastritis

782

3680

2.20

87.26

2.2

2.5

0.61

1.07

g/l

4.10

667

3109

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2032

8539

1.64

87.15

2.9

2.3

0.88

0.84

g/l

0.17

1731

7392

Amyloidosis

134

206

7.75

86.34

8.3

2.4

1.57

1.83

g/l

0.19

120

181

Other and unspecified diseases of blood and blood-forming organs

143

238

6.97

84.88

5.4

3.0

1.84

1.12

g/l

0.83

132

218

Other antidepressants

2267

7463

1.60

84.60

2.2

2.5

0.78

0.94

g/l

1.10

1928

6414

Secondary hypertension

232

568

4.26

84.60

2.5

2.2

0.42

1.17

g/l

2.14

206

481

Care involving use of rehabilitation procedures

1382

7514

1.78

83.98

2.5

2.3

0.80

0.86

g/l

0.31

1263

6365

Cardiomyopathy

504

1998

2.63

83.78

2.8

2.3

0.61

1.09

g/l

2.74

440

1680

Symptoms and signs involving the nervous and musculoskeletal systems

1305

7380

1.80

83.64

2.2

2.4

0.61

0.94

g/l

3.65

1147

6253

Intestinal infectious diseases

1956

9488

1.63

83.23

2.9

2.2

0.76

0.87

g/l

0.71

1694

8121

Chronic lower respiratory diseases

2516

8848

1.56

83.11

2.2

2.4

0.72

0.88

g/l

1.20

2201

7573

Other diseases of urinary system

2191

7786

1.60

82.87

2.4

0.73

0.93

g/l

1.78

1875

6692

Spinal stenosis

1261

5494

1.84

82.53

2.4

0.83

0.95

g/l

0.56

1068

4632

Follow-up examination after treatment for conditions other than malignant neoplasms

990

3282

2.01

82.38

2.2

2.4

0.62

0.85

g/l

1.30

879

2816

Benign neoplasms

1419

4519

1.80

82.18

2.3

1.4

0.74

0.38

g/l

4.33

1224

3945

922

4670

2.00

81.33

2.5

2.3

0.81

0.85

g/l

0.10

805

3976

Complications of procedures, not elsewhere classified

1731

9152

1.66

80.97

2.2

2.4

0.72

0.92

g/l

1.48

1485

7836

Neurological diseases

1758

5282

1.69

80.73

2.2

2.4

0.68

0.99

g/l

2.89

1519

4572

Other disorders of urethra and urinary system

1492

6541

1.74

80.66

2.3

2.4

0.68

0.96

g/l

2.33

1284

5586

Hypothyroidism, drug reimbursement

254

460

4.03

79.86

2.4

1.4

0.42

0.32

g/l

0.31

227

402

Complications of medical and surgical care

1611

9267

1.68

79.63

2.5

2.4

0.69

0.93

g/l

1.98

1390

7887

Disorders of other endocrine glands

952

4878

1.96

79.30

2.7

2.3

0.58

0.89

g/l

2.37

807

4157

Other and unspecified disorders of white blood cells

183

402

5.05

79.27

2.0

2.9

0.45

1.13

g/l

1.97

165

352

Thrombocytopenia, unspecified

256

721

3.82

78.67

2.0

2.6

0.93

1.24

g/l

0.40

207

630

Gingivitis and periodontal diseases

1978

6349

1.63

78.32

2.5

2.2

0.73

0.90

g/l

1.31

1696

5412

Dorsopathies

2120

6835

1.60

78.23

2.4

2.2

0.81

0.80

g/l

0.04

1840

5859

Fracture of lumbar spine and pelvis

601

2659

2.34

78.09

2.5

2.2

0.94

g/l

0.00

471

2218

Venous thromboembolism

1306

7316

1.77

78.05

2.9

2.4

1.10

0.98

g/l

0.40

1122

6161

Sicca syndrome [Sjögren]

290

892

3.46

77.45

1.9

2.6

0.47

0.94

g/l

2.06

253

768

Spondylosis

1234

5987

1.80

77.26

2.3

0.78

0.87

g/l

0.40

1066

5097

Other external causes of accidental injury

1762

5333

1.67

77.24

2.2

2.4

0.78

0.95

g/l

1.10

1503

4668

Use of hypnotics and sedatives

2271

8535

1.56

76.43

2.5

2.4

0.77

0.88

g/l

0.76

1928

7362

Asthma, including avohilmo

2438

9353

1.53

76.31

2.1

2.4

0.76

0.88

g/l

0.72

2121

8004

Bacterial pneumoniae

967

4519

1.94

76.15

3.8

2.1

1.26

0.95

g/l

1.19

863

3818

2433

8448

1.54

76.10

3.2

2.1

0.98

0.83

g/l

0.96

2094

7224

Chronic periodontitis, including avohilmo

1959

9228

1.59

75.91

2.4

0.75

0.88

g/l

0.76

1675

7926

Parodontitis or operation codes

1967

9232

1.59

75.86

2.4

0.75

0.88

g/l

0.82

1685

7927

Parodontitis

1965

9232

1.59

75.72

2.4

0.75

0.88

g/l

0.80

1683

7928

Gastrointestinal diseases

1129

3011

1.90

75.59

2.5

2.0

0.91

0.68

g/l

1.05

997

2631

Azathioprine

346

1192

3.00

75.11

1.9

2.4

0.41

0.77

g/l

2.03

305

1038

Accidents

1751

5333

1.66

74.97

2.2

2.4

0.72

0.95

g/l

1.87

1493

4668

Sulfasalazine

623

2839

2.25

74.83

1.9

2.4

0.61

0.85

g/l

1.08

546

2421

Certain disorders involving the immune mechanism

503

2103

2.48

74.57

3.0

2.2

0.76

0.82

g/l

0.14

448

1818

Other disorders of kidney and ureter

397

1488

2.81

74.51

2.8

2.4

0.78

1.02

g/l

0.63

366

1276

Hypertensive Renal Disease

161

334

5.31

74.50

1.8

2.8

0.43

1.73

g/l

3.54

147

280

Acquired haemolytic anaemia

132

231

6.60

74.47

3.8

2.4

1.23

1.03

g/l

0.16

118

203

Diseases of liver

814

4127

2.03

74.02

1.9

2.5

0.64

0.91

g/l

1.70

681

3550

Bacterial pneumonia, not elsewhere classified

924

4296

1.95

73.87

3.7

2.1

1.25

0.96

g/l

1.07

836

3630

Other joint disorders

1679

5438

1.66

72.87

2.2

2.4

0.70

0.91

g/l

1.46

1459

4693

Diseases of oral cavity, salivary glands and jaws

1971

6396

1.60

72.60

2.5

2.2

0.85

0.91

g/l

0.26

1682

5448

STROKE

1295

5191

1.76

72.46

2.6

2.5

0.72

1.04

g/l

2.41

1115

4422

Injuries to the abdomen, lower back, lumbar spine and pelvis

891

4666

1.94

71.85

2.5

2.3

0.84

0.95

g/l

0.40

723

3965

Infections of the skin and subcutaneous tissue

1158

6591

1.78

71.43

2.5

2.3

0.77

0.82

g/l

0.19

1023

5682

Benign neoplasms

1985

7086

1.58

71.11

2.4

2.3

0.86

g/l

0.02

1702

6129

Disorders of parathyroid gland

575

2577

2.29

70.40

2.6

2.3

0.63

0.97

g/l

1.62

480

2157

Haemolytic anaemias

151

312

5.36

70.35

3.6

2.3

1.10

1.08

g/l

0.02

135

270

SLE (Finngen)

141

275

5.61

69.85

1.9

2.4

0.38

1.02

g/l

1.43

130

250

Kidney transplant status

182

439

4.47

69.50

2.1

2.7

0.16

0.95

g/l

3.91

169

397

DVT of lower extremities and pulmonary embolism

1022

5681

1.84

69.23

3.0

2.4

1.13

0.98

g/l

0.44

867

4768

Falls/tendency to fall

2215

7278

1.54

69.04

2.3

2.4

0.70

0.91

g/l

1.89

1867

6383

Dizziness and giddiness

1607

8149

1.62

68.57

2.2

2.5

0.74

0.96

g/l

1.50

1380

6959

Injuries to the head

2218

9613

1.52

68.53

2.3

2.4

0.74

0.88

g/l

1.08

1870

8298

Cystitis

1760

6783

1.61

68.44

2.3

2.4

0.78

0.96

g/l

1.15

1506

5799

Other diseases of blood and blood-forming organs

237

698

3.64

68.04

4.5

2.6

1.62

1.13

g/l

0.87

212

615

Statin medication

1356

4473

1.72

67.59

2.2

2.6

0.51

1.05

g/l

7.39

1207

3812

Cough

868

4434

1.91

67.38

2.6

2.4

0.67

0.89

g/l

1.10

745

3797

Other special examinations and investigations of persons without complaint or reported diagnosis

1368

4061

1.72

67.13

2.3

2.4

0.90

0.88

g/l

0.04

1193

3476

Disorders of eyelid, lacrimal system and orbit

1808

9142

1.57

67.07

2.6

2.4

0.83

0.91

g/l

0.39

1532

7812

Seronegative rheumatoid arthritis

310

1074

3.01

67.00

2.2

2.9

0.74

1.21

g/l

1.20

269

917

Persons encountering health services for examination and investigation

1378

4061

1.72

66.96

2.2

2.4

0.82

0.88

g/l

0.22

1202

3476

Cerebrovascular diseases

1712

7823

1.59

65.86

2.4

2.5

0.78

1.00

g/l

1.47

1442

6652

Diseases of the eye and adnexa

1535

4675

1.66

65.68

2.2

0.88

0.74

g/l

0.57

1342

4103

Other diseases of pleura

1116

5721

1.77

65.48

2.5

0.83

1.10

g/l

1.31

946

4812

Other/unspecified dorsalgia

797

4162

1.94

65.05

2.9

2.2

0.76

0.82

g/l

0.20

682

3526

Other intervertebral disc disorders

1711

6649

1.59

64.67

2.3

2.2

0.93

0.83

g/l

0.43

1489

5682

Chronic rhinitis, nasopharyngitis and pharyngitis

691

3466

2.04

64.59

2.1

2.3

0.77

0.81

g/l

0.10

600

2990

Hypertensive Heart Disease

590

2258

2.20

64.28

2.0

2.6

0.66

1.21

g/l

3.73

505

1867

Isolated proteinuria

129

252

5.69

64.15

3.2

2.8

0.45

1.53

g/l

2.10

118

223

Seropositive rheumatoid arthritis, wide

681

3415

2.05

64.15

2.0

2.4

0.75

0.89

g/l

0.55

600

2884

Diseases of the respiratory system

1357

4034

1.71

63.84

2.6

2.0

0.87

0.82

g/l

0.14

1190

3468

Viral hepatitis, IBD co-morbidity

112

189

6.14

63.76

2.0

1.9

0.67

1.14

g/l

0.44

169

Explicit bacterial Sepsis

292

1009

3.03

63.60

4.2

2.3

2.05

0.96

g/l

1.69

248

861

Myalgia

485

2134

2.33

63.58

2.2

0.63

0.89

g/l

1.09

417

1824

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

665

3319

2.06

63.51

2.0

2.4

0.75

0.89

g/l

0.53

585

2807

Unspecified privation

308

1098

2.94

63.45

2.1

2.4

0.40

0.98

g/l

3.05

277

956

Benign neoplasm: Colon, unspecified

601

2878

2.15

63.41

2.4

1.5

0.90

0.50

g/l

2.18

493

2430

Parodontitis and operation codes

1811

9200

1.55

63.16

2.4

2.5

0.77

0.86

g/l

0.45

1549

7908

Other/unspecified seropositive rheumatoid arthritis

673

3380

2.05

63.14

2.0

2.4

0.76

0.90

g/l

0.52

592

2859

Gastro-oesophageal reflux disease

1423

7835

1.63

62.92

2.1

2.5

0.70

0.93

g/l

1.58

1168

6749

Peripheral artery disease

1116

5237

1.76

62.77

2.1

2.5

0.62

1.18

g/l

6.34

969

4372

Disorders of choroid and retina

1782

8449

1.56

62.60

2.5

0.94

0.95

g/l

0.02

1489

7206

Disorders of lens

1541

6084

1.62

62.57

2.7

2.5

0.94

0.90

g/l

0.13

1290

5301

Pulmonary heart disease, diseases of pulmonary circulation

794

4230

1.93

62.51

2.7

2.4

0.88

0.99

g/l

0.27

681

3553

Abnormal findings on diagnostic imaging of lung

1145

6608

1.72

62.42

2.4

2.5

1.05

1.00

g/l

0.13

979

5554

Bacterial pneumonia (organism specified)

1030

5379

1.78

62.38

4.0

2.2

1.30

0.96

g/l

1.52

920

4499

Vasculitis limited to skin, not elsewhere classified

124

241

5.80

62.26

2.6

2.7

0.56

0.86

g/l

0.47

112

212

Streptococcal septicaemia

252

815

3.26

61.85

4.0

2.3

2.16

1.05

g/l

1.44

211

688

Systemic lupus erythematosus

141

308

4.99

61.27

1.9

2.3

0.38

0.97

g/l

1.35

130

274

Idiopathic gout

294

1049

2.98

60.98

2.1

2.4

0.46

1.16

g/l

3.16

248

895

Mixed connective tissue disease

215

640

3.58

60.66

1.7

2.7

0.65

0.84

g/l

0.29

197

565

Weight loss

292

1039

2.96

60.62

2.3

2.4

0.44

0.99

g/l

2.57

250

899

Nerve, nerve root and plexus disorders

2200

9410

1.48

60.54

2.4

0.75

0.89

g/l

1.02

1901

8039

Glucagon-like peptide-1 (GLP-1) analogues

1325

6723

1.65

60.29

2.2

2.6

0.72

1.06

g/l

2.65

1128

5669

Intracranial trauma

1030

4402

1.77

60.20

2.3

2.4

0.79

0.97

g/l

0.69

868

3810

Persons with potential health hazards related to communicable diseases

627

3088

2.05

59.83

2.5

2.1

0.63

0.66

g/l

0.10

565

2745

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2029

8885

1.50

59.82

2.4

0.89

0.88

g/l

0.04

1743

7616

Hernia

1925

8704

1.52

59.64

2.6

2.3

0.97

0.83

g/l

0.72

1646

7448

Bronchitis

2148

9589

1.48

59.55

3.3

2.2

0.90

0.85

g/l

0.22

1851

8214

Coxarthrosis [arthrosis of hip](FG)

1157

4963

1.71

59.49

2.3

2.7

0.76

1.16

g/l

3.63

976

4198

Giant cell arteritis

173

456

4.18

59.19

1.7

2.9

0.33

1.46

g/l

3.73

151

385

Pruritus

296

1073

2.88

59.03

2.2

2.4

0.67

0.93

g/l

0.57

261

928

Exposure to other specified factors

1411

8354

1.60

58.85

2.2

2.4

0.63

0.83

g/l

1.47

1208

7237

Diabetes, varying definitions

2052

8272

1.50

58.48

2.0

2.5

0.61

0.92

g/l

3.90

1762

7091

Depression or dysthymia

1516

5338

1.61

58.45

2.2

2.5

0.77

0.92

g/l

0.75

1275

4648

Asthma, hospital admissions , main diagnosis only

1632

9539

1.55

58.35

2.2

2.4

0.75

0.87

g/l

0.70

1418

8155

Unspecified haematuria

983

4848

1.77

58.33

2.3

2.5

1.07

g/l

0.00

844

4079

Viral pneumonia

320

1214

2.74

58.29

3.8

2.1

1.21

1.02

g/l

0.29

273

1030

Diabetes mellitus

2057

8292

1.50

58.25

2.0

2.5

0.61

0.92

g/l

3.85

1765

7108

Gonarthrosis [arthrosis of knee](FG)

1523

5667

1.60

58.24

2.1

2.6

0.81

1.06

g/l

1.70

1307

4839

Any event in cancer register

1832

7167

1.53

58.11

3.7

1.7

1.17

0.57

g/l

7.20

1593

6165

Other specified/unspecified systemic involvement of connective tissue

193

552

3.73

57.90

1.8

2.8

0.70

0.86

g/l

0.21

179

483

Mood disorders, excluding more controls

1916

7783

1.51

57.71

2.2

2.5

0.71

0.86

g/l

1.04

1632

6754

Dialysis

143

332

4.66

57.51

2.6

2.1

0.46

1.26

g/l

1.95

130

300

Fibromyalgia

208

625

3.46

57.20

2.4

2.0

0.57

0.80

g/l

0.47

187

553

Abnormal weight loss

274

974

2.98

57.13

2.1

2.4

0.42

1.06

g/l

3.20

234

842

Hypo-osmolality and hyponatraemia

435

1917

2.34

56.90

2.7

2.1

0.81

1.12

g/l

0.74

366

1596

COPD (mode)

717

2984

1.95

56.75

1.9

2.1

0.76

0.92

g/l

0.56

615

2502

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

147

354

4.55

56.67

2.4

1.4

1.16

0.52

g/l

1.04

130

300

Other disorders of veins

856

4805

1.82

56.60

2.3

2.4

0.75

0.84

g/l

0.26

731

4085

Benzodiazepine use

2016

9786

1.48

56.21

2.2

2.4

0.68

0.89

g/l

2.07

1677

8446

Other cataract

1028

4666

1.74

56.19

2.7

2.5

1.02

0.96

g/l

0.16

876

4048

Pulmonary embolism

718

3837

1.92

56.07

2.8

2.4

0.88

0.97

g/l

0.19

616

3229

Pulmonary heart disease

718

3845

1.92

55.71

2.8

2.4

0.88

0.98

g/l

0.22

616

3234

Other disorders involving the immune mechanism, not elsewhere classified

124

264

5.15

55.70

2.4

2.8

0.47

1.30

g/l

1.87

112

240

Immunodeficiency with predominantly antibody defects

113

223

5.61

55.55

5.1

2.2

0.85

0.64

g/l

0.28

102

208

Other nutritional deficiencies

1204

7266

1.64

55.49

2.1

2.4

0.51

0.79

g/l

3.63

1040

6312

SLE, strict definition

135

309

4.76

55.44

1.9

2.1

0.39

0.89

g/l

1.01

124

276

SLE, ICD10

135

309

4.76

55.44

1.9

2.1

0.39

0.89

g/l

1.01

124

276

Injuries to the hip and thigh

1049

5720

1.71

55.42

2.2

2.4

0.78

1.04

g/l

1.62

832

4835

Immunodeficiencies

163

429

4.07

55.31

4.6

2.5

0.94

0.96

g/l

0.02

145

382

Obesity related asthma

710

3795

1.91

55.19

2.1

2.4

0.64

0.88

g/l

1.04

602

3273

Other acute lower respiratory infections

1089

6275

1.68

54.78

3.4

2.3

0.89

0.97

g/l

0.28

962

5304

Direct fill therapy

325

1282

2.63

54.67

4.2

2.3

1.06

0.92

g/l

0.21

287

1129

Other arthrosis

1095

4682

1.70

54.60

2.2

2.5

0.69

0.96

g/l

1.45

952

4012

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1956

8105

1.49

54.54

2.1

2.5

0.69

0.93

g/l

2.46

1691

6938

Other and unspecified vasculitis limited to skin

112

224

5.62

54.50

2.8

0.62

0.91

g/l

0.42

102

198

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

128

288

4.94

54.05

2.6

1.4

1.26

0.51

g/l

1.09

114

243

Chronic periodontitis, complicated

282

1050

2.83

53.82

3.8

2.5

0.69

1.06

g/l

1.00

257

914

Symptoms and signs involving the digestive system and abdomen

2079

7113

1.48

53.78

2.3

2.4

0.69

0.91

g/l

2.26

1802

6072

Other arrhythmias

1231

5842

1.63

53.77

2.2

2.4

0.62

0.91

g/l

2.52

1031

5034

Non-allergic asthma (mode), excluding more controls

404

1749

2.34

53.75

2.0

1.9

0.79

0.92

g/l

0.22

347

1478

Speech therapy

641

3349

1.97

53.68

2.3

0.73

0.88

g/l

0.51

595

2832

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

140

7.23

53.53

2.7

1.4

1.98

0.53

g/l

2.02

120

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1284

8126

1.60

52.96

2.3

2.4

0.64

0.95

g/l

2.74

1109

6899

Injuries to the thorax

975

5788

1.72

52.93

2.5

2.4

0.74

0.93

g/l

1.08

813

4935

Fracture of rib(s), sternum and thoracic spine

694

3740

1.90

52.81

2.8

2.4

0.81

0.94

g/l

0.46

582

3182

Arthrosis

1451

5085

1.59

52.81

2.2

2.5

0.65

0.97

g/l

2.52

1259

4364

Polyuria

555

2778

2.06

52.76

2.0

2.4

0.75

1.00

g/l

0.87

482

2348

Paroxysmal tachycardia

413

1531

2.33

52.69

2.0

2.2

0.56

1.06

g/l

1.76

351

1320

External causes of morbidity and mortality

1349

4214

1.62

52.56

2.3

2.4

0.76

0.94

g/l

0.83

1159

3685

Persons encountering health services for specific procedures, not carried out

201

625

3.37

52.52

2.2

2.1

0.60

0.93

g/l

0.72

182

556

Acute bronchitis

874

4950

1.76

52.08

3.4

2.2

0.90

0.97

g/l

0.23

773

4154

Hyperparathyroidism

480

2275

2.16

51.27

2.7

2.3

0.73

0.95

g/l

0.69

405

1897

Factors influencing health status and contact with health services

667

1705

1.99

51.05

2.5

2.1

1.20

0.92

g/l

0.68

588

1466

Shoulder lesions

1571

6326

1.54

51.03

2.4

2.5

0.78

0.94

g/l

0.90

1351

5388

Vocal cord dysfunction

262

881

2.83

51.02

2.7

2.5

1.17

0.95

g/l

0.22

219

779

Type 2 diabetes

1985

8121

1.47

50.94

2.0

2.5

0.62

0.93

g/l

4.01

1709

6950

Senile cataract

1423

5691

1.57

50.92

2.7

2.5

0.96

0.93

g/l

0.10

1179

4948

Other gastritis (incl. Duodenitis)

554

2805

2.03

50.89

2.3

2.4

0.78

0.95

g/l

0.48

472

2394

Abdominal and pelvic pain

2054

7113

1.47

50.87

2.4

0.69

0.91

g/l

2.25

1761

6072

Other autoimmune haemolytic anaemias

119

7.88

50.84

3.1

2.4

1.66

0.69

g/l

0.69

103

Other symptoms and signs involving cognitive functions and awareness

993

5615

1.69

50.48

2.1

2.5

0.83

1.08

g/l

1.19

813

4736

Episodal and paroxysmal disorders

2184

7823

1.44

50.26

2.1

2.4

0.65

0.91

g/l

2.84

1878

6725

Sleep disorders (combined)

1981

9003

1.46

50.12

2.2

2.4

0.79

0.86

g/l

0.37

1700

7764

Diseases of pulp and periapical tissues, including avohilmo

2198

8003

1.44

50.04

2.3

2.4

0.81

0.89

g/l

0.46

1879

6871

All influenza

528

2646

2.04

49.68

4.9

2.0

1.55

0.87

g/l

2.23

445

2253

Mood [affective] disorders

1977

9029

1.45

49.61

2.1

2.4

0.68

0.83

g/l

1.01

1690

7779

Temporal arteritis

150

406

4.06

49.49

1.7

3.0

0.30

1.58

g/l

3.90

131

344

In situ neoplasms

729

3869

1.83

49.45

2.5

1.5

0.88

0.46

g/l

2.52

611

3243

Mood disorders

1982

9052

1.45

49.35

2.1

2.4

0.68

0.83

g/l

1.10

1695

7798

Dental pulpitis 2

1554

5221

1.54

49.13

2.3

2.4

0.88

0.94

g/l

0.22

1319

4441

Abnormal findings on examination of urine, without diagnosis

154

424

3.90

49.12

3.6

2.8

0.52

1.24

g/l

1.86

138

373

Dental pulpitis 4

2195

8017

1.44

49.12

2.3

2.4

0.81

0.89

g/l

0.46

1876

6889

Sciatica+with lumbago

985

5660

1.68

49.11

2.2

2.3

0.68

0.81

g/l

0.70

867

4847

Dental pulpitis 1

2194

8022

1.43

48.87

2.3

2.4

0.81

0.89

g/l

0.46

1876

6892

Cardiomyopathy, other and unspecified

233

828

2.96

48.53

2.5

2.2

0.59

1.17

g/l

1.79

204

701

Diabetes, insulin treatment (Kela reimbursement)

2042

8743

1.44

48.51

2.1

2.5

0.68

0.91

g/l

2.25

1767

7475

Insulin medication

1248

6838

1.58

48.47

2.1

2.5

0.53

1.01

g/l

6.08

1071

5803

Hernia of abdominal wall, postoperative

359

1567

2.35

48.13

2.0

2.1

0.68

0.97

g/l

0.91

320

1372

Atherosclerosis, excluding cerebral and coronary sclerosis

1015

4954

1.67

48.08

2.1

2.5

0.61

1.19

g/l

5.99

879

4125

Dental caries 1

1702

5852

1.50

47.86

2.2

2.4

0.91

0.95

g/l

0.13

1452

4993

Dental caries, including avohilmo

1699

5849

1.50

47.53

2.2

2.4

0.91

0.94

g/l

0.11

1449

4990

Any mental disorder

2269

8074

1.42

47.53

2.2

2.5

0.85

0.87

g/l

0.09

1921

6994

Hyperkalaemia

173

525

3.50

47.44

2.9

2.3

0.81

1.39

g/l

0.79

145

448

ILD, hospital admission 2, with pulmonary infections

268

1036

2.71

47.43

2.4

2.0

0.66

0.98

g/l

0.77

237

871

Systemic lupus erythematosus, unspecified

116

267

4.74

47.37

1.9

2.2

0.28

0.68

g/l

0.96

107

238

Anxiety disorders, excluding more controls

1549

6866

1.51

47.20

2.3

2.4

0.61

0.78

g/l

1.44

1352

5983

Agranulocytosis

291

1175

2.58

46.95

3.6

2.3

1.71

0.98

g/l

1.33

260

1020

IgA nephropathy (IgA glomerulonephritis)

199

5.43

46.65

1.7

2.9

0.15

1.21

g/l

2.54

179

Depression

1787

8499

1.46

46.50

2.2

2.4

0.67

0.81

g/l

0.90

1527

7349

Osteonecrosis

182

579

3.34

46.28

7.6

2.2

1.49

1.03

g/l

0.65

160

514

Diabetes medication

2011

8606

1.43

46.18

2.0

2.5

0.64

0.90

g/l

3.11

1732

7364

Coxarthrosis

1066

4475

1.64

46.10

2.2

2.6

0.70

1.09

g/l

3.40

904

3810

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

109

244

4.87

46.08

2.0

2.9

0.19

1.26

g/l

3.00

100

221

Obesity

1115

7008

1.60

46.08

2.0

2.4

0.51

0.79

g/l

3.43

968

6076

Dental pulpitis 2, only avohilmo

1574

5376

1.52

46.03

2.2

2.5

0.84

0.96

g/l

0.52

1328

4570

Non-allergic asthma (mode)

404

1866

2.19

46.02

2.0

1.9

0.79

0.90

g/l

0.20

347

1582

Obesity and other hyperalimentation

1120

7048

1.59

45.90

2.0

2.4

0.51

0.79

g/l

3.49

971

6111

Asthma/COPD (KELA code 203)

1805

8836

1.45

45.79

2.1

2.4

0.75

0.88

g/l

0.71

1543

7562

Viral infections characterized by skin and mucous membrane lesions

807

4734

1.73

45.67

3.6

2.3

1.35

0.79

g/l

2.60

702

4059

Obesity, other/unspecified

621

3378

1.87

45.61

1.7

2.3

0.47

0.79

g/l

2.49

553

2945

Diseases of the digestive system

983

6076

1.64

45.26

2.3

2.4

0.93

0.98

g/l

0.15

835

5115

Giant cell arteritis with polymyalgia rheumatica

150

433

3.80

45.07

1.7

2.8

0.30

1.35

g/l

3.40

131

370

Other functional intestinal disorders

879

5035

1.69

45.02

2.6

2.4

1.06

1.00

g/l

0.15

732

4273

Secondary and unspecified malignant neoplasm of lymph nodes

247

943

2.75

44.97

1.9

2.6

0.54

1.18

g/l

2.74

219

818

Visual disturbances

951

5854

1.65

44.94

2.4

0.75

0.91

g/l

0.75

828

4975

Psychiatric diseases

2195

7846

1.41

44.87

2.2

2.5

0.78

0.86

g/l

0.44

1866

6808

Dental caries 1 and operation codes

1840

6534

1.46

44.83

2.2

2.4

0.84

0.91

g/l

0.27

1564

5584

Symptoms and signs involving speech and voice

706

4020

1.79

44.80

2.6

2.3

0.63

0.91

g/l

1.52

598

3420

Disorders of gallbladder, biliary tract and pancreas

1999

9132

1.42

44.78

2.4

0.82

0.91

g/l

0.46

1697

7833

Conjunctivitis

1316

7575

1.53

44.49

2.3

0.84

0.75

g/l

0.35

1143

6528

Coxibs

605

1678

1.95

44.40

2.2

2.4

0.81

0.95

g/l

0.36

527

1431

Visual disturbances and blindness

1023

6431

1.62

44.32

2.4

0.74

0.93

g/l

1.04

881

5452

Methotrexate

321

1388

2.38

44.17

1.9

2.5

0.70

0.81

g/l

0.26

290

1187

Chronic nephritic syndrome

137

375

3.92

44.11

2.6

2.8

0.35

1.37

g/l

2.78

125

334

Abnormalities of heart beat

685

3845

1.79

43.95

2.2

2.3

0.93

0.90

g/l

0.08

576

3262

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

940

5707

1.64

43.46

2.0

2.2

0.79

0.71

g/l

0.23

813

4928

Other abnormal findings of blood chemistry

140

393

3.81

43.38

4.5

2.4

1.79

1.23

g/l

0.77

131

349

Other anxiety disorders

705

3568

1.77

43.04

1.9

2.2

0.48

0.67

g/l

0.99

630

3131

Urticaria and erythema

665

3760

1.80

42.98

2.4

2.3

0.76

0.79

g/l

0.07

578

3248

Dysphagia

554

2973

1.91

42.82

2.6

2.4

0.83

1.05

g/l

0.64

468

2497

Allergic conjunctivitis

972

5979

1.62

42.81

2.0

2.3

0.78

0.71

g/l

0.22

840

5169

Cutaneous abscess, furuncle and carbuncle

511

2668

1.96

42.79

2.0

2.3

0.66

0.83

g/l

0.55

458

2317

Secondary right heart disease

150

446

3.62

42.79

2.1

2.6

0.76

1.48

g/l

1.19

135

383

Anxiety (asthma-related co-morbidities)

966

4712

1.63

42.74

1.9

2.3

0.44

0.74

g/l

2.69

858

4146

Prurigo nodularis

101

227

4.90

42.68

1.7

3.6

0.40

1.28

g/l

1.63

199

Benign neoplasm: Colon, unspecified

601

3319

1.86

42.64

2.4

0.90

0.97

g/l

0.18

493

2807

Other bacterial intestinal infections

417

2037

2.10

42.44

3.4

2.2

1.07

0.94

g/l

0.25

349

1721

Seropositive rheumatoid arthritis, strict definition

373

1750

2.20

42.37

1.8

2.4

0.70

0.94

g/l

0.75

332

1512

Soft tissue disorders related to use, overuse and pressure

553

2975

1.90

42.29

2.2

2.4

0.71

1.03

g/l

1.52

485

2534

Irritable bowel syndrome

518

2726

1.94

42.25

2.4

2.3

0.61

0.86

g/l

1.16

437

2346

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1170

7662

1.55

42.22

2.2

2.5

0.64

0.95

g/l

2.48

1007

6504

Conduction disorders

645

3006

1.82

41.86

2.3

0.77

1.10

g/l

1.41

547

2512

Other and unspecified immunodeficiencies with predominantly antibody defects

100

7.45

41.63

5.2

2.7

0.34

0.81

g/l

0.71

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1149

5073

1.57

41.58

2.8

1.5

1.14

0.49

g/l

6.14

964

4298

Retention of urine

771

3858

1.72

41.55

2.2

2.5

0.84

1.14

g/l

1.57

655

3238

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

142

415

3.68

41.55

3.0

1.4

1.69

0.39

g/l

3.68

123

356

Endocarditis

118

304

4.16

41.38

1.8

2.3

0.61

1.61

g/l

1.24

104

264

Dental caries 1, only avohilmo

1721

6110

1.46

41.37

2.2

2.5

0.88

0.95

g/l

0.25

1468

5218

Other disorders of lacrimal gland

693

4019

1.76

41.23

2.9

2.4

0.85

0.93

g/l

0.20

582

3438

Diffuse large B-cell lymphoma, helper endpoint

150

457

3.53

41.17

1.7

1.4

0.68

0.38

g/l

0.73

134

390

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

150

457

3.53

41.17

1.7

1.4

0.68

0.38

g/l

0.73

134

390

Benign neoplasm of other and ill-defined parts of digestive system

398

1938

2.12

40.96

2.2

1.5

0.65

0.48

g/l

0.67

345

1638

Dental caries 3

1742

6212

1.45

40.78

2.2

2.4

0.93

0.94

g/l

0.04

1487

5310

All anxiety disorders

976

4935

1.61

40.73

1.9

2.3

0.44

0.73

g/l

2.64

867

4321

Insulin, intermediate and long-acting

1135

7301

1.55

40.70

2.1

2.5

0.49

0.98

g/l

6.78

979

6200

Other (seronegative) rheumatoid arthritis, wide

452

2310

2.01

40.64

2.1

2.3

0.78

0.90

g/l

0.30

396

1961

Other dialysis

112

283

4.31

40.58

2.7

2.9

0.51

1.35

g/l

1.61

103

251

Other coagulation defects

185

639

3.03

40.55

2.7

2.6

0.63

1.13

g/l

1.46

164

568

Subjective visual disturbances

513

2734

1.92

40.52

2.3

0.60

0.84

g/l

0.90

452

2336

Other medical care

840

5023

1.66

40.50

3.9

2.3

1.37

1.01

g/l

1.42

732

4198

Other retinal disorders

1344

7300

1.50

40.49

2.4

2.5

0.96

1.00

g/l

0.13

1103

6178

Acetic acid derivatives and related substances

600

1674

1.89

40.41

2.2

2.4

0.86

0.96

g/l

0.23

527

1427

Spondylopathies in diseases classified elsewhere

121

6.77

40.27

18.2

1.6

4.01

1.02

g/l

2.11

101

Disorders of conjunctiva

1464

8443

1.47

40.04

2.4

2.3

0.85

0.78

g/l

0.24

1270

7259

Early onset COPD, excluding more controls

420

2097

2.05

40.01

2.1

2.0

0.62

0.88

g/l

0.77

368

1802

Nausea and vomiting

538

2868

1.88

39.99

2.8

2.4

0.70

1.02

g/l

1.21

469

2408

Undetermined asthma, excluding more controls

256

1046

2.51

39.87

2.2

1.8

1.02

0.76

g/l

0.27

222

894

Adverse effects, not elsewhere classified

380

1838

2.11

39.57

2.1

2.3

0.71

0.79

g/l

0.19

349

1609

Other CVD

474

2487

1.96

39.53

2.6

2.3

0.81

1.10

g/l

0.80

382

2059

Fracture of shoulder and upper arm

732

4361

1.71

39.33

2.7

2.4

0.82

0.94

g/l

0.44

601

3714

Other abnormalities of plasma proteins

138

6.11

39.11

5.8

3.3

2.60

0.63

g/l

2.75

121

Neurotic, stress-related and somatoform disorders

1574

7810

1.45

39.07

2.3

2.4

0.57

0.78

g/l

2.00

1380

6751

Other and unspecified coagulation defects

137

406

3.56

38.96

2.7

2.6

0.57

1.15

g/l

1.25

123

361

Selective serotonin reuptake inhibitors

1970

7463

1.40

38.91

2.3

2.5

0.70

0.94

g/l

2.31

1693

6414

Hypotension

418

2119

2.04

38.65

2.7

2.3

0.73

1.17

g/l

1.47

331

1756

Gonarthrosis

1283

4910

1.52

38.64

2.1

2.5

0.75

1.01

g/l

1.84

1107

4202

Arthropathies in other diseases classified elsewhere

114

302

4.03

38.42

2.4

2.3

0.92

1.29

g/l

0.32

262

Biological medication for rheuma

297

1319

2.31

38.39

1.6

2.4

0.26

0.79

g/l

4.55

270

1175

Cardiomyopathies, Primary/intrinsic

302

1355

2.30

38.36

1.9

2.3

0.47

1.03

g/l

2.65

265

1134

Noninfective enteritis and colitis

862

5378

1.62

38.33

2.4

2.3

0.91

0.85

g/l

0.18

741

4626

Rash and other nonspecific skin eruption

246

1013

2.52

38.10

2.0

2.4

0.39

1.04

g/l

3.61

221

882

Other diseases of liver

385

1902

2.08

38.06

2.2

2.3

0.51

0.87

g/l

1.85

330

1657

Other disorders of teeth and supporting structures

442

2291

1.97

37.97

3.2

2.2

1.33

0.91

g/l

1.04

372

1954

Anxiety disorders

1589

7916

1.44

37.96

2.3

2.4

0.59

0.78

g/l

1.66

1391

6835

Insulin, combination of fast acting with intermediate-acting or long-acting

1249

7802

1.49

37.92

2.1

2.4

0.53

1.01

g/l

6.44

1072

6624

Cardiomyopathy in other diseases

10.93

37.88

9.3

2.3

0.96

0.90

g/l

0.03

Other diseases of pericardium

134

400

3.56

37.79

2.0

2.4

0.63

1.43

g/l

1.03

113

340

Presence of cardiac and vascular implants and grafts

1064

5256

1.56

37.79

1.9

2.4

0.81

1.03

g/l

1.06

886

4453

Injury, poisoning and certain other consequences of external causes

1062

3398

1.58

37.72

2.2

2.5

0.82

1.06

g/l

1.16

915

2958

Hard cardiovascular diseases

1634

7408

1.43

37.60

2.5

0.77

0.95

g/l

1.24

1406

6316

Atopic dermatitis

858

4557

1.62

37.59

1.8

2.2

0.56

0.70

g/l

0.64

751

3979

Cardiomyopathy (excluding other)

309

1413

2.26

37.48

1.9

2.2

0.51

1.02

g/l

2.23

271

1177

Dental caries 3 and operation codes

1857

6832

1.41

37.36

2.3

2.4

0.89

0.90

g/l

0.05

1586

5847

Injuries to the shoulder and upper arm

1610

9591

1.42

37.28

2.6

2.4

0.79

0.89

g/l

0.61

1348

8239

Other respiratory diseases principally affecting the interstitium

442

2313

1.97

37.26

2.3

0.70

1.05

g/l

1.36

392

1942

Voice disturbances

554

3106

1.82

37.22

2.7

2.4

0.66

0.88

g/l

0.81

474

2655

Other headache syndromes

765

4676

1.66

37.16

2.0

2.5

0.65

0.86

g/l

0.99

672

4028

ILD, hospital admissions 3, with pneumonia sepsis

230

932

2.58

37.11

2.2

2.1

0.57

1.09

g/l

1.45

205

783

Lumbar disc prolapse

1181

6285

1.51

37.08

2.4

2.3

0.91

0.80

g/l

0.47

1044

5392

Overexertion and strenuous or repetitive movements

231

935

2.56

37.05

2.5

2.4

0.63

1.07

g/l

1.28

198

832

Other and unspecified types of non-Hodgkin lymphoma, hilmo

142

447

3.41

37.00

3.0

2.7

1.69

1.41

g/l

0.30

123

386

Amputation

270

1177

2.39

36.90

1.8

2.5

0.59

1.23

g/l

2.02

244

984

Benign neoplasm: Sigmoid colon

403

2050

2.02

36.81

2.4

1.5

0.99

0.52

g/l

1.52

352

1727

Parodontitis or/and operation codes

1201

4762

1.52

36.61

2.4

2.5

0.70

0.90

g/l

1.14

1034

4095

Bacterial intestinal infections, IBD co-morbidities

417

2152

1.99

36.46

3.5

2.2

1.03

0.88

g/l

0.30

350

1823

Unspecified fall

945

6058

1.57

36.36

2.4

0.77

0.94

g/l

0.76

764

5169

Other pulmonary heart/vessel disease

152

504

3.21

36.24

2.1

2.5

0.76

1.48

g/l

1.25

135

437

Other and unspecified effects of external causes

476

2564

1.89

36.20

2.0

2.3

0.70

0.79

g/l

0.26

431

2239

Cardiodefibrillation

851

5388

1.61

36.01

2.4

2.5

0.73

1.07

g/l

2.23

731

4538

Non-Hodgkin lymphoma, all

142

455

3.35

36.00

3.8

2.7

1.76

1.39

g/l

0.37

125

390

Asthma and allergy, excluding more controls

194

717

2.72

36.00

1.9

1.7

0.53

0.63

g/l

0.19

169

634

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1045

4689

1.55

35.97

2.9

1.5

1.22

0.49

g/l

6.09

882

3953

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

8.08

35.96

3.7

1.3

1.06

0.53

g/l

0.55

Disorder of lipoprotein metabolism, unspecified

329

1569

2.16

35.93

1.9

2.2

0.60

1.16

g/l

1.89

284

1320

Volume depletion

225

914

2.55

35.88

2.0

2.2

0.46

1.34

g/l

3.68

186

761

Zoster [herpes zoster]

415

2152

1.98

35.87

3.8

2.3

1.61

0.88

g/l

1.89

351

1821

Abnormal involuntary movements

306

1419

2.22

35.86

2.0

2.4

0.48

1.07

g/l

3.09

266

1225

Concussion

801

4312

1.62

35.33

2.2

2.4

0.72

0.98

g/l

0.98

672

3727

Other reaction to severe stress, and adjustment disorders

564

3219

1.77

35.29

2.6

2.2

0.56

0.68

g/l

0.42

506

2833

Other noninfective gastroenteritis and colitis

484

2643

1.87

35.28

2.7

2.2

0.84

g/l

0.02

417

2248

Postmenopausal osteoporosis with pathological fracture

189

717

2.80

35.23

1.8

2.3

0.59

0.90

g/l

0.60

144

599

Polyarthrosis

429

2164

1.95

35.11

2.5

2.6

0.78

1.05

g/l

0.87

360

1824

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1010

4552

1.55

35.09

2.8

1.5

1.19

0.50

g/l

5.66

854

3835

Sleep apnoea

1789

8823

1.39

35.03

2.2

2.5

0.79

0.86

g/l

0.34

1528

7624

Fracture of femur

600

3190

1.75

34.90

2.4

2.3

0.95

1.12

g/l

0.47

442

2648

Special screening examination for infectious and parasitic diseases

355

1282

2.09

34.78

2.4

2.2

0.52

0.66

g/l

0.36

312

1147

Undetermined asthma

256

1115

2.35

34.64

2.2

1.8

1.02

0.73

g/l

0.31

222

944

Sleep apnoea, including avohilmo

1871

8903

1.38

34.49

2.2

2.5

0.76

0.87

g/l

0.63

1593

7695

Rotator cuff syndrome

1203

6088

1.48

34.41

2.4

2.5

0.74

0.94

g/l

1.13

1030

5178

Pleural effusion

386

1986

2.00

34.28

2.8

2.3

0.49

1.17

g/l

5.85

338

1671

Other diseases of the digestive system

701

4289

1.67

34.27

2.1

2.4

0.93

1.06

g/l

0.39

591

3590

Type 2 diabetes, definitions combined

1833

7984

1.38

34.23

2.0

2.6

0.69

0.95

g/l

2.35

1556

6825

ILD, hospital admissions

376

1921

2.02

34.16

2.4

0.72

1.04

g/l

0.96

334

1624

Amputation of toe

202

802

2.65

34.14

1.7

2.6

0.39

1.25

g/l

3.98

182

685

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1018

4611

1.54

34.14

2.9

1.5

1.20

0.49

g/l

6.04

858

3882

GI-bleeding

702

4302

1.66

34.08

2.2

2.3

0.98

1.07

g/l

0.25

593

3593

Other interstitial pulmonary diseases

380

1954

2.01

33.88

2.4

2.3

0.72

1.03

g/l

0.97

337

1649

Acute upper respiratory infections of multiple and unspecified sites

1307

6797

1.45

33.83

3.5

2.2

0.82

0.78

g/l

0.17

1126

5860

Acute sinusitis

876

5260

1.57

33.77

3.3

2.1

0.81

0.70

g/l

0.42

750

4588

Diabetic retinopathy, excluding more controls

508

1557

1.88

33.72

1.9

2.2

0.46

0.90

g/l

2.74

443

1321

Dental pulpitis 4, only avohilmo

2147

8371

1.35

33.69

2.1

2.5

0.75

0.92

g/l

1.31

1845

7181

Diffuse large B-cell lymphoma

150

516

3.11

33.69

1.7

2.9

0.68

1.50

g/l

1.96

134

443

Interstitial lung disease

380

1960

2.00

33.58

2.4

2.3

0.72

1.03

g/l

0.98

337

1655

Interstitial lung disease endpoints

380

1960

2.00

33.58

2.4

2.3

0.72

1.03

g/l

0.98

337

1655

Osteopathy in diseases classified elsewhere

8.80

33.54

14.7

3.0

1.51

0.63

g/l

0.90

Reactive arthropathies, FINNGEN

154

534

2.99

33.45

2.5

2.7

0.35

1.30

g/l

3.56

130

459

Asthma and allergy

194

745

2.62

33.39

1.9

1.8

0.53

0.68

g/l

0.32

169

654

Type 2 diabetes, strict (exclude DM1)

1837

8042

1.38

33.36

2.0

2.6

0.69

0.94

g/l

2.32

1561

6873

COPD

986

5385

1.53

33.24

2.0

2.5

0.88

1.06

g/l

0.64

846

4509

Chronic sinusitis

793

5025

1.60

33.23

2.4

0.84

0.82

g/l

0.05

694

4328

Deposits [accretions] on teeth

158

537

2.95

33.18

5.2

2.1

0.74

1.07

g/l

0.64

147

475

Superficial injury of head

447

2431

1.87

33.13

2.0

2.3

0.50

0.86

g/l

2.00

379

2062

Convulsions, not elsewhere classified

377

1912

1.98

33.02

1.7

2.1

0.55

0.91

g/l

1.70

329

1630

Benign neoplasm: Ascending colon

303

1451

2.16

32.87

2.4

1.5

1.05

0.52

g/l

1.66

257

1223

Dental caries 3, only avohilmo

1741

6457

1.39

32.85

2.2

2.5

0.87

0.95

g/l

0.34

1486

5525

Disorders of lacrimal system

809

5173

1.59

32.82

2.8

2.3

0.86

0.91

g/l

0.14

679

4397

Diseases of the myoneural junction and muscle

288

1353

2.20

32.79

1.7

2.3

0.36

1.02

g/l

4.60

239

1155

Other (not insulin) diabetes medications

1876

8351

1.37

32.68

2.0

2.5

0.67

0.93

g/l

2.80

1610

7124

Artrosis, including avohilmo

1649

6536

1.40

32.30

2.2

2.5

0.80

0.90

g/l

0.46

1415

5636

Other diseases of anus and rectum

594

3531

1.71

32.27

2.5

2.4

0.84

1.03

g/l

0.59

477

2988

Peripheral artery operations in Hilmo

319

1569

2.10

32.10

1.9

2.4

0.66

1.28

g/l

2.25

288

1317

Other diseases of upper respiratory tract

2175

8555

1.34

31.93

2.3

2.4

0.93

0.87

g/l

0.22

1870

7310

Open wound of head

987

6521

1.51

31.89

2.3

2.4

0.72

0.97

g/l

1.68

823

5574

Personality disorders, excluding more controls

384

2011

1.94

31.82

1.9

2.3

0.29

0.70

g/l

3.78

338

1802

Other neurological diseases

1458

8418

1.41

31.80

2.5

0.71

1.01

g/l

3.12

1225

7137

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

341

1727

2.04

31.73

1.6

2.4

0.53

1.02

g/l

1.99

288

1488

Pericarditis

105

300

3.70

31.69

2.2

2.3

1.06

1.61

g/l

0.44

259

Open wound of lower leg

310

1516

2.10

31.60

2.2

0.63

0.99

g/l

1.29

265

1305

Viral pneumonia (unknown virus, not influenza)

157

569

2.87

31.57

3.1

2.6

0.68

1.08

g/l

0.71

131

503

Dental pulpitis 1, only avohilmo

2138

8417

1.34

31.50

2.1

2.5

0.72

0.92

g/l

1.77

1834

7219

AV-block

396

1907

1.93

31.44

2.3

2.2

0.85

1.21

g/l

1.12

333

1571

Type 1 diabetes

462

2578

1.82

31.28

2.0

2.3

0.51

0.89

g/l

1.77

412

2237

Urticaria

499

2852

1.78

31.27

2.4

2.2

0.65

0.77

g/l

0.33

435

2478

Fibrosis and cirrhosis of liver

199

818

2.55

31.24

1.6

2.7

0.84

1.13

g/l

0.43

171

715

In situ neoplasms

729

4609

1.61

31.17

2.5

2.4

0.88

0.95

g/l

0.19

611

3865

Dental operations, only avohilmo

1501

5490

1.41

31.14

2.3

2.4

0.92

g/l

0.02

1275

4691

Idiopathic thrombocytopenic purpura

272

3.86

31.04

2.5

2.8

1.07

1.06

g/l

0.01

237

Iron deficiency anaemia secondary to blood loss (chronic)

354

1830

1.99

30.91

2.2

2.3

1.14

1.00

g/l

0.24

279

1549

Benign neoplasm: Transverse colon

244

1101

2.30

30.87

2.5

1.5

0.81

0.54

g/l

0.60

205

927

Dental operations

1412

5134

1.43

30.63

2.4

2.3

1.01

0.88

g/l

0.52

1194

4383

DVT of lower extremities

424

2333

1.86

30.52

3.1

2.3

1.55

0.86

g/l

1.99

355

1982

Enterocolitis due to Clostridium difficile

262

1221

2.22

30.49

4.0

2.2

1.19

0.96

g/l

0.34

224

1038

Insulin, fast-acting

695

4362

1.62

30.47

2.0

2.3

0.39

0.90

g/l

5.63

608

3737

Other/unspecified cytomegaloviral diseases

150

5.03

30.39

6.3

2.7

0.56

1.22

g/l

0.85

138

Stroke, excluding SAH

1289

6779

1.43

30.34

2.4

2.5

0.75

1.06

g/l

2.28

1087

5724

Type 2 diabetes, definitions combined, including avohilmo

1812

7967

1.36

30.32

2.0

2.6

0.66

0.94

g/l

3.00

1548

6811

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

258

3.89

30.23

4.8

1.4

1.63

0.46

g/l

1.05

221

Trochanteric bursitis

290

1408

2.12

30.19

2.4

2.3

0.68

1.00

g/l

0.90

255

1189

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

204

860

2.45

30.10

3.4

2.3

1.23

1.04

g/l

0.26

179

748

Need for immunization against other single viral diseases

156

4.87

29.85

2.7

2.4

0.51

0.94

g/l

0.55

142

Cellulitis

431

2398

1.83

29.81

2.7

2.3

0.81

0.90

g/l

0.18

382

2066

Stroke, including SAH

1336

7065

1.42

29.75

2.5

0.74

1.06

g/l

2.61

1125

5977

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

6.51

29.44

3.7

2.2

1.06

0.92

g/l

0.09

Obesity due to excess calories

771

4996

1.56

29.42

2.0

2.5

0.50

0.83

g/l

3.48

667

4342

Phlebitis and thrombophlebitis (not including DVT)

464

2650

1.79

29.42

2.9

2.3

0.91

0.84

g/l

0.17

401

2270

Migraine

721

3891

1.59

29.32

2.0

2.3

0.50

0.73

g/l

1.48

640

3413

Other inflammation of eyelid

287

1405

2.10

29.30

2.9

2.4

0.94

0.95

g/l

0.02

239

1225

Recurrent or chronic depression

657

2929

1.64

29.19

2.0

2.3

0.50

0.79

g/l

1.78

581

2605

Heart failure and hypertrophic cardiomyopathy

177

4.64

29.14

3.1

2.6

0.83

1.42

g/l

0.51

151

Allergic asthma (mode), excluding more controls

339

1721

1.96

29.06

2.0

1.8

0.61

0.67

g/l

0.16

305

1498

Cytomegalovirus infection, IBD co-morbidity

185

4.45

28.99

5.9

2.6

0.50

1.03

g/l

0.77

168

Tumor necrosis factor alpha inhibitors

246

1137

2.21

28.97

1.6

2.4

0.30

0.74

g/l

2.86

223

1026

Later onset COPD, excluding more controls

471

2097

1.79

28.77

1.7

2.1

0.72

0.96

g/l

0.77

401

1713

Lichen simplex chronicus and prurigo

165

647

2.66

28.58

2.1

2.8

0.46

1.11

g/l

2.31

143

560

Carcinoma in situ of skin of scalp and neck

247

3.96

28.55

2.1

1.4

0.91

0.49

g/l

0.50

208

Hypertrophic cardiomyopathy

124

421

3.13

28.46

3.0

0.65

1.39

g/l

1.33

111

368

Cytomegaloviral disease

192

4.32

28.43

5.8

2.6

0.49

0.92

g/l

0.62

176

Ischaemic Stroke, excluding all haemorrhages

1218

6537

1.43

28.33

2.4

2.5

0.74

1.08

g/l

2.76

1024

5500

Pacemaker

741

4677

1.57

28.26

2.2

2.4

0.99

1.13

g/l

0.39

606

3871

Spondyloarthritis

348

1840

1.93

28.26

2.3

0.85

0.92

g/l

0.13

308

1573

Substance abuse, excluding more controls

995

5975

1.47

28.20

1.7

2.5

0.55

0.92

g/l

2.47

828

5208

ILD, hospital admissions 1, main diag only

330

1725

1.98

28.17

2.4

0.67

1.04

g/l

1.14

295

1466

Rheumatism, unspecified

285

1412

2.07

28.08

2.3

2.4

0.78

0.95

g/l

0.36

256

1197

Other diseases of intestine

275

1349

2.10

27.96

2.8

2.2

0.87

1.00

g/l

0.23

240

1144

Benign neoplasm of other and ill-defined parts of digestive system

398

2216

1.84

27.71

2.2

2.4

0.65

0.94

g/l

1.20

345

1890

Acute upper respiratory infections

1953

9326

1.32

27.66

3.2

2.2

0.97

0.84

g/l

0.65

1677

7990

Injuries to the knee and lower leg

2170

9586

1.30

27.59

2.2

2.4

0.59

0.90

g/l

4.66

1842

8259

Deforming dorsopathies

495

2931

1.71

27.43

2.4

2.3

0.86

0.87

g/l

0.04

419

2488

Carcinoma in situ of skin of other and unspecified parts of face

202

889

2.37

27.28

2.3

1.5

0.79

0.53

g/l

0.61

178

726

Migraine with aura

352

1887

1.89

27.25

1.6

2.3

0.33

0.72

g/l

2.81

315

1655

Sequelae of external causes of morbidity and mortality

511

3064

1.70

27.20

2.7

2.3

0.81

0.90

g/l

0.21

456

2622

Eosinophilic disease (BM)

5.80

27.16

2.4

1.5

0.49

0.90

g/l

0.39

Failure and rejection of transplanted organs and tissues

105

5.69

27.15

7.5

2.6

0.27

1.38

g/l

1.52

Pyoderma gangrenosum

7.43

27.05

2.3

2.1

0.40

1.01

g/l

0.62

Reactive arthropathies

180

753

2.46

26.95

2.3

2.5

0.31

1.07

g/l

3.78

152

658

Calcific aortic valvular stenosis, operated

672

4229

1.59

26.87

2.4

1.01

1.12

g/l

0.24

569

3491

Calcific aortic valvular stenosis

672

4229

1.59

26.87

2.4

1.01

1.12

g/l

0.24

569

3491

Nonalcoholic fatty liver disease

199

873

2.35

26.85

2.2

2.6

0.52

1.04

g/l

1.60

172

777

Calcific aortic valvular stenosis, including rheumatic fever

674

4246

1.58

26.73

2.4

1.01

1.12

g/l

0.25

570

3506

Somatoform disorder

305

1574

1.98

26.72

2.5

2.3

0.60

0.90

g/l

1.02

266

1375

Other chronic obstructive pulmonary disease

926

5269

1.48

26.71

1.9

2.5

0.79

1.07

g/l

1.35

793

4407

Calcific aortic valvular stenosis, diagnosis (helper)

671

4228

1.58

26.69

2.4

1.01

1.12

g/l

0.24

568

3490

Operations 2 for CAVS

671

4228

1.58

26.69

2.4

1.01

1.12

g/l

0.24

568

3490

Insulin, fast-acting or short human

698

4526

1.56

26.63

2.0

2.3

0.38

0.90

g/l

5.74

611

3869

Myeloproliferative diseases

216

988

2.27

26.55

3.1

2.5

1.33

1.02

g/l

0.58

186

854

Disorders of continuity of bone

192

833

2.37

26.52

3.4

2.1

0.93

0.81

g/l

0.15

169

743

Functional dyspepsia

491

2932

1.70

26.44

2.5

2.4

0.81

0.90

g/l

0.21

422

2529

Biguanides

1819

8515

1.33

26.43

2.1

2.5

0.70

0.93

g/l

1.97

1565

7268

Diseases of spleen

143

4.80

26.35

2.3

2.5

0.56

0.95

g/l

0.41

125

Phobic anxiety disorders

178

746

2.42

26.29

2.1

0.27

0.65

g/l

1.90

162

676

1056

6838

1.43

26.10

1.7

2.5

0.55

0.94

g/l

2.85

891

5930

Alcohol use disorder, Swedish definition

1016

6608

1.44

26.10

1.7

2.5

0.56

0.94

g/l

2.58

856

5734

Spondylopathies (FG)

227

1060

2.18

26.06

1.9

2.6

0.74

1.06

g/l

0.68

201

927

Fungal Sepsis

106

346

3.24

26.01

2.9

2.6

0.62

1.33

g/l

1.64

301

Cerebral palsy and other paralytic syndromes

239

1148

2.14

25.70

2.0

2.4

0.50

1.01

g/l

1.59

211

1004

Essential (haemorrhagic) thrombocythaemia

110

370

3.15

25.68

2.6

1.4

1.20

0.41

g/l

1.74

319

Other diseases of hard tissues of teeth

1085

5716

1.43

25.66

2.9

2.2

0.77

0.84

g/l

0.28

931

4921

Charcot foot

159

4.53

25.64

2.5

3.1

0.89

1.73

g/l

0.65

143

Osteomyelitis

157

634

2.58

25.62

2.1

2.2

0.49

1.11

g/l

1.30

136

558

Drug-induced osteoporosis with pathological fracture

169

4.49

25.58

1.6

2.7

0.25

0.72

g/l

1.09

148

Progressive vascular leukoencephalopathy

109

367

3.18

25.54

2.3

2.6

0.71

1.34

g/l

0.96

303

Allergic asthma (mode)

339

1798

1.87

25.52

2.0

1.8

0.61

0.65

g/l

0.11

305

1561

Oxicams

483

1607

1.73

25.22

2.4

0.77

1.00

g/l

0.65

413

1363

Marginal zone B-cell lymphoma

6.14

25.16

1.9

2.3

2.12

0.77

g/l

0.91

Injuries to the elbow and forearm

1205

7903

1.39

25.11

2.2

2.4

0.64

0.84

g/l

1.42

1008

6798

Invasive ventilation

181

787

2.39

25.11

2.4

1.34

1.25

g/l

0.06

154

682

Other symptoms and signs involving the urinary system

235

1135

2.13

25.02

2.2

2.6

0.86

1.11

g/l

0.52

223

955

Secondary uncertain malignant neoplasm

294

1538

1.97

25.01

2.0

2.4

0.71

1.04

g/l

1.11

255

1302

Myeloproliferative diseases (CML excluded)

198

897

2.30

24.98

3.2

2.5

1.38

1.09

g/l

0.49

171

775

Hypokalaemia

241

1176

2.11

24.89

2.8

2.2

0.64

1.12

g/l

1.47

203

995

1094

7008

1.41

24.88

1.7

2.5

0.56

0.94

g/l

2.77

924

6083

Carcinoma in situ of skin of scalp and neck

273

3.57

24.59

2.1

2.7

0.91

1.29

g/l

0.34

235

Diabetic neuropathy

261

1313

2.04

24.57

2.3

2.1

0.68

0.76

g/l

0.12

228

1115

Abnormal serum enzyme levels

627

4000

1.57

24.54

2.2

2.5

0.98

0.99

g/l

0.02

553

3412

L01XX Other antineoplastic agents

161

674

2.51

24.53

4.4

2.7

1.60

1.20

g/l

0.44

145

583

Other disorders of eye and adnexa

263

1333

2.02

24.38

2.1

2.3

0.66

0.88

g/l

0.41

238

1163

Rare circulating lymphoid malignancy

298

3.35

24.30

4.8

3.0

1.63

1.27

g/l

0.20

263

Basal cell carcinoma, including avohilmo

1206

6924

1.39

24.22

2.8

2.4

1.18

1.03

g/l

0.54

1006

5786

Other disorders of bone

344

1905

1.84

24.21

3.7

2.0

0.89

0.82

g/l

0.14

295

1682

Mixed and other personality disorders

143

565

2.60

24.20

2.1

2.2

0.08

0.66

g/l

5.82

130

516

Metatarsalgia

191

863

2.27

24.01

2.5

2.1

0.71

0.95

g/l

0.52

165

744

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

588

3762

1.59

23.97

2.6

2.3

0.56

0.89

g/l

1.75

511

3223

Elevated blood glucose level

177

777

2.35

23.91

2.0

2.3

0.34

0.93

g/l

3.02

146

682

Other and unspecified drugs and medicaments

185

828

2.31

23.91

3.3

2.4

1.18

1.06

g/l

0.13

160

724

Cirrhosis of liver, NAS

136

532

2.69

23.89

1.7

2.8

0.90

1.42

g/l

0.64

118

464

Benign neoplasm: Stomach

215

1023

2.17

23.87

2.4

1.5

0.70

0.50

g/l

0.41

181

865

Basal cell carcinoma

1179

6849

1.39

23.74

2.8

2.4

1.15

1.05

g/l

0.34

985

5722

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

277

3.36

23.54

1.5

2.2

0.48

0.96

g/l

0.88

255

Other diseases of arteries and capillaries

204

956

2.20

23.53

2.3

2.5

0.75

1.01

g/l

0.51

174

816

Psoriasis

528

3311

1.62

23.51

1.9

2.4

0.77

0.90

g/l

0.29

461

2858

Other chronic obstructive pulmonary disease, including avohilmo

1105

6649

1.40

23.47

1.9

2.6

0.90

1.04

g/l

0.40

946

5613

Oter anti-inflammatory and antirheumatic agents, non-steroids

473

1557

1.71

23.43

2.5

0.92

1.03

g/l

0.24

397

1315

Psoriatic and enteropathic arthropathies

201

935

2.20

23.42

1.8

2.6

0.84

1.16

g/l

0.46

175

816

Injuries to the ankle and foot

1068

7003

1.40

23.39

2.1

2.3

0.59

0.76

g/l

0.88

934

6122

Disorders of muscles

200

931

2.20

23.34

1.7

2.1

0.58

1.00

g/l

0.71

180

803

Ischemic heart diseases

1550

7348

1.33

23.33

2.5

0.82

0.95

g/l

0.71

1354

6231

Other pleural conditions

246

1242

2.04

23.30

2.7

2.4

0.72

1.23

g/l

1.71

212

1040

Hypoparathyroidism

109

386

2.99

23.29

2.1

2.6

0.36

1.00

g/l

1.33

336

Papulosquamous disorders

726

4897

1.50

23.17

2.2

2.4

0.87

0.90

g/l

0.06

632

4216

Benign neoplasm: Rectum, anus and anal canal

394

2309

1.74

22.99

2.5

1.5

0.93

0.50

g/l

1.50

346

1952

Other enthesopathies

514

3218

1.62

22.97

2.2

2.3

0.69

0.93

g/l

1.03

441

2757

Implicit fungal Sepsis

324

3.17

22.95

3.1

2.6

0.68

1.39

g/l

1.46

282

Ischaemic heart disease, wide definition

1537

7291

1.33

22.95

2.5

0.80

0.97

g/l

1.02

1340

6183

Type 1 diabetes, wide definition, subgroup 1

349

1970

1.80

22.93

2.0

2.2

0.39

0.93

g/l

2.46

307

1724

Infection of intervertebral disc (pyogenic)

139

4.66

22.91

2.4

0.54

0.89

g/l

0.54

119

Pneumonia derived septicemia

303

3.23

22.90

5.1

2.8

4.11

0.99

g/l

2.39

264

Diseases of external ear

616

4027

1.55

22.86

2.1

2.4

0.79

0.88

g/l

0.20

489

3458

Diseases of salivary glands

350

1986

1.79

22.76

2.4

2.2

0.54

0.90

g/l

1.95

291

1685

Budesonide

227

1119

2.07

22.70

2.3

2.5

0.65

0.82

g/l

0.31

192

968

Complications of internal orthopaedic prosthetic devices, implants and grafts

478

2958

1.65

22.66

2.1

2.3

0.59

0.98

g/l

2.35

398

2471

Disorders of skin appendages

762

5205

1.48

22.63

2.3

1.01

0.76

g/l

0.85

684

4502

Other and unspecified acquired haemolytic anaemias

5.67

22.62

3.0

1.8

0.58

0.71

g/l

0.11

Renal tubulo-interstitial disorders in diseases classified elsewhere

5.74

22.61

6.6

2.3

0.91

1.06

g/l

0.10

Injuries to unspecified part of trunk, limb or body region

205

978

2.16

22.55

1.7

2.5

0.90

1.07

g/l

0.26

175

859

Other enthesopathy of foot (+metatarsalgia)

196

919

2.19

22.48

2.5

2.2

0.69

0.97

g/l

0.67

170

795

Behavioural syndromes associated with physiological disturbances and physical factors

463

2837

1.65

22.46

2.1

0.55

0.72

g/l

0.52

398

2484

Pyogenic arthritis

147

613

2.48

22.33

2.8

2.4

0.86

1.25

g/l

0.66

125

522

L04AC Interleukin inhibitors

104

365

2.96

22.32

1.8

2.1

0.05

0.79

g/l

3.66

335

Hypothyroidism, strict autoimmune

1223

5966

1.37

22.15

2.0

2.6

0.81

0.98

g/l

0.80

1050

5049

Disorders of adult personality and behaviour

407

2423

1.70

22.15

1.9

2.2

0.27

0.75

g/l

5.30

357

2156

Superficial injury of lower leg

415

2487

1.69

22.12

2.0

2.2

0.53

0.92

g/l

1.66

344

2142

Nonorganic sleeping disorders, excluding more controls

280

1497

1.90

22.05

1.8

2.4

0.61

0.83

g/l

0.53

244

1318

Benign neoplasm: Sigmoid colon

403

2408

1.71

22.01

2.4

0.99

g/l

0.00

352

2044

Pain in thoracic spine

263

1381

1.94

21.96

3.0

2.2

0.91

0.87

g/l

0.06

234

1185

Meniscus derangement

990

4840

1.41

21.83

2.4

2.5

0.79

0.94

g/l

0.71

825

4162

Other specified and unspecified disorders of eye and adnexa

105

377

2.92

21.78

2.3

2.6

0.94

1.14

g/l

0.13

334

Benign neoplasm: Ascending colon

303

1677

1.86

21.77

2.4

1.05

1.06

g/l

0.01

257

1425

Bipolar affective disorders

280

1504

1.89

21.72

1.9

2.4

0.45

0.87

g/l

1.71

248

1335

Benign neoplasm: Rectum

350

2018

1.77

21.72

2.4

1.5

0.78

0.53

g/l

0.85

310

1703

Memory loss

231

1172

2.04

21.70

2.1

2.5

0.57

1.10

g/l

2.05

192

1009

Benign neoplasm: Transverse colon

244

1263

2.00

21.63

2.5

0.81

1.14

g/l

0.76

205

1088

Mycoses

483

3028

1.62

21.60

2.9

2.3

0.72

0.87

g/l

0.50

420

2596

Generalized anxiety disorder

207

1004

2.09

21.56

1.8

2.4

0.37

0.69

g/l

1.03

183

898

Sequelae of cerebrovascular disease

736

4426

1.48

21.46

2.0

2.4

0.78

1.11

g/l

1.33

600

3717

Malignant neoplasm of skin

1284

7251

1.35

21.37

2.7

2.5

1.03

1.06

g/l

0.09

1068

6102

Filling of root of tooth

264

3.31

21.31

4.5

2.9

0.92

0.95

g/l

0.03

245

General examination and investigation of persons without complaint and reported diagnosis

1058

4053

1.40

21.24

2.3

2.4

0.81

0.88

g/l

0.28

897

3470

Migraine without aura

257

1353

1.92

21.17

2.2

0.28

0.59

g/l

1.94

229

1206

Benign neoplasm: Caecum

225

1141

2.03

21.11

2.8

1.5

1.06

0.51

g/l

1.35

197

960

Fenamates

296

1078

1.88

21.07

2.2

2.4

0.47

0.85

g/l

1.63

258

917

Cholelithiasis, broad definition with cholecystitis

1621

8598

1.30

21.05

2.4

0.95

0.93

g/l

0.06

1367

7348

Other/unspecified reactive arthropathies

143

606

2.44

21.02

2.6

0.37

1.05

g/l

2.41

123

542

Gastric ulcer

379

2253

1.72

21.02

2.0

2.4

0.64

1.10

g/l

1.76

316

1897

Other peripheral vascular diseases

175

809

2.23

20.95

1.8

2.5

0.57

1.01

g/l

1.19

156

711

Gastroduodenal ulcer

536

3464

1.57

20.82

2.0

2.5

0.71

1.11

g/l

1.81

454

2924

Valvular operations

295

1638

1.84

20.81

1.9

2.2

1.16

1.15

g/l

0.02

260

1356

Decubitus ulcer and pressure area

141

598

2.45

20.80

1.6

2.5

0.19

1.16

g/l

5.20

112

503

Pneumococcal septicemia

294

3.15

20.80

5.1

2.9

4.21

1.03

g/l

2.27

255

Abnormal findings in nipple discharge synovial fluid wound secretions

114

4.72

20.79

3.5

2.5

1.25

0.84

g/l

0.25

102

Other viral diseases

428

2619

1.65

20.76

3.3

2.2

0.80

0.75

g/l

0.08

389

2298

Other and unspecified aplastic anaemias

5.22

20.66

1.6

2.4

0.58

0.74

g/l

0.17

Other embolism and thrombosis

267

1444

1.89

20.54

3.0

2.3

1.02

0.96

g/l

0.09

234

1225

Other general symptoms and signs

317

2.99

20.53

1.5

2.6

1.20

1.14

g/l

0.04

276

Adalimumab

151

661

2.34

20.49

1.4

2.3

0.21

0.80

g/l

3.26

138

596

Thoracic aortic aneurysm

298

1671

1.83

20.48

2.4

2.5

0.82

1.14

g/l

0.73

243

1434

All influenza (not pneumonia)

265

1428

1.89

20.47

4.9

2.0

1.63

0.87

g/l

1.28

222

1223

Benign neoplasm of other and unspecified endocrine glands

241

1262

1.95

20.46

2.4

1.5

0.43

0.47

g/l

0.12

203

1077

Cramp and spasm

108

409

2.75

20.19

2.7

2.6

1.05

1.08

g/l

0.03

367

Disorders of sclera, cornea, iris and ciliary body

934

6765

1.39

20.17

2.3

2.4

0.82

0.83

g/l

0.01

814

5804

Carcinoma in situ of skin of other and unspecified parts of face

202

1006

2.09

20.10

2.3

2.4

0.79

1.23

g/l

1.08

178

836

Sequelae of other external causes

125

510

2.54

20.05

3.0

2.6

0.69

1.27

g/l

1.08

118

451

Paracetamol of NSAID medication

290

777

1.90

20.02

2.7

2.1

1.04

0.93

g/l

0.14

254

678

Substance abuse

995

6961

1.38

19.96

1.7

2.5

0.55

0.93

g/l

2.56

828

6045

Abnormal findings on diagnostic imaging of other body structures

263

1430

1.88

19.94

2.9

2.4

1.24

0.79

g/l

0.77

234

1234

Heart failure and coronary heart disease

745

3855

1.46

19.93

2.1

2.5

0.70

1.22

g/l

3.91

638

3171

Aortic aneurysm

482

3030

1.59

19.86

2.4

2.5

0.88

1.28

g/l

1.35

387

2568

Other encephalitis

225

3.42

19.76

1.9

2.9

1.67

0.83

g/l

0.51

202

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

292

1644

1.82

19.72

2.3

1.5

0.67

0.49

g/l

0.62

256

1395

Erosion of teeth, including avohilmo

284

1529

1.82

19.51

2.4

2.2

0.53

0.87

g/l

1.11

245

1326

Anaemia in chronic diseases classified elsewhere

223

3.44

19.44

1.8

2.8

0.33

1.13

g/l

1.54

198

Persistent mood disorders

340

2005

1.72

19.36

2.1

2.3

0.65

0.86

g/l

0.57

305

1735

Noninfectious colitis NAS

254

1377

1.88

19.36

2.5

2.3

0.84

0.95

g/l

0.17

221

1187

Mental and behavioural disorders due to psychoactive substance use

1020

7107

1.37

19.35

1.7

2.5

0.58

0.92

g/l

2.17

851

6164

Non-selective monoamine reuptake inhibitors

711

4798

1.45

19.33

2.3

2.5

0.76

0.97

g/l

0.96

617

4081

Personality disorders

384

2336

1.66

19.32

1.9

2.2

0.29

0.75

g/l

4.37

338

2080

Fissure and fistula of anal and rectal regions

430

2694

1.62

19.31

2.3

0.76

0.88

g/l

0.26

360

2330

Other viral hepatitis

108

417

2.66

19.28

2.3

2.0

0.68

g/l

0.00

382

Gonarthrosis,primary

1760

8753

1.27

19.11

2.1

2.5

0.82

0.95

g/l

0.80

1483

7481

Missing teeth due to accident, extraction or parodontitis

234

1243

1.93

19.08

3.5

2.1

1.52

0.83

g/l

1.20

203

1068

Peripheral arterial reconstruction

376

2296

1.67

18.97

1.8

2.4

0.57

1.17

g/l

3.27

321

1905

Cholelithiasis

1552

8505

1.29

18.85

2.4

0.94

g/l

0.01

1306

7269

Etanercept

121

500

2.49

18.82

1.9

2.5

0.46

0.96

g/l

1.48

111

454

Encephalitis

237

3.28

18.81

1.9

2.8

1.64

0.89

g/l

0.45

213

Osteonecrosis due to drugs

125

4.42

18.70

16.7

2.1

1.45

0.81

g/l

0.60

110

853

5806

1.40

18.64

3.0

2.4

1.28

1.04

g/l

0.77

705

4835

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1126

6689

1.34

18.58

2.8

2.4

1.05

1.06

g/l

0.03

937

5597

Actinic keratosis

797

5422

1.42

18.51

3.0

2.4

1.33

1.04

g/l

0.91

659

4518

Fracture of foot, except ankle

382

2349

1.65

18.51

2.1

2.2

0.65

0.84

g/l

0.45

330

2069

Atopic dermatitis, strict definition with reimbursement

372

2200

1.65

18.40

2.0

2.1

0.41

0.66

g/l

1.05

325

1949

Type 1 diabetes, wide definition

360

2181

1.67

18.40

2.0

2.2

0.38

0.92

g/l

2.68

316

1900

Disorders of the thyroid gland

1698

8782

1.27

18.38

2.1

2.5

0.79

0.91

g/l

0.70

1455

7507

Other metabolic disorders

220

1158

1.94

18.36

3.6

2.1

0.90

0.91

g/l

0.01

203

1010

Temporomandibular joint disorders

230

1227

1.90

18.31

2.7

2.2

0.93

0.81

g/l

0.18

202

1039

Retinal detachments and breaks

694

4869

1.44

18.25

2.6

2.5

0.82

0.97

g/l

0.52

593

4127

Coronary atherosclerosis

1357

6744

1.31

18.23

2.4

2.6

0.76

0.99

g/l

1.60

1199

5702

Amiodarone users

233

1259

1.91

18.20

2.0

2.5

0.26

1.11

g/l

7.12

211

1075

Carcinoma in situ of skin

178

879

2.09

18.11

2.0

1.5

1.09

0.49

g/l

0.83

153

736

Skin changes due to chronic exposure to nonionizing radiation

812

5545

1.40

18.06

3.0

2.4

1.31

1.05

g/l

0.84

673

4616

Intracranial injury

976

6996

1.36

18.06

2.3

2.4

0.74

0.96

g/l

1.15

808

5989

Cervicalgia

357

2175

1.67

18.01

2.3

0.85

0.89

g/l

0.07

306

1837

5-aminosalicylic acid

309

1810

1.73

18.00

1.9

2.3

0.81

0.77

g/l

0.07

268

1570

Viral hepatitis

128

553

2.37

17.99

2.2

0.63

0.89

g/l

0.32

111

499

Alcoholic liver disease

208

1086

1.97

17.96

1.4

2.6

0.27

1.13

g/l

5.53

168

940

Other interventions on the root canals of the tooth

132

4.10

17.93

5.2

1.9

0.55

0.89

g/l

0.39

122

Haemorrhage, not elsewhere classified

331

2.84

17.89

2.5

2.8

0.82

1.19

g/l

0.42

276

Psoriatic arthropathies

176

868

2.07

17.75

1.8

2.4

0.93

1.04

g/l

0.12

151

762

Use of pramipexole

437

2810

1.58

17.75

1.9

2.3

0.47

0.89

g/l

2.87

357

2397

Fall on and from stairs and steps

452

2928

1.57

17.66

2.2

2.3

0.63

0.86

g/l

0.84

367

2513

Persons encountering health services in other circumstances

588

4020

1.48

17.52

2.5

2.3

0.79

0.88

g/l

0.22

510

3394

Radiculopathy

322

1928

1.70

17.46

2.6

2.3

0.92

0.98

g/l

0.09

278

1624

Postprocedural endocrine and metabolic disorders, not elsewhere classified

205

1073

1.95

17.44

3.5

2.2

0.76

0.93

g/l

0.24

188

939

Other and unspecified myopathies

187

952

2.02

17.43

1.8

2.4

0.42

1.19

g/l

3.55

148

815

COPD, early/later onset

933

5829

1.37

17.43

1.9

2.5

0.78

1.11

g/l

1.65

798

4899

Degeneration of macula and posterior pole

957

5865

1.36

17.35

2.4

2.5

1.11

1.09

g/l

0.05

770

4889

Superficial injury of hip and thigh

278

1602

1.77

17.33

2.0

2.4

0.37

1.07

g/l

5.70

234

1371

Polyarthritis, unspecified

320

2.83

17.28

3.0

2.2

0.75

1.23

g/l

0.55

279

Vasomotor and allergic rhinitis

549

3660

1.49

17.26

2.3

0.58

0.74

g/l

0.73

476

3184

Extrapyramidal and movement disorders

701

4978

1.43

17.24

2.1

2.5

0.55

1.00

g/l

3.87

595

4186

Injury of unspecified body region

158

760

2.14

17.18

1.6

2.6

0.86

1.15

g/l

0.42

133

668

Idiopathic urticaria

150

3.79

17.16

1.1

2.2

0.00

0.51

g/l

2.05

137

Other extrapyramidal and movement disorders in other diseases

430

2776

1.58

17.15

2.3

0.62

0.91

g/l

1.10

375

2369

Panic disorder

191

980

1.97

17.12

1.5

2.4

0.29

0.74

g/l

2.53

171

876

Amputation of foot

274

3.03

17.10

1.8

2.9

0.15

1.56

g/l

3.98

237

COPD, hospital admissions

923

5793

1.36

17.03

1.9

2.5

0.77

1.10

g/l

1.75

786

4869

KRA_PSY_EATING, excluding more controls

291

2.85

17.01

1.4

1.8

0.11

0.40

g/l

1.10

265

Opening and dilatation of root channel of tooth

121

524

2.37

16.99

3.6

2.4

1.10

0.82

g/l

0.31

104

473

Substance use, excluding alcohol

303

1796

1.71

16.98

1.6

2.3

0.49

0.81

g/l

1.19

248

1592

Migraine with aura and triptan purchases

195

1011

1.96

16.97

1.5

2.0

0.34

0.56

g/l

0.84

180

890

Collagenous colitis

183

937

2.01

16.77

3.1

2.4

1.09

0.91

g/l

0.22

160

822

Other diseases of the respiratory system

412

2650

1.58

16.73

2.1

2.3

0.95

1.07

g/l

0.18

342

2223

Other respiratory disorders and diseases

412

2650

1.58

16.73

2.1

2.3

0.95

1.07

g/l

0.18

342

2223

Acute myeloid leukaemia and myelodysplastic syndromes

178

3.55

16.70

2.0

2.7

1.21

0.56

g/l

0.36

154

Chronic ulcer of skin, not elsewhere classified

153

737

2.14

16.65

2.7

2.4

0.59

1.01

g/l

0.92

129

639

Hallux valgus (acquired)

567

2796

1.48

16.53

2.3

2.6

0.97

1.00

g/l

0.04

475

2382

Spirochaetal infections, other/unspecified

178

910

2.01

16.43

2.4

2.6

0.79

1.06

g/l

0.50

143

796

Drug-induced polyneuropathy

5.20

16.38

14.1

1.6

1.94

0.37

g/l

1.11

Thyrotoxicosis

430

2803

1.56

16.37

2.0

2.3

0.46

0.83

g/l

2.10

370

2399

Other complications of surgical and medical care, not elsewhere classified

183

945

1.98

16.31

3.1

2.3

1.04

0.92

g/l

0.15

153

825

Other hammer toe(s) (acquired)

327

1873

1.67

16.29

1.9

2.7

0.52

1.14

g/l

3.32

269

1567

Crystal arthropathies, rheuma endpoint

171

3.56

16.27

2.1

2.9

0.32

1.98

g/l

2.95

143

Dentofacial anomalies [including malocclusion]

376

2350

1.60

16.26

2.6

2.2

0.70

0.80

g/l

0.27

338

2037

Eosinophilia

147

3.79

16.25

2.4

2.0

0.49

0.98

g/l

0.53

134

Cervical disc disorders

639

4512

1.43

16.19

2.4

2.3

0.66

0.86

g/l

0.81

551

3849

COPD related to multimorbidity

805

4962

1.38

16.19

1.8

2.5

0.74

1.11

g/l

2.04

680

4160

Protozoal diseases

271

2.96

16.16

5.6

2.8

0.85

1.39

g/l

0.57

240

Other symptoms and signs involving the circulatory and respiratory systems

127

574

2.27

16.14

2.1

2.5

1.45

0.83

g/l

0.50

108

494

Other infectious diseases

170

862

2.03

16.06

3.0

2.4

0.47

1.13

g/l

2.04

151

745

Chronic viral hepatitis

332

2.69

15.98

1.8

0.58

0.68

g/l

0.08

312

Enthesopathies of lower limb, excluding foot

350

2191

1.62

15.86

2.5

2.3

0.70

0.84

g/l

0.35

305

1877

Scoliosis

142

676

2.14

15.79

1.8

2.2

0.70

1.07

g/l

0.73

121

581

Benign neoplasm: Stomach

215

1187

1.86

15.73

2.4

0.70

1.01

g/l

0.73

181

1025

Other degenerative diseases of the nervous system

491

2497

1.51

15.67

1.8

2.4

0.96

1.23

g/l

0.69

380

2113

Stomatitis and related lesions

145

699

2.12

15.63

2.6

2.0

1.19

0.94

g/l

0.25

128

606

Motor neuron disease

141

3.75

15.60

1.4

2.0

0.22

1.66

g/l

1.81

119

Congenital malformations, deformations and chromosomal abnormalities

846

6021

1.35

15.53

2.1

2.3

0.56

0.74

g/l

1.05

742

5240

Other disorders of eyelid

852

6138

1.36

15.47

2.2

2.5

0.84

1.01

g/l

0.70

720

5167

Sleep disorders

325

2011

1.64

15.47

1.7

2.3

0.57

0.83

g/l

0.74

280

1766

Excessive attrition of teeth

561

2076

1.48

15.43

2.3

2.2

0.81

0.93

g/l

0.30

477

1786

Benign neoplasm: Caecum

225

1268

1.82

15.41

2.8

2.4

1.06

1.01

g/l

0.07

197

1095

Acute pancreatitis

371

2375

1.59

15.40

2.0

2.4

0.49

0.96

g/l

2.89

321

2020

Other and unspecified injuries of head

122

554

2.27

15.40

1.7

2.5

0.69

1.15

g/l

0.80

100

485

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

352

2220

1.60

15.38

2.2

2.3

0.38

0.71

g/l

2.28

297

1981

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

236

1347

1.79

15.38

2.2

1.5

1.29

0.55

g/l

1.62

205

1130

Disorders of synovium and tendon

832

5559

1.36

15.35

2.0

2.4

0.76

0.89

g/l

0.53

710

4745

Myeloid leukaemia

229

3.08

15.35

1.7

1.4

0.31

0.46

g/l

0.30

198

Agoraphobia

137

3.67

15.29

1.9

1.7

0.35

0.62

g/l

0.45

129

Psoriasis vulgaris

334

2090

1.62

15.27

1.9

2.3

0.82

0.87

g/l

0.08

288

1830

Myocardial infarction

1022

5597

1.32

15.22

2.3

2.5

0.69

1.03

g/l

2.68

875

4691

Bronchiectasis

184

980

1.93

15.13

2.8

2.5

0.73

1.05

g/l

0.77

163

819

Lesion of lateral popliteal nerve

106

458

2.39

15.09

2.4

0.40

1.32

g/l

2.68

399

Suppurative and necrotic conditions of lower respiratory tract

124

575

2.23

14.96

2.9

2.7

0.26

1.31

g/l

4.81

104

502

Neuromuscular dysfunction of bladder

179

947

1.94

14.92

2.2

2.7

0.69

1.23

g/l

1.32

157

824

Juvenile arthritis (FINNGEN)

220

3.02

14.91

1.9

2.0

1.03

1.29

g/l

0.18

200

Insomnia

244

1415

1.75

14.91

1.7

2.3

0.59

0.91

g/l

0.73

214

1247

Nonorganic sleeping disorders

280

1685

1.68

14.90

1.8

2.3

0.61

0.83

g/l

0.52

244

1487

Myelodysplastic syndrome

4.59

14.89

2.4

1.9

1.65

0.51

g/l

0.43

Exclusions for E4_PCOS_BROAD

270

1610

1.70

14.87

3.2

2.2

0.48

0.91

g/l

2.04

235

1407

Motor neuron disease (with DMD)

146

3.61

14.81

1.4

2.0

0.22

1.59

g/l

1.77

124

Mucosal proctocolitis

202

1112

1.85

14.75

2.4

0.66

0.80

g/l

0.28

185

987

Sequelae with surgical and medical care as external cause

378

2457

1.56

14.73

2.4

2.3

0.87

0.94

g/l

0.10

331

2088

Transient ischemic attack

1023

6518

1.31

14.71

2.4

2.5

0.68

1.07

g/l

3.87

856

5480

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

152

3.55

14.67

6.3

1.3

2.19

0.41

g/l

0.86

134

Sequelae of injuries of lower limb

170

889

1.95

14.64

2.2

2.5

0.39

1.03

g/l

2.48

156

787

Other crystal arthropathies

183

3.32

14.64

2.1

0.32

1.96

g/l

2.55

151

Fracture of skull and facial bones

346

2204

1.59

14.63

2.3

2.2

0.79

0.83

g/l

0.07

294

1926

Vitamin B12 deficiency anaemia

223

1271

1.79

14.62

2.0

2.4

0.51

1.05

g/l

1.83

191

1076

Migraine without aura and triptan purchases

191

1035

1.87

14.59

1.7

2.1

0.22

0.53

g/l

1.85

170

922

Thyroiditis, ILD-related definition

186

1002

1.89

14.58

2.4

0.39

0.81

g/l

1.77

160

874

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

247

1398

1.73

14.56

1.8

2.3

0.29

0.89

g/l

4.77

214

1236

Benign neoplasm: Adrenal gland

149

748

2.05

14.55

2.2

1.5

0.45

0.52

g/l

0.11

125

645

Traumatic subdural haemorrhage

251

1456

1.73

14.48

2.6

2.3

1.45

1.35

g/l

0.12

199

1218

Pneumonia due to other infectious organisms, not elsewhere classified

264

2.84

14.46

5.4

1.9

1.30

0.95

g/l

0.22

224

Nonischemic cardiomyopathy

124

583

2.20

14.44

1.8

2.5

0.24

1.29

g/l

4.23

108

502

Sub-endpoint used in defining T1D endpoints

489

3303

1.47

14.40

1.9

2.2

0.47

0.93

g/l

2.77

433

2815

Carcinoma in situ of skin of upper limb, including shoulder

222

3.07

14.40

2.6

1.4

0.57

0.40

g/l

0.32

182

Allergic rhinitis

390

2533

1.54

14.36

2.4

2.1

0.61

0.69

g/l

0.22

341

2231

Recurring oral aphthae, including avohilmo

243

1427

1.73

14.29

2.7

2.4

0.89

0.93

g/l

0.06

213

1237

Paralytic ileus and intestinal obstruction

449

3041

1.49

14.28

2.4

0.77

1.07

g/l

0.85

386

2562

Thyrotoxicosis, other and/or unspecified

328

2077

1.60

14.27

2.1

2.4

0.50

0.82

g/l

1.17

288

1795

Other and unspecified urticaria

301

1868

1.63

14.22

2.6

2.2

0.78

0.86

g/l

0.15

264

1634

Fracture of lower leg, including ankle

920

6994

1.32

14.20

2.1

2.4

0.53

0.87

g/l

3.04

780

5999

Fracture of forearm

905

6451

1.32

14.15

2.2

2.4

0.68

0.88

g/l

1.00

752

5500

Congenital malformations of the urinary system

105

465

2.32

14.09

2.1

2.6

0.27

1.07

g/l

2.92

415

Atopic dermatitis, strict definition

348

2190

1.57

14.08

2.0

2.1

0.36

0.68

g/l

1.51

308

1951

Spondylolisthesis/Spondylolysis

310

1945

1.62

14.04

2.7

2.3

0.99

0.90

g/l

0.16

266

1659

Carcinoma in situ of skin of lower limb, including hip

188

3.23

14.02

3.0

1.4

0.50

0.40

g/l

0.19

155

Open wound of ankle and foot

178

959

1.89

14.01

2.6

2.4

0.47

1.12

g/l

2.66

155

841

Ptosis of eyelid

228

1328

1.76

13.94

2.7

2.5

0.94

1.08

g/l

0.25

206

1145

Unspecified acute lower respiratory infection

252

1504

1.70

13.93

3.0

2.2

0.89

0.95

g/l

0.08

225

1303

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

119

3.88

13.92

1.6

1.2

0.50

0.38

g/l

0.09

106

Propionic acid derivatives

498

1697

1.49

13.90

2.6

2.4

1.30

0.94

g/l

0.97

437

1450

Anti-inflammatory and antirheumatic products, non-steroids

498

1697

1.49

13.90

2.8

2.4

1.41

0.94

g/l

1.19

437

1450

Faecal incontinence

187

1030

1.86

13.81

1.8

2.3

0.66

0.91

g/l

0.51

158

873

Ankylosing spondylitis

155

802

1.97

13.78

1.6

2.1

0.80

1.00

g/l

0.28

138

697

Inflammatory bowel disease

491

3409

1.45

13.73

2.2

2.3

0.92

0.82

g/l

0.20

422

2976

Lupus erythematosus

233

2.93

13.72

2.2

2.5

0.09

0.97

g/l

2.37

206

Hypermobility syndrome

299

2.63

13.70

2.3

2.0

0.29

0.58

g/l

0.60

280

Other disorders of skin and subcutaneous tissue, not elsewhere classified

267

1628

1.67

13.66

2.6

2.2

0.66

0.88

g/l

0.60

216

1387

Chronic pancreatitis

237

1405

1.72

13.54

2.0

2.5

0.26

0.98

g/l

6.47

207

1213

Melanocytic naevi

406

2727

1.50

13.46

2.5

1.5

0.78

0.43

g/l

1.29

363

2355

Alcohol induced polyneuropathy

4.35

13.46

1.4

2.1

0.16

1.24

g/l

1.42

Benign neoplasm of other and unspecified endocrine glands

241

1438

1.71

13.44

2.4

0.43

1.01

g/l

3.23

203

1251

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

844

6281

1.33

13.43

2.4

0.92

0.84

g/l

0.16

723

5415

Cholera

101

452

2.32

13.36

3.8

2.4

0.67

0.81

g/l

0.20

394

Other spirochaetal diseases

446

3063

1.48

13.32

2.7

2.4

1.03

0.86

g/l

0.34

372

2636

Internal derangement of knee

575

4116

1.40

13.32

2.1

2.5

0.52

0.91

g/l

2.89

477

3548

Special screening examination for neoplasms

427

2.34

13.27

3.4

2.4

0.91

0.78

g/l

0.12

365

Acute pancreatitis (for exclusion)

371

2459

1.53

13.24

2.0

2.3

0.49

0.94

g/l

2.77

321

2100

Lyme disease

442

3034

1.48

13.24

2.7

2.4

1.04

0.87

g/l

0.35

368

2613

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

205

1176

1.78

13.22

2.1

1.5

1.27

0.54

g/l

1.39

180

996

Diabetic retinopathy

621

2829

1.40

13.19

2.0

2.1

0.56

0.78

g/l

0.97

537

2415

Primary biliary cholangitis (PBC)

189

3.11

13.16

1.5

2.0

0.84

1.08

g/l

0.16

173

Myocardial infarction, without ST-elevation

802

5605

1.33

13.14

2.3

2.4

0.76

1.11

g/l

2.23

671

4680

Candidiasis

230

1363

1.72

13.12

3.3

2.3

0.77

0.86

g/l

0.19

197

1181

Biomechanical lesions, not elsewhere classified

105

481

2.26

13.11

2.5

2.7

0.65

1.22

g/l

1.03

425

Oesophageal varices

399

2.39

13.10

1.6

2.7

0.46

1.23

g/l

1.62

348

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

237

1419

1.70

13.05

2.6

1.5

0.99

0.51

g/l

1.66

198

1150

Cystic kidney disease

274

2.69

12.96

1.8

2.6

0.25

1.08

g/l

2.11

245

Herpesviral [herpes simplex] infections

194

1100

1.80

12.95

3.9

2.3

1.60

0.80

g/l

1.28

176

965

Other disorders of glucose regulation and pancreatic internal secretion

151

793

1.94

12.91

2.2

2.4

0.18

1.13

g/l

7.04

132

692

Pyothorax

428

2.33

12.83

3.1

2.6

0.33

1.40

g/l

3.58

371

Disorders of vitreous body and globe

916

6917

1.30

12.83

2.4

2.5

1.04

0.92

g/l

0.38

793

5860

Bullous disorders

128

639

2.07

12.80

2.2

2.6

0.62

1.28

g/l

1.91

113

551

Early onset COPD

420

2881

1.48

12.68

2.1

2.5

0.62

0.96

g/l

1.19

368

2462

Macular pucker

310

2002

1.58

12.63

2.0

2.4

0.96

0.99

g/l

0.04

250

1700

Gingival hyperplasia

266

2.69

12.61

2.3

2.1

0.85

1.13

g/l

0.21

236

Major coronary heart disease event excluding revascularizations

1280

7098

1.25

12.60

2.4

2.6

0.73

1.00

g/l

2.20

1092

5988

Vitreous haemorrhage

195

1119

1.78

12.58

1.9

2.5

0.82

1.01

g/l

0.28

175

965

Fibroblastic disorders

416

2851

1.48

12.57

2.6

2.4

0.86

1.10

g/l

0.65

352

2395

Other and unspecified mood [affective] disorders

404

2.31

12.54

1.6

2.3

0.26

0.60

g/l

1.08

368

Inflammatory diseases of the central nervous system

148

780

1.94

12.54

2.8

2.5

1.48

0.96

g/l

0.52

125

688

Major coronary heart disease event

1376

7433

1.24

12.54

2.3

2.6

0.78

1.00

g/l

1.54

1183

6289

Carcinoma in situ of skin of trunk

316

2.56

12.50

2.6

1.5

0.75

0.60

g/l

0.20

263

Viral pneumonia (known virus, not influenza)

217

2.90

12.49

6.2

2.9

1.71

0.95

g/l

0.55

190

Benign neoplasm: Rectum, anus and anal canal

394

2680

1.49

12.48

2.5

2.3

0.93

0.96

g/l

0.06

346

2265

Mental and behavioural disorders due to alcohol

845

6319

1.31

12.47

1.7

2.5

0.56

0.93

g/l

2.15

708

5495

Sequelae of injuries, of poisoning and of other consequences of external causes

381

2572

1.50

12.42

2.6

2.3

0.86

0.83

g/l

0.04

327

2249

Other and unspecified visual disturbances

173

962

1.84

12.41

2.9

2.3

0.94

0.93

g/l

0.00

159

841

Restless leg syndrome

225

1348

1.70

12.40

2.3

2.4

0.42

0.98

g/l

2.89

200

1171

Poisoning by drugs, medicaments and biological substances

323

2105

1.55

12.39

2.3

2.2

0.43

0.78

g/l

2.02

274

1869

Carcinoma in situ of skin

178

1002

1.83

12.38

2.0

2.5

1.09

1.22

g/l

0.11

153

847

Disorders of vitreous body

889

6745

1.30

12.38

2.4

2.5

1.02

0.92

g/l

0.31

769

5724

Colonic or urogenital fistula

463

3250

1.44

12.32

2.4

2.3

0.74

0.88

g/l

0.35

389

2798

Other inflammatory liver diseases

128

648

2.03

12.25

1.9

2.8

0.64

1.06

g/l

0.81

104

573

Chronic tubulo-interstitial nephritis

367

2.39

12.21

2.4

2.2

0.29

0.99

g/l

2.00

318

Mental and behavioural disorders due to alcohol, excluding acute intoxication

743

5628

1.33

12.15

1.7

2.4

0.57

0.89

g/l

1.48

617

4894

Ulcerative colitis

384

2608

1.49

12.13

2.4

2.2

1.04

0.80

g/l

0.50

327

2270

Localized swelling, mass and lump of skin and subcutaneous tissue

510

3651

1.41

12.12

2.4

1.11

0.93

g/l

0.34

444

3103

Benign neoplasm: Rectum

350

2340

1.52

12.11

2.4

0.78

0.98

g/l

0.56

310

1987

Myeloid leukaemia

261

2.69

12.10

1.7

3.0

0.31

1.36

g/l

2.41

231

Pemphigoid

291

2.60

12.09

1.6

2.9

0.31

1.39

g/l

2.54

243

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

126

3.55

12.07

3.0

1.3

0.38

0.41

g/l

0.03

112

Guillain-Barre syndrome

146

3.34

12.06

2.0

2.8

0.27

1.02

g/l

1.13

130

COPD-related respiratory insufficiency

249

1544

1.65

12.06

2.0

2.4

1.01

1.18

g/l

0.23

207

1282

Other/unspecified rheumatoid arthritis

248

1539

1.64

11.94

2.0

2.3

0.92

0.91

g/l

0.02

215

1298

Delirium, not induced by alcohol and other psychoactive substances

224

1355

1.68

11.88

2.0

2.4

1.25

1.13

g/l

0.16

177

1142

Hodgkin lymphoma

200

2.90

11.85

1.3

0.17

0.40

g/l

0.88

181

Myocardial infarction, strict

935

5328

1.29

11.85

2.1

2.5

0.70

1.04

g/l

2.49

800

4454

Coxarthrosis, primary

1141

7943

1.26

11.82

2.3

2.5

0.74

1.05

g/l

2.84

957

6696

Exclusions for E4_PCOS_CONSORTIUM

1070

5304

1.27

11.80

2.3

0.49

0.77

g/l

2.67

895

4587

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

3.88

11.77

6.5

1.3

2.34

0.57

g/l

0.50

Conjunctivitis (acute, non atopic)

399

2739

1.47

11.72

3.1

2.2

1.05

0.75

g/l

0.67

350

2374

Allergic urticaria

131

678

1.97

11.72

2.3

2.4

0.36

0.91

g/l

1.36

110

606

Other specified/unspecified inflammatory spondylopathies

348

2.38

11.71

2.0

0.50

0.82

g/l

0.57

309

Poisoning by medicine

292

1886

1.56

11.70

2.4

2.2

0.45

0.80

g/l

1.74

249

1673

Benign neoplasm of mouth and pharynx

190

1105

1.75

11.69

3.1

1.5

1.21

0.52

g/l

1.46

160

942

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

398

2.27

11.66

1.5

1.9

0.16

0.61

g/l

1.90

372

COPD, hospital admissions 3, with asthma pneumonia sepsis

538

3324

1.39

11.56

2.0

2.4

0.84

1.20

g/l

1.17

456

2768

Other immunodeficiencies

3.99

11.55

5.5

2.3

2.36

0.69

g/l

0.76

Acute posthaemorrhagic anaemia

321

2.45

11.51

3.2

2.9

0.82

1.39

g/l

0.67

275

Dental caries 2 and operation codes

1096

6963

1.26

11.40

2.5

2.3

0.72

0.71

g/l

0.02

950

6079

Open wound of forearm

152

835

1.85

11.35

2.2

2.4

0.62

1.11

g/l

1.16

135

731

Dental caries 2

1122

7073

1.25

11.33

2.5

2.3

0.72

0.71

g/l

0.02

972

6174

Other benign neoplasms of skin

581

4216

1.36

11.28

3.2

1.5

0.97

0.47

g/l

2.30

481

3561

COPD, hospital admission 2, with asthma infections

624

3974

1.35

11.27

2.0

2.4

0.85

1.14

g/l

0.94

529

3328

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

693

4616

1.33

11.22

2.7

1.5

0.86

0.47

g/l

2.36

597

3896

Pain and other conditions associated with female genital organs and menstrual cycle

242

1447

1.62

11.21

2.0

0.45

0.62

g/l

0.50

211

1270

Symptoms and signs involving emotional state

195

2.85

11.19

1.6

2.1

0.37

0.77

g/l

0.64

173

Specific personality disorders

301

1978

1.54

11.17

1.8

2.2

0.33

0.75

g/l

3.10

263

1754

Cyst of kidney

145

792

1.88

11.16

3.4

2.6

1.47

1.26

g/l

0.21

134

688

Cardiomyopathy, Hypertrophic obstructive

169

3.05

11.15

1.7

2.6

0.29

2.26

g/l

2.79

146

Heartburn

180

1045

1.75

11.15

2.1

2.5

0.69

1.10

g/l

0.78

153

897

Hyperplasia of prostate

708

3048

1.34

11.11

2.4

2.7

1.01

1.17

g/l

0.46

607

2629

Carcinoma in situ of skin of upper limb, including shoulder

256

2.65

11.07

2.6

3.4

0.57

1.43

g/l

1.49

214

Demyelinating diseases of the central nervous system

128

671

1.94

11.04

1.6

2.3

0.49

0.79

g/l

0.53

115

601

Other localized connective tissue disorders

181

2.96

11.04

3.1

2.4

1.94

0.85

g/l

0.60

163

Iridocyclitis

375

2587

1.47

11.03

2.6

2.2

1.31

0.87

g/l

0.98

326

2222

Otitis externa

346

2350

1.49

11.01

2.2

2.3

0.87

0.82

g/l

0.07

285

2044

Transport accidents

630

4186

1.34

11.00

2.0

2.4

0.75

0.90

g/l

0.42

549

3685

Temporomandibular joint disorders, including avohilmo

533

3900

1.37

10.97

2.4

2.3

0.71

0.72

g/l

0.02

471

3406

Benign neoplasm: Rectosigmoid junction

405

2.25

10.97

2.0

1.5

0.81

0.43

g/l

0.51

345

Hydronephrosis

191

1133

1.71

10.96

2.2

0.86

0.97

g/l

0.17

169

970

Mental and behavioural disorders due to sedatives or hypnotics

107

529

2.06

10.94

1.5

2.3

0.33

0.72

g/l

1.23

478

Alcohol-induced chronic pancreatitis

126

662

1.95

10.90

2.0

2.6

0.23

1.29

g/l

5.01

105

586

Pollen allergy

195

1150

1.69

10.84

2.7

2.1

0.67

0.55

g/l

0.23

166

1051

Other diseases of lip and oral mucosa

266

1717

1.57

10.81

2.5

2.3

0.83

0.90

g/l

0.11

230

1450

Respiratory insufficiency

148

818

1.84

10.81

1.6

1.7

0.48

1.05

g/l

1.73

119

674

Traumatic subarachnoid haemorrhage

281

2.49

10.80

2.9

2.0

0.86

1.53

g/l

0.57

244

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

179

1049

1.74

10.80

3.3

2.5

0.88

1.00

g/l

0.14

158

921

Alcohol-induced acute pancreatitis

331

2.38

10.78

2.3

2.8

0.42

1.32

g/l

2.05

302

Other shoulder lesions

146

805

1.84

10.78

1.9

2.1

0.43

1.00

g/l

1.62

130

696

Other lack of coordination

146

3.17

10.73

1.8

2.8

0.38

1.33

g/l

1.51

131

Sarcoidosis

236

1486

1.61

10.72

2.2

2.3

0.74

0.95

g/l

0.37

206

1301

Other local infections of skin and subcutaneous tissue

174

1014

1.75

10.68

3.1

2.4

0.71

0.99

g/l

0.53

146

883

Ankylosing spondylitis, ICD10

149

831

1.83

10.63

1.6

2.5

0.74

1.01

g/l

0.40

132

740

Malignant melanoma, excluding all cancers (controls excluding all cancers)

298

1982

1.53

10.60

2.6

1.5

1.14

0.51

g/l

1.74

243

1675

Keratitis

546

4043

1.36

10.59

2.1

2.3

0.59

0.85

g/l

1.60

476

3477

Dementia in Alzheimer disease

143

2144

0.56

10.57

1.7

2.4

1.90

1.32

g/l

0.42

1762

Diagnoses used for exclusion with ILD

456

3285

1.40

10.56

2.3

0.84

0.97

g/l

0.29

381

2786

Other diseases of pancreas

150

842

1.83

10.56

2.2

2.6

0.54

1.06

g/l

1.40

127

727

Other viral diseases, not elsewhere classified

257

1649

1.57

10.55

3.1

2.3

0.92

0.88

g/l

0.04

234

1450

Carcinoma in situ of skin of trunk

342

2.36

10.55

2.6

0.75

1.54

g/l

1.27

295

Mature T/NK-cell lymphomas, hilmo

143

3.21

10.54

1.6

2.9

0.50

1.07

g/l

0.50

128

Paraplegia, diplegia of upper limbs

197

2.81

10.52

1.8

2.8

0.55

1.09

g/l

0.69

176

Infections with a predominantly sexual mode of transmission

360

2483

1.46

10.48

2.0

2.1

0.52

0.68

g/l

0.57

316

2215

Abnormal results of function studies

148

828

1.82

10.47

2.7

2.6

1.20

0.92

g/l

0.32

124

732

Follicular lymphoma

446

2.16

10.47

1.5

1.4

0.52

0.40

g/l

0.21

386

Other and unspecified local infections of skin and subcutaneous tissue

163

939

1.77

10.44

3.2

2.4

0.74

1.05

g/l

0.55

140

821

Emotionally unstable personality disorder

138

754

1.85

10.44

1.7

1.9

0.16

0.63

g/l

3.41

123

691

Other diseases of stomach and duodenum

129

694

1.91

10.41

2.2

2.7

0.97

1.22

g/l

0.25

114

602

Malignant neoplasm of bone and articular cartilage

3.90

10.39

7.2

2.5

0.63

1.14

g/l

0.41

Artificial joint operation, meniscal resection

1653

9241

1.20

10.37

2.3

2.5

0.76

0.93

g/l

1.23

1374

7926

Hypothyroidism, other/unspecified

1498

8232

1.21

10.36

2.1

2.5

0.74

0.90

g/l

0.90

1291

7041

Other disorders of gingiva or/and edentulous alveolar ridge

427

2.16

10.33

2.4

2.1

0.68

0.99

g/l

0.32

374

Problems related to lifestyle

147

823

1.81

10.31

1.6

2.5

0.87

1.08

g/l

0.18

125

719

Diplopia

228

1438

1.61

10.31

2.4

2.2

0.59

0.96

g/l

1.40

202

1244

Personal history of other diseases and conditions

137

747

1.85

10.30

3.9

2.1

1.20

0.67

g/l

0.60

121

670

Striking against or struck by other objects

456

3295

1.39

10.27

1.9

2.3

0.75

0.80

g/l

0.11

381

2885

Other specified and unspecified personality disorders

129

695

1.88

10.26

1.8

2.3

0.16

0.77

g/l

4.17

112

629

Benign neoplasm: Pancreas

247

2.58

10.24

2.7

1.4

0.91

0.31

g/l

1.35

209

Social phobias

394

2.18

10.23

1.6

2.0

0.11

0.58

g/l

2.56

363

Olecranon bursitis

116

607

1.96

10.18

2.2

0.94

1.23

g/l

0.30

102

522

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

449

3236

1.39

10.17

2.1

2.2

0.47

0.75

g/l

1.48

396

2868

Folate deficiency anaemia

3.92

10.12

2.5

2.1

1.41

0.84

g/l

0.28

Inflammatory diseases of female pelvic organs

852

5057

1.28

10.12

1.8

2.4

0.53

0.72

g/l

1.05

725

4346

Carpal tunnel syndrome

1008

7336

1.25

10.05

2.3

2.4

0.59

0.85

g/l

2.29

886

6269

Vascular disorders of the intestines

133

731

1.86

10.03

2.4

2.2

1.01

1.08

g/l

0.09

118

616

Other nonthrombocytopenic purpura

4.06

10.03

2.6

2.1

0.75

0.77

g/l

0.01

Other or unspecified ileus, impaction or obstruction

314

2136

1.49

9.97

2.3

0.95

1.00

g/l

0.07

268

1796

Artificial joint re-operation

148

844

1.80

9.95

2.1

2.6

0.67

1.17

g/l

1.40

131

724

Abrasion of teeth

376

1929

1.45

9.95

2.7

2.3

0.73

0.96

g/l

0.67

316

1653

Other symptoms and signs involving the nervous and musculoskeletal systems

638

4878

1.32

9.94

2.3

2.4

0.73

0.95

g/l

1.04

557

4177

Hypothyreosis and Thyroxine purchase for inclusion criteria

1557

8620

1.20

9.94

2.1

2.4

0.77

0.90

g/l

0.73

1343

7370

Tubulo-interstitial nephritis, not specified as acute or chronic

123

662

1.90

9.88

2.8

2.1

0.86

1.00

g/l

0.18

102

572

Alcohol use disorder, ICD-based

674

5200

1.31

9.85

1.7

2.4

0.52

0.91

g/l

1.88

566

4513

Insulin, fast-acting (human)

208

1296

1.62

9.84

1.8

2.1

0.32

0.90

g/l

2.91

185

1140

Leukaemia of unspecified cell type

4.20

9.82

2.4

1.1

2.00

0.31

g/l

0.43

Emphysema

144

817

1.80

9.81

2.7

2.6

1.58

1.12

g/l

0.34

127

689

Carbimazole or st.post thyroidectomy, condition for graves disease

316

2161

1.48

9.79

2.7

2.3

0.42

0.85

g/l

2.49

277

1868

Ocular pain

128

700

1.86

9.78

1.7

2.4

0.38

0.98

g/l

2.21

116

620

Hallux rigidus

238

1536

1.57

9.75

2.3

2.6

1.10

1.05

g/l

0.05

192

1302

Benign neoplasm: Adrenal gland

149

856

1.78

9.75

2.2

2.6

0.45

1.06

g/l

2.07

125

753

Artificial opening status

113

597

1.95

9.71

2.6

2.4

0.82

1.00

g/l

0.13

520

Carcinoma in situ of skin of ear and external auricular canal

134

3.18

9.69

1.7

1.5

2.39

0.39

g/l

0.74

111

Eating disorder

383

2.16

9.67

1.4

1.7

0.11

0.45

g/l

1.63

355

Polyarteritis nodosa and related conditions

103

3.46

9.62

2.0

2.6

0.03

0.87

g/l

2.33

Adrenocortical insufficiency

316

2.32

9.61

2.2

2.7

0.42

0.96

g/l

0.79

283

Carcinoma in situ of skin of lower limb, including hip

232

2.60

9.58

3.0

2.8

0.50

1.20

g/l

1.22

193

Other disorders of bladder

221

1413

1.59

9.49

2.5

0.76

1.22

g/l

0.97

174

1208

Other and unspecified erythematous conditions

293

2.37

9.48

2.4

2.5

1.32

0.97

g/l

0.21

258

Other abnormal immunological findings in serum

135

3.08

9.45

2.0

2.7

0.90

0.69

g/l

0.16

122

Dermatitis due to substances taken internally

477

2.04

9.40

3.3

2.8

1.23

1.18

g/l

0.03

422

Ascites

142

813

1.79

9.40

1.6

2.5

0.74

1.23

g/l

0.96

124

691

Drug-induced cataract

215

2.62

9.40

3.3

2.8

0.32

0.97

g/l

1.15

194

Dislocation, sprain and strain of joint and ligaments of hip

365

2.21

9.38

2.0

2.6

0.88

1.41

g/l

0.62

323

Other specified/unspecified soft tissue disorders

464

2.05

9.38

2.6

2.1

0.92

1.18

g/l

0.30

397

Speech disturbances, not elsewhere classified

163

970

1.71

9.37

2.0

2.4

0.50

1.08

g/l

2.17

132

837

Melanocytic naevi of lower limb, including hip

332

2.26

9.36

2.8

1.4

0.66

0.32

g/l

0.40

295

Other disorders of adrenal gland

372

2.18

9.30

2.1

2.8

0.39

1.00

g/l

1.06

334

Calculus of kidney and ureter

528

3976

1.34

9.28

2.3

2.4

0.74

0.99

g/l

0.95

448

3407

Syphilis

217

2.58

9.19

2.5

2.6

0.51

1.07

g/l

1.00

195

Superficial injury of abdomen, lower back and pelvis

223

1438

1.57

9.17

2.1

2.2

0.55

0.88

g/l

1.19

194

1254

Asthma and opportunity respiratory infection

103

539

1.97

9.16

2.6

2.7

0.82

1.30

g/l

0.80

459

Nummular dermatitis

146

849

1.75

9.13

2.5

2.7

0.85

1.19

g/l

0.51

127

732

Diseases of male genital organs

876

3520

1.27

9.11

2.1

2.5

0.86

1.03

g/l

0.67

772

3063

Exfoliative dermatitis

3.58

9.11

1.5

2.9

0.76

0.95

g/l

0.09

Hypoglycaemia, other or unspecified

113

609

1.89

9.08

1.8

2.5

0.21

1.19

g/l

5.20

102

540

Other bursopathies

221

1427

1.57

9.08

3.1

2.2

0.94

1.00

g/l

0.07

195

1214

Fall involving bed

312

2.30

9.08

2.2

2.6

0.67

1.19

g/l

0.70

264

Familial hypercholesterolemia

278

1887

1.49

9.03

2.7

2.3

1.02

1.22

g/l

0.36

234

1573

Melanoma in situ of other and unspecified parts of face

108

3.37

9.03

3.2

1.2

1.32

0.18

g/l

0.78

Oral leukoplakia and related diseases, including avohilmo

164

988

1.69

9.03

2.0

2.5

0.53

0.97

g/l

1.51

131

857

Carcinoma in situ of other and unspecified digestive organs

244

2.48

9.02

2.7

1.3

0.66

0.47

g/l

0.14

209

Ulcerative ileocolitis

305

2.28

9.01

3.0

2.3

0.71

0.82

g/l

0.13

277

Injuries to the neck

317

2208

1.45

8.93

3.1

2.2

0.59

0.81

g/l

0.58

266

1927

Lesion of ulnar nerve

233

1532

1.54

8.83

2.2

0.60

0.96

g/l

1.24

210

1335

Cervicocranial syndrome

167

1015

1.67

8.82

2.2

2.3

0.70

1.03

g/l

0.62

149

864

Retinal vascular occlusion

233

1535

1.54

8.82

2.6

2.4

0.75

1.03

g/l

0.66

200

1288

Unspecified nephritic syndrome

216

2.55

8.81

1.9

2.7

0.22

1.03

g/l

2.10

191

Synovial cyst of popliteal space [Baker]

132

754

1.79

8.80

3.1

2.1

1.11

1.15

g/l

0.03

119

639

Intestinal stricture

529

4017

1.33

8.80

2.4

2.3

0.82

0.95

g/l

0.32

449

3399

Monoamine oxidase A inhibitors

201

1281

1.59

8.76

2.0

2.5

0.61

1.01

g/l

0.98

172

1110

Thyrotoxicosis with toxic multinodular goitre

123

691

1.83

8.75

1.6

2.4

0.36

0.88

g/l

2.08

102

593

Benign neoplasm: Descending colon

126

713

1.81

8.73

2.1

1.5

0.60

0.58

g/l

0.03

102

615

Presence of other functional implants

1058

6150

1.23

8.72

2.7

2.4

1.12

1.01

g/l

0.30

825

5240

Diseases of the ear and mastoid process

1976

8620

1.16

8.72

2.4

2.3

0.83

0.79

g/l

0.15

1680

7494

Other juvenile arthritis

186

2.62

8.71

2.0

1.7

0.81

1.13

g/l

0.22

170

Retinal vascular disorders

235

1556

1.54

8.68

2.6

2.4

0.75

1.02

g/l

0.67

202

1305

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

370

2.15

8.68

2.1

2.9

0.85

1.14

g/l

0.32

328

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

207

1329

1.57

8.67

2.3

0.29

0.78

g/l

2.87

171

1200

Hemiplegia

492

1.97

8.65

1.6

2.4

0.29

1.06

g/l

2.83

430

Eating disorders

110

595

1.87

8.64

2.0

0.13

0.66

g/l

3.34

540

Cervicobrachial syndrome

319

2240

1.44

8.62

2.3

0.95

0.82

g/l

0.19

286

1903

Arthropathic psoriasis

188

1185

1.61

8.61

1.8

2.5

0.88

0.95

g/l

0.08

161

1045

6-mercaptopurine

142

2.88

8.60

1.5

2.8

0.01

1.01

g/l

2.28

129

Other infective otitis externa

106

571

1.90

8.59

2.1

2.5

0.13

1.08

g/l

6.02

500

Other/unspecified enthesopathies of lower limb, excluding foot

111

606

1.86

8.58

1.9

2.2

0.48

0.96

g/l

1.24

529

Disorders of vestibular function (Vertigo)

797

6355

1.25

8.50

2.3

2.5

0.86

0.94

g/l

0.24

653

5371

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

4.37

8.48

9.0

2.6

0.61

0.86

g/l

0.21

Left bundle-branch block

129

741

1.78

8.46

1.8

2.4

0.56

1.15

g/l

1.30

104

620

Secondary thrombocytopenia

107

3.26

8.45

2.7

1.8

0.90

0.96

g/l

0.03

Intestinal malabsorption

407

2.07

8.45

1.9

2.9

0.92

1.26

g/l

0.28

366

Algoneurodystrophy

238

2.42

8.44

1.3

2.2

0.01

0.82

g/l

3.37

216

Speech and linguistic disorders, excluding more controls

330

2.13

8.43

1.8

2.2

0.84

0.89

g/l

0.04

288

Mixed hyperlipidaemia

415

2.06

8.41

1.4

2.3

0.44

1.43

g/l

2.69

364

Melanoma in situ

416

2.06

8.39

3.0

1.4

1.23

0.52

g/l

0.99

352

Benign neoplasm: Other and unspecified parts of mouth

309

2.24

8.38

3.3

1.4

1.42

0.43

g/l

0.94

272

Vitamin deficiency

450

2.00

8.35

3.0

2.5

0.43

1.28

g/l

2.16

396

Vitamin deficiency, wide

450

2.00

8.35

3.0

2.5

0.43

1.28

g/l

2.16

396

Acute pharyngitis

169

1036

1.63

8.34

2.7

2.2

0.59

0.69

g/l

0.21

158

936

Microscopic polyangiitis

4.02

8.33

1.6

2.3

0.10

0.55

g/l

0.98

Acute nephritic syndrome

192

2.60

8.30

2.5

2.9

0.51

1.06

g/l

0.81

170

Epilepsy

471

3536

1.34

8.29

2.0

2.4

0.75

0.97

g/l

0.65

386

3017

Fall on same level involving ice and snow

899

7330

1.23

8.29

2.2

2.5

0.56

0.89

g/l

3.19

748

6282

Other specified/unspecified bacterial intestinal infections

121

688

1.80

8.25

2.6

2.4

0.62

1.02

g/l

0.89

602

Hodgkin lymphoma, hilmo

241

2.40

8.25

1.3

3.0

0.17

1.16

g/l

2.91

220

Other skin changes

289

2014

1.45

8.24

3.2

2.4

1.08

1.05

g/l

0.04

241

1719

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

253

2.34

8.22

1.6

1.9

0.20

0.73

g/l

1.16

239

Drug-induced osteoporosis

109

3.21

8.21

2.0

2.8

1.56

0.64

g/l

0.62

Alcohol abuse, main dg, excluding more controls

213

1397

1.54

8.17

1.3

2.6

0.20

0.86

g/l

6.40

179

1241

Other disorders of the musculoskeletal system and connective tissue

252

1715

1.49

8.15

2.4

0.66

0.94

g/l

0.79

223

1486

Melanocytic naevi of trunk

166

1030

1.63

8.11

2.4

1.5

0.62

0.49

g/l

0.30

146

896

Dermatographic urticaria

525

1.90

8.06

2.0

2.5

0.31

0.89

g/l

1.69

476

Myocarditis

306

2.19

8.06

2.6

2.3

0.94

1.15

g/l

0.15

259

Acute generalized exanthematous pustulosis

429

2.01

8.03

3.5

2.8

1.82

1.32

g/l

0.30

377

Other erythematous conditions

328

2.17

8.02

2.5

1.32

1.05

g/l

0.17

292

Exposure to other and unspecified inanimate mechanical forces

103

562

1.87

8.01

2.5

2.6

0.85

1.11

g/l

0.34

496

Bacterial, viral and other infectious agents

123

709

1.76

7.95

2.7

2.4

0.34

0.87

g/l

2.07

107

640

Bullous pemphigoid

234

2.41

7.93

1.5

3.0

0.37

1.17

g/l

1.66

199

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

122

2055

0.59

7.93

2.0

1.5

0.73

0.48

g/l

0.54

101

1732

Covid-19 suspected case

259

1781

1.47

7.87

3.0

2.3

0.67

0.81

g/l

0.31

230

1570

Other specified/unspecified hearing loss

155

956

1.65

7.85

2.3

0.72

1.01

g/l

0.51

139

819

Anogenital herpesviral [herpes simplex] infection

363

2.07

7.83

2.1

1.8

0.44

0.74

g/l

0.53

331

Neuralgia and neuritis, unspecified

440

1.97

7.79

3.2

2.1

0.64

1.16

g/l

0.66

383

Dissociative [conversion] disorders

234

2.35

7.78

1.6

2.1

0.34

0.85

g/l

0.84

209

Hypothyroidism, strict autoimmune, 3 medication purchases required

1377

7979

1.18

7.76

2.1

2.4

0.77

0.91

g/l

0.69

1180

6805

Disorders of oesophagus in diseases classified elsewhere

199

2.51

7.75

4.5

3.0

0.91

1.13

g/l

0.20

171

Total colectomy operation

366

2.07

7.74

2.5

2.6

0.05

1.30

g/l

5.22

329

Total colectomy

366

2.07

7.74

2.5

2.6

0.05

1.30

g/l

5.22

329

Barrett oesophagus

506

1.91

7.72

2.0

2.9

0.54

1.26

g/l

1.63

443

Adhesive capsulitis of shoulder

268

1866

1.45

7.69

2.0

2.3

0.39

0.98

g/l

3.51

229

1585

Trigger finger

212

1410

1.52

7.66

1.8

2.3

0.93

0.91

g/l

0.02

188

1222

Mental and behavioural disorders due to opioids

193

2.48

7.62

1.7

0.12

0.74

g/l

1.51

181

Intestinal adhesions without obstruction

148

909

1.66

7.62

2.7

2.2

0.94

1.04

g/l

0.09

126

776

Fracture of neck

110

624

1.80

7.62

3.9

2.5

0.73

1.20

g/l

0.72

546

Portal vein thrombosis

136

2.85

7.61

1.7

2.2

0.96

1.20

g/l

0.12

125

Psoriatic arthropathies, ICD10

172

1096

1.59

7.59

1.9

2.5

0.95

0.94

g/l

0.01

147

963

Deviated nasal septum

533

4134

1.30

7.59

2.8

2.5

0.99

0.88

g/l

0.26

466

3587

Urolithiasis

559

4369

1.29

7.57

2.3

2.4

0.73

1.03

g/l

1.31

471

3732

Primary gonarthrosis, bilateral

925

6680

1.22

7.53

2.0

2.6

0.70

1.02

g/l

1.94

778

5648

Abnormal spermatozoa

1578

0.54

7.52

2.3

2.6

2.99

1.13

g/l

1.18

1342

Inguinal hernia

996

5561

1.21

7.51

2.9

2.3

1.09

0.90

g/l

0.77

853

4758

Acute and subacute iridocyclitis

298

2124

1.42

7.51

2.7

2.3

1.32

0.85

g/l

0.86

259

1837

Retinal detachment with retinal break

232

1583

1.49

7.47

2.6

2.4

1.33

0.97

g/l

0.53

199

1355

Benign neoplasm: Rectosigmoid junction

470

1.93

7.46

2.0

3.0

0.81

1.39

g/l

0.74

404

Ovarian cyst

517

2291

1.31

7.45

1.9

2.2

0.55

0.74

g/l

0.75

447

1972

Carcinoma in situ of colon

121

2.96

7.45

3.5

1.2

0.84

0.35

g/l

0.24

102

Diseases of inner ear

919

7439

1.22

7.43

2.2

2.5

0.83

0.93

g/l

0.36

757

6318

Other demyelinating diseases of the central nervous system

252

2.27

7.43

1.7

2.1

0.93

0.76

g/l

0.11

231

Haemorrhoids and perianal venous thrombosis

475

3640

1.31

7.43

2.3

2.5

1.30

1.07

g/l

0.47

397

3070

Carcinoma in situ of skin of ear and external auricular canal

156

2.72

7.41

1.8

2.5

2.39

1.19

g/l

0.36

131

Superficial injury of thorax

227

1543

1.49

7.40

1.5

2.4

0.44

0.97

g/l

3.34

189

1338

Rosacea

178

1150

1.57

7.40

2.3

2.4

0.97

0.83

g/l

0.17

159

1004

Follicular lymphoma, hilmo

508

1.89

7.36

1.5

3.1

0.52

1.45

g/l

2.44

443

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

352

2586

1.37

7.34

2.2

0.38

0.73

g/l

2.44

297

2299

Recurring oral aphthae

422

1.96

7.34

3.2

2.8

1.60

0.99

g/l

0.43

377

Anterior Iridocyclitis

317

2294

1.40

7.32

2.7

2.3

1.25

0.81

g/l

0.83

276

1984

Leukaemia of unspecified cell type

3.39

7.31

2.4

2.3

2.00

0.55

g/l

0.36

Other sleep disorders

173

1114

1.57

7.29

1.9

2.4

0.62

0.96

g/l

1.03

138

971

Supplementary factors related to causes of morbidity and mortality classified elsewhere

447

3412

1.32

7.23

2.0

2.3

0.92

0.86

g/l

0.12

363

2950

Benign neoplasm of mouth and pharynx

190

1254

1.54

7.20

3.1

2.4

1.21

1.02

g/l

0.24

160

1093

Dipeptidyl peptidase 4 (DPP-4) inhibitors

225

1539

1.49

7.19

1.8

2.4

0.62

1.13

g/l

1.91

194

1314

Congenital malformations of the circulatory system

191

1221

1.53

7.15

1.6

2.4

0.36

0.95

g/l

3.65

160

1077

Fracture at wrist and hand level

484

3738

1.30

7.13

2.2

2.3

0.73

0.80

g/l

0.15

412

3250

Injuries to the wrist and hand

1556

9753

1.16

7.08

2.2

2.4

0.72

0.83

g/l

0.63

1348

8399

Postmenopausal bleeding

476

1997

1.32

7.06

2.3

0.66

0.84

g/l

0.47

393

1696

Melanocytic naevi of lower limb, including hip

372

2.01

7.06

2.8

2.6

0.66

0.86

g/l

0.19

333

Benign neoplasm: Pancreas

293

2.16

7.02

2.7

2.9

0.91

1.30

g/l

0.45

257

Arterial embolism and thrombosis

106

609

1.77

7.02

1.6

2.6

0.50

1.40

g/l

2.72

515

Impacted cerumen

175

1142

1.56

7.02

1.8

2.4

0.27

0.96

g/l

5.78

115

982

Angina pectoris

1105

6285

1.19

7.01

2.4

2.6

0.89

1.02

g/l

0.58

954

5292

Crushed, pushed or stepped on by crowd or human stampede

478

1.87

6.97

2.9

2.3

0.44

0.72

g/l

0.54

434

Pneumothorax

121

723

1.70

6.97

2.2

2.4

0.96

1.20

g/l

0.18

106

632

Colectomy operation

299

2165

1.40

6.96

2.6

2.3

0.76

0.96

g/l

0.44

259

1836

Suggestive for eosinophilic asthma

159

1018

1.59

6.93

2.2

2.4

1.45

0.99

g/l

0.34

146

883

Any event in hilmo or specialist outpatient

14.30

6.93

3.2

2.0

0.08

0.00

g/l

—

Background retinopathy and retinal vascular changes

204

2.39

6.89

2.2

3.2

0.76

0.99

g/l

0.19

180

Misadventures to patients during surgical and medical care

223

1536

1.47

6.85

2.0

2.3

0.53

0.94

g/l

1.68

187

1318

Benign neoplasm of major salivary glands

157

1005

1.59

6.85

1.9

1.5

0.57

0.53

g/l

0.08

136

857

Sacroiliitis, not elsewhere classified

287

2.12

6.84

2.0

1.8

0.23

0.75

g/l

1.45

258

Benign neoplasm: Duodenum

243

2.26

6.84

2.7

1.4

0.71

0.39

g/l

0.43

206

Other follicular disorders

100

569

1.78

6.84

1.9

2.5

0.66

0.98

g/l

0.57

514

Diabetic retinopathy, strict definition

291

1844

1.40

6.81

1.9

2.1

0.47

0.71

g/l

0.61

248

1569

Other/unspecified enthesopathies, not elsewhere classified

146

920

1.61

6.81

1.7

2.1

0.59

1.04

g/l

1.04

125

783

Other psoriatic arthropathies

165

1070

1.56

6.80

1.9

2.5

0.99

0.94

g/l

0.05

141

942

Other disorders of patella

206

1397

1.49

6.79

2.0

2.4

0.44

0.94

g/l

2.42

186

1241

Benign neoplasm: Skin of eyelid, including canthus

240

1680

1.45

6.77

3.3

1.5

0.85

0.50

g/l

1.01

201

1420

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

371

2788

1.34

6.76

1.6

2.7

0.31

0.96

g/l

7.90

326

2433

Liver disorders in diseases classified elsewhere

6.34

6.76

2.2

1.2

1.89

0.26

g/l

0.62

Infection due to other mycobacteria

145

2.66

6.75

1.7

2.4

0.62

1.04

g/l

0.39

120

Arthropathy in hypersensitivity reactions classified elsewhere

17.55

6.74

1.7

1.3

0.10

0.79

g/l

—

Carcinoma in situ of other and unspecified digestive organs

278

2.17

6.73

2.7

3.1

0.66

1.58

g/l

0.85

238

Other and unspecified glaucoma

135

839

1.64

6.72

1.9

2.6

0.71

1.16

g/l

0.86

110

709

Benign neoplasm: Small intestine

408

1.94

6.71

2.5

1.4

0.88

0.45

g/l

0.74

350

Other maltreatment syndromes

193

2.38

6.70

1.5

1.6

0.35

0.66

g/l

0.47

176

Superficial injury of wrist and hand

250

1765

1.43

6.68

1.9

2.3

0.72

0.83

g/l

0.23

217

1559

Adenomyosis (Endometriosis of uterus)

217

1495

1.47

6.67

2.3

0.67

0.72

g/l

0.11

192

1273

Squamous cell neoplasms and carcinomas of the skin

237

1663

1.45

6.65

2.6

2.4

0.99

1.13

g/l

0.25

198

1375

Benign neoplasm of breast

176

1163

1.53

6.64

2.6

1.5

0.64

0.38

g/l

0.69

148

983

Abscess of anal and rectal regions

120

724

1.68

6.64

1.3

2.3

1.31

1.02

g/l

0.16

109

639

D07AA Corticosteroids, weak (group I)

192

1289

1.50

6.64

1.9

2.3

0.59

0.87

g/l

0.71

159

1143

Fentanyl

155

997

1.57

6.59

6.6

1.8

1.88

0.96

g/l

1.29

121

824

Hernia of abdominal wall

740

6069

1.23

6.59

2.4

0.82

0.90

g/l

0.30

660

5166

Drug-induced adrenocortical insufficiency

165

2.53

6.58

1.9

2.3

0.06

0.73

g/l

2.54

148

Vitamin D deficiency

129

2.72

6.58

1.7

2.3

0.27

0.71

g/l

0.77

116

Inflammatory disease of uterus

172

1133

1.53

6.56

1.7

2.2

0.65

0.58

g/l

0.11

148

995

Systemic atrophies primarily affecting the central nervous system

440

1.89

6.54

1.4

2.9

0.36

1.36

g/l

2.97

385

Parkinson's disease, excluding more controls

236

1615

1.44

6.54

2.0

2.4

0.36

1.29

g/l

6.88

193

1361

Other and unspecified injuries of lower leg

105

614

1.74

6.54

2.2

2.5

0.94

1.00

g/l

0.05

542

Suicide or other Intentional self-harm

317

2337

1.37

6.54

2.3

0.36

0.78

g/l

3.16

268

2072

Disorders of orbit

418

1.91

6.54

2.9

2.6

0.70

0.97

g/l

0.24

374

Other/unspecified disorders of vestibular function

412

1.92

6.52

1.9

2.5

0.44

1.29

g/l

1.76

361

Other obstetric conditions, not elsewhere classified

243

1100

1.44

6.49

1.5

1.8

0.16

0.30

g/l

0.93

219

1015

Erythema multiforme

203

2.34

6.49

2.1

2.6

0.92

1.19

g/l

0.18

181

Bronchitis, not specified as acute or chronic

139

876

1.61

6.49

2.0

2.4

0.64

1.01

g/l

0.85

121

735

Use of anticholinesterases

385

4073

0.76

6.48

1.9

2.4

1.12

1.23

g/l

0.19

281

3350

N06DA Anticholinesterases

385

4073

0.76

6.48

1.9

2.4

1.12

1.23

g/l

0.19

281

3350

Type of accident

413

3170

1.31

6.48

2.0

2.2

0.92

0.87

g/l

0.10

333

2743

Parkinson's disease, strict definition, excluding more controls

220

1499

1.46

6.47

2.0

2.3

0.36

1.32

g/l

6.43

181

1267

Superficial injury of shoulder and upper arm

165

1082

1.54

6.46

2.2

2.3

0.60

1.02

g/l

0.93

139

946

Blepharochalasis

503

3965

1.28

6.46

2.1

2.5

0.47

0.99

g/l

5.16

425

3352

Mental disorders, not otherwise specified

105

616

1.73

6.45

1.8

2.2

0.42

0.66

g/l

0.49

561

Procreative management

370

2351

1.33

6.45

1.9

2.1

0.56

0.68

g/l

0.35

333

2099

Idiopathic pulmonary fibrosis

145

927

1.60

6.44

2.2

2.6

0.75

1.19

g/l

0.83

124

780

Panniculitis affecting regions of neck and back

336

2.01

6.43

1.8

2.2

0.59

1.34

g/l

1.35

294

Gonarthrosis, primary, with knee surgery

1027

7097

1.19

6.41

2.2

2.6

0.72

1.02

g/l

2.16

855

6002

MS-disease / Multiple Sclerosis

536

1.78

6.40

1.7

2.2

0.39

0.74

g/l

0.89

484

Other disorders of nervous system

117

711

1.68

6.38

2.6

2.4

0.60

1.29

g/l

1.40

624

Hyperkinetic disorders, excluding more controls

287

2.05

6.31

1.4

1.7

0.61

0.37

g/l

0.28

268

Disorders of magnesium metabolism

3.63

6.31

1.2

1.3

0.14

1.05

g/l

1.22

Alcohol dependence

431

3341

1.30

6.30

1.7

2.5

0.53

0.93

g/l

1.12

356

2913

therapeutic use

326

2.03

6.30

1.6

2.5

0.55

1.47

g/l

1.26

281

Chronic laryngitis and laryngotracheitis

225

1579

1.44

6.29

1.7

2.3

0.60

0.89

g/l

0.48

179

1352

Contact with and exposure to communicable diseases

310

2281

1.36

6.29

2.8

2.1

0.69

0.62

g/l

0.13

271

2047

Otalgia

117

715

1.66

6.22

2.0

2.3

0.62

0.87

g/l

0.41

631

Other/unspecified synovitis and tenosynovitis

170

1132

1.52

6.21

1.9

2.1

1.04

0.97

g/l

0.06

151

965

Anosmia

108

2.80

6.21

2.2

1.4

0.55

0.24

g/l

0.37

Disorders of ocular muscles, binocular movement, accommodation and refraction

627

5042

1.24

6.21

2.3

0.89

0.78

g/l

0.34

550

4362

Umbilical hernia

414

3200

1.30

6.20

2.3

2.4

0.85

g/l

0.01

374

2786

Drug-induced neutropenia

125

779

1.63

6.18

3.3

2.6

1.17

1.05

g/l

0.10

111

682

Polycythaemia vera

335

1.99

6.17

3.0

1.4

1.06

0.47

g/l

0.68

282

Disorders of optic nerve and visual pathways

137

872

1.59

6.16

2.4

2.5

0.26

0.99

g/l

4.10

120

775

Congenital malformations of cardiac septa

467

1.81

6.15

1.6

2.5

0.36

0.93

g/l

1.97

421

Other congenital malformations

102

602

1.71

6.13

2.0

2.5

0.50

0.76

g/l

0.42

538

Crohn's disease NAS

529

1.77

6.12

1.9

2.5

0.51

1.00

g/l

1.10

473

Somnolence, stupor and coma

406

1.89

6.11

1.5

3.1

0.23

1.53

g/l

3.87

351

Acute bronchiolitis

202

2.20

6.10

6.4

2.0

0.66

0.29

g/l

0.53

183

Astigmatism

470

1.81

6.10

2.4

2.6

0.87

0.96

g/l

0.10

410

Other and unspecified psoriasis

114

697

1.67

6.09

2.1

2.6

0.65

1.15

g/l

0.78

100

615

Testicular dysfunction

255

2.12

6.04

1.9

2.7

0.67

1.00

g/l

0.30

228

Melanocytic naevi

406

3142

1.30

6.02

2.5

2.3

0.78

0.84

g/l

0.12

363

2713

Other and unspecified rosacea

135

862

1.59

6.02

2.4

2.5

0.72

0.90

g/l

0.24

121

761

Other bursitis of hip

172

2.40

6.01

2.3

1.8

0.23

1.53

g/l

2.12

144

severe traumatic brain injury, does not include concussion

371

2840

1.32

6.01

2.4

2.3

1.05

1.06

g/l

0.01

300

2390

Amenorrhoea

400

1.87

6.00

2.0

2.1

0.20

0.70

g/l

1.66

356

Postprocedural disorders of nervous system

480

1.79

6.00

2.3

2.2

0.98

0.71

g/l

0.33

442

Cholecystectomy

1170

8898

1.17

5.99

2.4

0.86

0.92

g/l

0.20

993

7564

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

231

1052

1.43

5.99

1.5

1.8

0.16

0.31

g/l

0.90

209

973

Superficial injury of ankle and foot

137

877

1.58

5.98

1.9

2.3

1.05

0.89

g/l

0.13

115

785

Palmar fascial fibromatosis [Dupuytren]

270

1974

1.38

5.98

2.6

2.4

0.94

1.17

g/l

0.41

221

1650

Acute peritonitis

109

662

1.68

5.98

2.3

2.6

0.74

1.29

g/l

0.81

101

577

Ulcerative colitis, NAS

194

1338

1.46

5.96

2.1

2.4

0.63

0.92

g/l

0.89

172

1176

Otitis externa, unspecified

151

990

1.54

5.96

2.1

2.4

0.91

0.92

g/l

0.00

128

870

Melanoma in situ

470

1.82

5.93

3.0

2.8

1.23

1.51

g/l

0.24

407

Hypopituitarism

527

1.75

5.90

3.0

2.6

0.65

1.18

g/l

1.15

481

Lactose intolerance

231

2.17

5.89

1.5

1.8

0.40

0.96

g/l

0.90

208

Pneumonia due to Streptococcus pneumoniae

354

1.93

5.89

5.5

2.1

2.67

1.14

g/l

1.00

302

Maternal care for other conditions predominantly related to pregnancy

194

1321

1.46

5.88

2.0

0.79

0.38

g/l

1.02

174

1205

ILD-related respiratory insufficiency

363

1.93

5.87

1.9

2.8

0.78

1.45

g/l

0.60

310

Follicular cysts of skin and subcutaneous tissue

273

2005

1.37

5.86

2.6

2.3

1.41

0.83

g/l

0.97

247

1732

Other orthopaedic follow-up care

544

1.74

5.86

1.8

2.1

0.77

0.95

g/l

0.12

474

Childhood asthma (age<16), excluding more controls

355

1.82

5.85

1.4

0.51

0.39

g/l

0.14

328

Entropion and trichiasis of eyelid

161

1077

1.52

5.85

2.6

2.5

1.50

1.20

g/l

0.30

134

907

Benign neoplasm: Other and unspecified parts of mouth

356

1.93

5.84

3.3

2.8

1.42

1.44

g/l

0.01

316

Benign neoplasm: Parotid gland

126

798

1.60

5.84

2.0

1.5

0.71

0.47

g/l

0.44

109

679

Acne

454

1.80

5.82

2.0

1.6

0.60

0.52

g/l

0.06

419

Other disorders of ear

1568

9174

1.14

5.80

2.6

2.4

1.02

0.85

g/l

0.72

1286

7915

Nontoxic goitre/thyroid nodule

485

3861

1.27

5.78

2.3

2.4

0.87

0.92

g/l

0.11

412

3254

COPD, hospital admissions 1, only main diagnosis

635

4425

1.23

5.77

2.0

2.4

1.00

1.10

g/l

0.21

535

3712

Chondrocostal junction syndrome [Tietze]

343

1.94

5.77

1.9

2.4

0.73

1.00

g/l

0.32

298

Acute gastritis

129

824

1.59

5.76

1.6

2.6

0.42

1.00

g/l

2.42

107

714

Benign neoplasm: Descending colon

126

803

1.60

5.73

2.1

2.6

0.60

1.29

g/l

1.89

102

702

Hepatic failure, not elsewhere classified

344

1.94

5.73

1.5

3.0

0.84

1.55

g/l

0.87

300

Right bundle-branch block

351

1.92

5.73

2.9

2.3

0.27

1.48

g/l

3.38

300

Other and/or unspecified nontoxic goitre

143

937

1.55

5.72

2.3

0.56

0.85

g/l

0.72

125

811

Childhood asthma (age<16)

358

1.80

5.72

1.4

0.51

0.33

g/l

0.23

331

Erythema nodosum

275

2.05

5.70

3.0

2.3

0.51

0.89

g/l

0.44

247

IBD patients in KELA-register

300

2247

1.34

5.65

2.4

2.2

0.85

0.76

g/l

0.14

263

1983

Speech and linguistic disorders

398

1.82

5.63

1.8

2.0

0.82

0.54

g/l

0.27

355

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

226

1622

1.41

5.63

2.3

1.5

1.09

0.48

g/l

1.27

185

1375

Use of donepezil

197

2670

0.70

5.63

1.9

2.4

1.23

1.19

g/l

0.05

141

2175

Dental caries 1 and operation codes, only avohilmo

424

1653

1.30

5.59

2.7

3.0

0.88

1.04

g/l

0.36

377

1417

Coeliac disease

175

1200

1.47

5.58

2.9

2.3

0.87

0.85

g/l

0.02

149

1045

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.13

5.56

2.0

2.6

0.16

0.94

g/l

1.37

Assault

140

917

1.54

5.55

1.7

2.3

0.58

0.78

g/l

0.30

119

837

Thyroiditis

110

683

1.64

5.54

2.2

2.5

0.39

0.78

g/l

1.10

602

Disorders of psychological development

509

1.70

5.54

1.7

1.9

0.68

0.57

g/l

0.11

458

Event of undetermined intent

494

1.75

5.49

2.5

2.4

0.63

0.90

g/l

0.46

449

Leiomyoma of uterus

611

2800

1.23

5.49

2.2

1.5

0.50

0.37

g/l

0.57

507

2423

Generalized skin eruption due to drugs and medicaments

378

1.87

5.48

3.6

2.7

1.55

1.40

g/l

0.07

335

Abscess of lung

124

2.59

5.47

1.9

2.7

0.05

1.09

g/l

2.14

111

Triptan medication for migraine, min. 3 purchases

634

4109

1.22

5.45

2.3

2.2

0.57

0.65

g/l

0.34

566

3639

Other specified/unspecified spondylopathies

260

2.06

5.43

3.4

2.3

2.27

1.35

g/l

0.39

219

Atypical mycobacterium lung infection

113

2.69

5.43

1.7

2.3

0.69

0.43

g/l

0.19

Seborrhoeic keratosis

369

2866

1.30

5.43

2.8

2.4

1.25

0.96

g/l

0.61

310

2416

Xerosis cutis

162

2.38

5.42

2.0

2.7

0.34

0.70

g/l

0.50

145

Postzoster neuralgia

137

2.51

5.41

3.3

2.4

0.94

1.02

g/l

0.04

114

Congenital malformations and deformations of the musculoskeletal system

545

1.70

5.41

1.5

2.1

1.09

0.58

g/l

0.43

492

Obsessive-compulsive disorder

293

1.96

5.40

2.3

2.2

0.38

0.59

g/l

0.30

272

910

0.50

5.40

1.2

2.5

0.19

1.30

g/l

5.85

778

Polycystic ovarian syndrome, consortium definition

967

4966

1.18

5.39

2.0

2.3

0.76

0.69

g/l

0.25

803

4282

Tinnitus

373

2903

1.30

5.39

2.7

2.3

0.69

0.82

g/l

0.33

327

2511

Atypical facial pain

483

1.75

5.37

2.7

2.5

1.91

0.89

g/l

0.79

418

Iridocyclitis in diseases classified elsewhere

156

2.38

5.36

2.0

2.6

2.59

1.16

g/l

0.60

142

Golimumab

220

2.13

5.35

1.9

1.8

0.11

0.71

g/l

1.99

209

Other and unspecified parapsoriasis

3.63

5.35

1.6

2.0

0.61

0.56

g/l

0.03

Drug-induced Cushing's syndrome

12.38

5.33

2.4

1.0

0.11

1.22

g/l

—

Other hearing loss

503

3992

1.25

5.32

2.7

2.3

1.24

1.02

g/l

0.47

403

3357

Crohn disease

168

1154

1.47

5.32

1.6

2.3

0.29

0.86

g/l

3.18

149

1019

Other abnormal uterine and vaginal bleeding

355

1950

1.31

5.29

2.2

2.3

1.06

0.80

g/l

0.49

270

1650

Cerebral cysts

470

1.75

5.29

1.5

2.5

0.70

0.98

g/l

0.38

420

Cluster headache, strict

255

2.04

5.28

1.9

3.0

0.31

0.67

g/l

0.61

229

Superficial injury of forearm

123

793

1.57

5.28

1.7

2.2

0.46

0.90

g/l

1.11

103

708

Other diseases of jaws

599

1.66

5.27

4.1

2.1

0.71

0.96

g/l

0.40

523

Other and unspecified disorders of vitreous body

680

5639

1.21

5.24

2.4

2.5

0.99

0.91

g/l

0.18

582

4798

Other and unspecified iridocyclitis

384

1.83

5.21

3.2

2.4

1.74

1.25

g/l

0.35

345

Other diseases of oesophagus

159

1087

1.48

5.21

2.3

2.6

1.23

1.18

g/l

0.04

137

929

Ventral hernia

380

2979

1.29

5.20

2.5

2.3

0.75

0.90

g/l

0.49

332

2525

Special screening examination for other diseases and disorders

112

709

1.60

5.20

3.1

2.3

0.63

0.87

g/l

0.36

102

602

Melanoma in situ of other and unspecified parts of face

147

2.45

5.19

3.2

2.9

1.32

0.76

g/l

0.28

125

Alcohol abuse, main dg

213

1535

1.40

5.19

1.3

2.3

0.20

0.90

g/l

6.34

179

1363

Other noninflammatory disorders of vulva and perineum

121

781

1.57

5.18

1.6

2.0

0.50

0.74

g/l

0.49

104

671

Benign neoplasm: Pituitary gland, craniopharyngeal duct

414

1.79

5.17

3.1

1.4

0.40

0.34

g/l

0.12

364

Deficiency of other B group vitamins

211

2.15

5.15

4.2

2.2

0.19

1.09

g/l

1.85

187

Extreme obesity with alveolar hypoventilation

394

1.82

5.12

2.2

2.8

1.01

1.24

g/l

0.20

351

Benign neoplasm of urinary organs

454

1.75

5.08

2.4

1.4

0.82

0.42

g/l

0.61

388

Benign neoplasm: Kidney

316

1.91

5.06

2.4

1.5

1.07

0.46

g/l

0.74

269

Disorders of speech understanding and production

227

2.06

5.06

2.0

2.5

1.00

0.53

g/l

0.32

197

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

355

2767

1.29

5.06

1.9

2.3

0.44

0.82

g/l

2.03

306

2440

Diseases of peritoneum

167

1160

1.46

5.06

2.1

2.4

0.79

1.09

g/l

0.49

147

999

Benign paroxysmal vertigo

459

3693

1.25

5.05

2.4

0.98

0.93

g/l

0.12

374

3127

Attention to artificial openings

389

1.81

5.03

1.8

2.2

0.41

1.35

g/l

2.75

342

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

411

1.79

5.03

4.7

1.4

2.51

0.44

g/l

1.37

356

Other disorders of optic [2nd] nerve and visual pathways

585

1.65

5.00

2.4

2.7

0.20

1.32

g/l

5.59

515

Disorders of refraction and accommodation

316

2421

1.31

4.99

2.2

0.79

0.75

g/l

0.05

276

2117

Malignant neoplasm of kidney, except renal pelvis

162

1123

1.46

4.99

2.0

2.5

1.43

1.10

g/l

0.34

143

965

Nail disorders

117

758

1.56

4.96

1.8

2.5

0.81

0.91

g/l

0.12

103

670

Other and unspecified trigeminal disorders

112

2.58

4.95

3.0

2.2

1.36

0.88

g/l

0.24

Benign neoplasm: Skin of ear and external auricular canal

384

1.81

4.93

2.2

1.4

1.20

0.41

g/l

0.84

330

Benign neoplasm: Appendix

101

2.70

4.92

1.5

1.3

0.00

0.43

g/l

1.38

Malignant melanoma

250

1870

1.35

4.89

2.5

2.4

0.98

1.03

g/l

0.07

203

1595

Excessive, frequent and irregular menstruation

517

2329

1.24

4.89

1.9

2.2

0.61

0.73

g/l

0.39

439

2003

Malignant neoplasm of urinary organs

174

1228

1.44

4.87

2.0

2.5

1.43

1.14

g/l

0.30

153

1046

Carcinoma in situ of colon

151

2.36

4.87

3.5

2.3

0.84

0.80

g/l

0.02

129

Recurrent dislocation and subluxation of joint

436

1.74

4.86

1.7

2.3

0.35

0.93

g/l

1.47

398

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

527

1.67

4.84

1.6

2.4

0.30

0.92

g/l

2.11

473

Melanocytic naevi of trunk

166

1161

1.44

4.84

2.4

0.62

0.93

g/l

0.80

146

1024

543

3955

1.23

4.84

2.4

2.3

1.21

1.10

g/l

0.20

429

3263

Menorrhagia

501

2241

1.24

4.81

2.0

2.2

0.80

0.76

g/l

0.06

406

1919

Other Crohn's disease

521

1.67

4.81

1.4

2.3

0.19

0.86

g/l

2.96

469

Cardiac arrest

493

1.65

4.80

2.2

2.3

1.10

1.40

g/l

0.31

410

Benign neoplasm: Duodenum

280

1.95

4.80

2.7

3.0

0.71

1.29

g/l

0.69

244

Sulfonylureas

688

4614

1.20

4.79

1.8

2.5

0.61

1.17

g/l

4.08

572

3818

Injury of eye and orbit

183

1305

1.41

4.77

1.7

2.3

0.46

0.85

g/l

0.70

152

1157

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

102

2.62

4.77

5.8

1.8

2.10

0.46

g/l

0.43

Benign neoplasm of eye and adnexa

148

1017

1.47

4.76

2.2

1.4

1.34

0.51

g/l

1.32

122

856

Benign neoplasm: Spinal meninges

2.76

4.76

1.5

1.2

0.62

0.37

g/l

0.21

Other and unspecified vascular occlusions

168

1184

1.44

4.75

2.6

2.5

0.82

1.04

g/l

0.39

145

1001

Dental caries 2, only avohilmo

1020

6972

1.16

4.75

2.5

2.3

0.74

0.71

g/l

0.08

878

6089

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

506

2512

1.24

4.74

2.3

1.6

1.27

0.52

g/l

3.26

428

2163

Unspecified lump in breast

230

1707

1.36

4.73

1.9

2.3

0.47

0.68

g/l

0.70

198

1457

Type1 diabetes, definitions combined, early onset

271

1.93

4.72

1.4

1.5

0.22

0.54

g/l

0.60

256

Inflammatory bowel disease, strict (require KELA)

300

2312

1.31

4.71

2.4

2.2

0.85

0.77

g/l

0.14

263

2043

Oral leukoplakia and related diseases

627

1.61

4.70

1.6

2.7

0.52

1.17

g/l

1.71

550

Impingement syndrome of shoulder

363

2868

1.27

4.70

2.5

0.98

0.99

g/l

0.02

299

2469

Other aneurysm

596

1.62

4.69

2.2

2.6

0.89

1.24

g/l

0.46

510

Cluster headache, wide

288

1.91

4.68

1.9

3.0

0.46

0.63

g/l

0.23

257

Cholecystitis

233

1736

1.36

4.68

2.3

2.4

1.01

1.03

g/l

0.03

193

1451

Plantar fascial fibromatosis

135

914

1.49

4.67

2.7

2.1

0.72

0.98

g/l

0.46

123

795

Specific development disorders of speech and language

290

1.88

4.67

2.0

2.3

0.82

0.62

g/l

0.14

257

Undefined dementia

1341

0.63

4.66

1.8

2.2

0.46

1.41

g/l

4.47

1072

Ankylosing spondylitis, strict definition

317

1.86

4.66

1.5

2.6

0.10

0.90

g/l

3.67

293

Follow-up examination after treatment for malignant neoplasms

162

1137

1.44

4.66

2.6

2.3

1.50

0.94

g/l

0.71

140

951

Endometriosis

472

2268

1.24

4.66

2.0

2.2

0.60

0.75

g/l

0.46

404

1948

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

459

1.71

4.65

1.8

1.4

1.08

0.36

g/l

0.68

398

Other condition

186

1338

1.40

4.64

2.1

2.3

1.04

0.92

g/l

0.12

167

1184

Ectropion of eyelid

452

1.72

4.64

1.5

2.5

0.73

1.51

g/l

0.81

363

Lung cancer and mesothelioma

303

2001

1.31

4.62

2.2

2.0

1.15

0.97

g/l

0.28

257

1674

Pure hyperglyceridaemia

200

2.11

4.62

2.0

2.5

0.51

1.51

g/l

1.12

179

Other and unspecified tonsillitis

343

2280

1.28

4.61

1.8

2.1

0.82

0.61

g/l

0.36

310

2054

Cardiac murmurs and other cardiac sounds

112

722

1.55

4.61

2.2

2.3

0.39

0.75

g/l

0.95

624

Chondropathies

208

1526

1.37

4.60

2.0

2.2

0.89

0.88

g/l

0.01

175

1344

Psoriasis (vulgaris), strict definition

262

1.95

4.60

1.5

2.7

0.60

1.00

g/l

0.48

242

Type 1 diabetes, definitions combined

595

1.60

4.59

2.1

0.52

0.77

g/l

0.39

548

Chronic hepatitis, not elsewhere classified

305

1.88

4.59

1.6

3.0

0.71

1.07

g/l

0.36

277

Bursitis of shoulder

214

2.06

4.58

3.0

1.9

0.13

1.58

g/l

3.59

186

Hyperaldosteronism

270

1.94

4.58

2.3

2.9

0.32

1.44

g/l

2.51

241

Other disorders of penis

141

968

1.47

4.57

1.8

2.5

0.65

1.03

g/l

0.62

118

833

Autoimmune hyperthyroidism

483

1.68

4.56

2.2

2.6

0.42

0.87

g/l

0.54

431

Bell's palsy

174

1242

1.42

4.56

2.8

2.2

0.67

1.04

g/l

0.75

146

1070

Atopic conjunctivitis

305

1.86

4.56

1.6

2.0

0.33

0.74

g/l

0.61

272

Other and unspecified nonorganic psychotic disorders

218

1613

1.36

4.55

1.6

2.3

0.43

0.78

g/l

1.15

185

1434

Coronary artery bypass grafting

527

3305

1.22

4.53

1.8

2.5

0.88

1.20

g/l

0.87

462

2736

Dermatophytosis

203

1489

1.38

4.53

2.6

2.4

0.67

1.01

g/l

0.71

177

1275

Pain associated with micturition

170

1210

1.42

4.53

2.8

2.4

1.55

0.94

g/l

0.70

144

1030

Viral meningitis

256

1.95

4.53

1.9

2.1

0.32

0.58

g/l

0.51

233

Medical abortion

890

4150

1.17

4.53

1.9

2.4

0.46

0.78

g/l

2.80

754

3544

Oesophagitis

563

1.63

4.50

2.2

2.8

0.63

1.27

g/l

1.41

493

Other deformities of toe(s)

329

1.83

4.49

1.8

2.1

0.85

1.27

g/l

0.36

282

Disorders of synovium and tendon in diseases classified elsewhere

169

2.19

4.47

1.7

2.1

0.23

1.31

g/l

2.03

149

Focal brain injury

571

1.61

4.46

1.9

2.2

0.89

1.20

g/l

0.31

487

Type 1 diabetes, strict (exclude DM2)

592

1.60

4.46

2.1

0.53

0.70

g/l

0.25

545

Coronary revascularization (ANGIO or CABG)

848

5083

1.17

4.45

2.0

2.5

0.84

1.04

g/l

0.91

742

4246

Disorders of sphingolipid metabolism and other lipid storage disorders

4.53

4.45

2.5

1.7

1.03

1.31

g/l

0.12

Diphtheria

10.12

4.44

3.9

4.3

0.13

0.61

g/l

—

Post-traumatic wound infection, not elsewhere classified

203

2.07

4.44

1.7

2.7

1.02

0.99

g/l

0.02

181

Urethral stricture

636

1.58

4.43

2.3

2.7

0.52

1.41

g/l

3.35

540

Unspecified dementia

1288

0.64

4.43

1.8

2.4

0.43

1.39

g/l

4.46

1051

Other and unspecified mononeuropathies of upper limb

245

1.96

4.40

2.2

2.3

0.49

0.99

g/l

0.56

219

Postprocedural disorders of digestive system, not elsewhere classified

317

1.84

4.39

1.9

2.9

0.56

1.19

g/l

0.93

282

Acidosis

191

2.10

4.38

2.6

2.4

0.90

2.03

g/l

0.55

172

Bicipital tendinitis

467

1.68

4.36

2.3

2.4

0.07

1.20

g/l

5.90

410

Unspecified/other endometriosis

614

1.58

4.33

1.9

0.28

0.64

g/l

1.20

533

Wet age-related macular degeneration

312

2405

1.29

4.32

2.5

2.3

1.32

1.11

g/l

0.33

255

1961

Viral infections of the central nervous system

101

655

1.56

4.32

2.5

2.4

0.78

0.97

g/l

0.23

579

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

408

3303

1.24

4.30

2.8

2.3

0.63

0.86

g/l

0.87

355

2871

Benign neoplasm: Small intestine

471

1.67

4.27

2.5

2.9

0.88

1.55

g/l

1.05

408

Disorders of optic nerve, not elsewhere classified

207

2.04

4.25

2.5

3.3

0.24

1.43

g/l

2.49

183

Psychotic depression

516

1.63

4.24

2.3

2.7

0.98

1.06

g/l

0.06

447

Atrophic disorders of skin

203

1506

1.36

4.23

2.1

2.3

0.27

0.78

g/l

3.73

177

1290

All dysplastic lesions of the cervix uteri, vagina or vulva

280

2158

1.30

4.21

2.2

2.1

0.58

0.53

g/l

0.13

249

1913

Pediculosis, acariasis and other infestations

456

1.67

4.20

2.6

2.3

0.63

1.13

g/l

0.71

413

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

202

1499

1.36

4.19

2.7

2.3

1.03

0.83

g/l

0.27

177

1324

Other or ill-defined heart diseases

441

1.68

4.18

1.5

2.1

0.36

1.24

g/l

1.83

382

Aortic arch syndrome [Takayasu]

8.86

4.18

1.8

1.1

0.13

0.00

g/l

—

Seborrhoeic dermatitis

140

978

1.45

4.18

2.4

2.5

0.95

1.07

g/l

0.16

114

847

Orchitis and epididymitis

137

953

1.45

4.18

2.1

2.5

1.16

1.06

g/l

0.08

113

812

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

135

2.29

4.16

2.7

1.3

0.51

0.35

g/l

0.16

116

Other symptoms and signs involving general sensations and perceptions

338

1.78

4.13

2.5

2.8

1.12

1.18

g/l

0.03

293

Atrial septal defect

263

1.88

4.12

1.9

2.2

0.48

0.95

g/l

0.79

241

Ulcerative colitis (strict definition, all Crohn cases excluded)

181

1325

1.38

4.10

3.0

2.4

1.24

0.87

g/l

0.49

158

1175

Septal defects

441

1.66

4.10

1.7

2.6

0.40

0.93

g/l

1.54

401

Use of other anti-dementia drugs

294

3243

0.78

4.09

1.9

2.4

1.83

1.25

g/l

0.82

210

2646

Use of memantine

294

3243

0.78

4.09

1.9

2.4

1.83

1.25

g/l

0.82

210

2646

Glucosamine medication

903

6275

1.15

4.08

2.6

2.5

0.88

1.01

g/l

0.50

766

5259

Benign neoplasm: salivary glands, exclude unknown (D119)

141

992

1.44

4.08

2.0

2.5

0.64

1.07

g/l

0.96

121

871

Vulvovaginal ulceration/inflammation in other diseases

376

1.72

4.07

1.8

2.2

0.12

0.51

g/l

1.65

338

Haemorrhagic disorder due to circulating anticoagulants

124

2.35

4.07

1.9

2.5

0.41

0.53

g/l

0.10

106

Other neurotic disorders

484

1.64

4.06

1.6

2.7

0.63

1.06

g/l

0.69

422

Alzheimer’s disease (undefined)

104

0.00

4.06

0.0

2.1

—

0.93

—

Thyrotoxicosis with diffuse goitre

183

1347

1.37

4.02

2.2

2.3

0.34

0.82

g/l

1.63

163

1186

Varicella [chickenpox]

296

1.81

4.02

6.0

2.3

1.67

0.53

g/l

0.85

269

Ulcerative colitis (strict definition, require KELA)

207

1554

1.34

3.99

2.7

2.3

1.08

0.82

g/l

0.37

181

1375

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

191

1418

1.36

3.94

2.6

1.5

0.98

0.56

g/l

0.90

153

1186

Other and unspecified follicular disorders

328

1.77

3.94

2.2

2.7

0.87

0.86

g/l

0.01

302

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

495

2459

1.21

3.94

2.3

1.6

1.29

0.52

g/l

3.26

418

2112

Diffuse brain injury

255

1.87

3.92

2.6

1.9

0.80

1.18

g/l

0.26

219

Other benign neoplasms of skin

581

4916

1.19

3.92

3.2

2.4

0.97

g/l

0.01

481

4167

Dissection of cerebral arteries, nonruptured

3.09

3.92

1.7

2.3

0.43

1.30

g/l

0.62

!Aliquae complicationes praecoces traumatis

359

1.73

3.90

2.5

2.6

0.65

0.93

g/l

0.33

324

Early complications of trauma

359

1.73

3.90

2.5

2.6

0.65

0.93

g/l

0.33

324

Other and specified injuries of hip and thigh

214

1.97

3.89

1.3

2.4

1.08

1.25

g/l

0.07

189

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

121

756

1.46

3.88

1.4

1.7

0.46

0.35

g/l

0.20

108

701

Varicose veins

1043

6949

1.14

3.88

2.4

0.83

0.97

g/l

0.56

869

5891

Injury of other and unspecified intrathoracic organs

625

1.54

3.87

1.8

2.4

0.71

1.28

g/l

0.95

547

Benign neoplasm: Kidney

346

1.74

3.85

2.4

2.8

1.07

1.00

g/l

0.06

304

Coxarthrosis, primary, with hip surgery

815

6720

1.16

3.85

2.3

2.5

0.71

1.05

g/l

2.68

678

5643

Open wound of hip and thigh

250

1.87

3.84

1.3

2.8

0.06

1.11

g/l

4.07

227

Drug-induced hypoglycaemia without coma

140

2.20

3.83

1.3

3.2

0.11

1.11

g/l

2.33

125

Vascular diseases of the intestine

407

1.68

3.83

2.4

2.5

0.73

1.36

g/l

1.03

351

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

178

1316

1.36

3.81

2.2

0.69

0.62

g/l

0.11

160

1151

Dissection of aorta

332

1.75

3.81

1.7

2.9

0.38

1.50

g/l

2.79

287

Other disorders of cornea

140

997

1.42

3.80

1.8

2.3

0.47

0.93

g/l

1.24

124

871

Benign neoplasm: Parotid gland

126

881

1.45

3.80

2.0

2.6

0.71

1.06

g/l

0.64

109

774

Unspecific neurodegenerative disorder

557

4539

0.84

3.80

1.9

2.5

1.31

1.13

g/l

0.37

402

3773

Spontaneous abortion

387

3220

0.81

3.78

2.1

2.4

0.62

0.64

g/l

0.07

338

2801

Carrier of infectious disease

195

1.99

3.78

1.4

2.0

0.26

1.27

g/l

1.85

175

Sequelae of injuries of neck and trunk

252

1.86

3.76

2.9

3.0

0.97

1.01

g/l

0.03

228

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

224

1717

1.31

3.76

2.7

2.3

1.07

0.82

g/l

0.39

198

1515

Disorders of breast

645

5117

1.17

3.74

2.1

2.4

0.47

0.74

g/l

2.18

545

4382

Scleritis and episcleritis

542

1.57

3.74

2.1

2.3

0.29

0.97

g/l

2.66

495

Benign neoplasm of major salivary glands

157

1145

1.39

3.73

1.9

2.5

0.57

1.05

g/l

1.34

136

992

Primary coxarthrosis, bilateral

490

4109

1.20

3.71

2.3

2.4

0.83

1.04

g/l

0.79

419

3428

Use of antiglaucoma preparations and miotics

143

1028

1.41

3.71

2.4

2.6

1.40

1.17

g/l

0.22

111

854

Alzheimer’s disease (undefined), excluding more controls

0.00

3.70

0.0

1.9

—

1.25

—

Other secondary gonarthrosis

568

1.56

3.70

2.5

2.9

0.80

1.30

g/l

0.87

498

Acute laryngitis and tracheitis

103

683

1.49

3.70

2.1

2.0

0.60

0.64

g/l

0.06

614

Other specified and unspecified retinal disorders

358

1.71

3.69

2.7

2.8

0.90

1.27

g/l

0.32

313

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

273

2127

1.27

3.68

2.0

2.1

0.49

0.73

g/l

0.90

244

1879

Triptan medication for migraine, single purchase ok

1014

6058

1.14

3.66

2.2

2.3

0.59

0.68

g/l

0.46

901

5299

Migraine, single triptan purchase ok & required. ICD-code if available is included

1014

6058

1.14

3.66

2.2

2.3

0.59

0.68

g/l

0.46

901

5299

Ganglion

254

1988

1.28

3.64

2.2

0.49

0.81

g/l

1.30

213

1716

Polyp of the female genital tract

452

2177

1.21

3.63

2.1

2.3

0.54

0.79

g/l

0.77

378

1859

Dental caries 3 and operation codes, only avohilmo

469

1952

1.21

3.62

2.7

2.9

0.74

1.03

g/l

0.91

419

1680

Visual impairment including blindness (binocular or monocular)

103

700

1.49

3.62

2.4

2.2

0.37

1.16

g/l

3.43

594

Benign neoplasm of brain and other parts of central nervous system

587

1.54

3.61

2.8

1.4

1.39

0.37

g/l

1.47

512

Benign neoplasm: Appendix

118

2.30

3.60

1.5

2.1

0.00

0.74

g/l

2.00

102

Other otitis externa (chronic)

644

1.51

3.60

2.3

2.6

1.13

1.05

g/l

0.04

565

Other salmonella infections

346

1.70

3.57

2.8

2.3

0.78

1.12

g/l

0.23

301

Acute suppurative otitis media

230

1662

1.30

3.56

3.0

2.0

0.86

0.64

g/l

0.32

208

1496

Malnutrition

172

2.03

3.55

1.6

2.5

1.52

0.85

g/l

0.35

148

Injury of muscle and tendon at lower leg level

215

1655

1.31

3.54

2.9

2.4

0.75

1.01

g/l

0.56

186

1465

Diseases of tongue

622

1.51

3.54

2.6

2.2

0.78

0.89

g/l

0.12

529

Disorder of external ear, unspecified

302

1.76

3.54

1.9

2.8

0.91

1.08

g/l

0.13

271

Single delivery by forceps and vacuum extractor

596

0.61

3.53

1.3

1.6

0.68

0.21

g/l

0.58

547

Lichen simplex chronicus

310

1.74

3.51

3.3

3.0

0.83

1.08

g/l

0.24

277

Benign neoplasm of meninges

145

1056

1.39

3.49

2.1

1.4

0.52

0.38

g/l

0.36

125

887

Postinflammatory hyperpigmentation

7.84

3.48

2.1

3.9

4.71

0.10

g/l

—

Visual field defects

132

948

1.41

3.46

2.3

2.2

0.75

1.11

g/l

0.66

111

822

Monocytic leukaemia

3.52

3.45

3.8

1.5

0.08

0.21

g/l

0.28

Irregular menses

524

3598

1.19

3.45

2.1

2.3

0.44

0.60

g/l

0.72

464

3166

Duodenal ulcer

177

1332

1.34

3.45

1.8

2.6

0.63

1.21

g/l

1.70

157

1133

Benign neoplasm of urinary organs

506

1.57

3.44

2.4

2.9

0.82

1.51

g/l

1.01

444

Open wound of abdomen, lower back and pelvis

216

1.88

3.44

1.8

2.4

0.28

0.94

g/l

1.06

196

Cluster headache, strict, including avohilmo

365

1.66

3.42

1.8

2.5

0.26

0.88

g/l

1.45

333

Gluteal tendinitis

335

1.70

3.42

2.1

2.3

0.58

0.90

g/l

0.45

289

Abdominal aortic aneurysm (AAA)

170

1263

1.35

3.42

2.2

2.5

1.12

1.48

g/l

0.46

134

1033

Nontoxic multinodular goitre

313

2536

1.24

3.40

2.1

2.5

0.97

0.96

g/l

0.01

258

2137

Benign neoplasm: Pituitary gland, craniopharyngeal duct

468

1.58

3.38

3.1

2.6

0.40

1.16

g/l

2.10

415

Subacute thyroiditis

337

1.69

3.36

3.0

2.3

0.60

0.80

g/l

0.22

300

Congenital malformations of heart and great arteries

149

1062

1.37

3.33

1.9

2.4

0.52

1.01

g/l

1.61

122

950

Maternal care for known or suspected fetal abnormality and damage

123

778

1.41

3.33

1.8

0.24

0.41

g/l

0.65

117

713

Lumbosacral root disorders, not elsewhere classified

109

2.27

3.32

2.7

2.3

0.89

1.39

g/l

0.24

Benign neoplasm of bone and articular cartilage

647

1.48

3.31

1.8

1.4

0.37

0.34

g/l

0.04

565

Premature rupture of membranes

1024

0.69

3.31

2.3

1.9

0.35

0.39

g/l

0.10

937

Benign neoplasm: Prostate

2.79

3.30

1.3

1.2

1.25

0.30

g/l

0.58

Type 1 diabetes, strict definition

367

1.64

3.30

1.4

1.5

0.19

0.58

g/l

0.96

346

Mental and behavioural disorders due to cannabinoids

115

2.20

3.30

1.7

1.5

0.13

0.61

g/l

0.87

107

Parapsoriasis

170

1.99

3.29

1.8

2.6

0.33

1.03

g/l

1.18

155

Benign neoplasm of breast

176

1334

1.33

3.28

2.6

2.2

0.64

0.66

g/l

0.03

148

1133

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

100

691

1.47

3.27

3.7

1.5

1.84

0.48

g/l

1.19

589

Infectious mononucleosis

416

1.60

3.26

1.8

1.6

0.34

0.47

g/l

0.26

387

Injury of muscle and tendon at hip and thigh level

130

943

1.39

3.23

2.0

2.4

0.78

1.09

g/l

0.50

118

835

Other specified/unspecified disorders of bone/cartilage

243

1.80

3.23

2.2

2.1

0.78

0.92

g/l

0.11

223

Senility

2.63

3.23

1.6

1.8

0.83

0.92

g/l

0.04

Salpingitis and oophoritis

236

1863

1.28

3.23

1.7

2.5

0.48

0.76

g/l

0.91

207

1615

Burns and corrosions

168

1268

1.33

3.22

2.0

2.3

0.66

0.92

g/l

0.39

143

1127

Status post-ami

886

0.65

3.21

1.6

2.6

1.81

1.60

g/l

0.07

710

Emergency coronary revascularization (for ACS)

988

6322

1.13

3.21

2.0

2.6

0.99

1.06

g/l

0.21

853

5278

Benign neoplasm: Spinal meninges

111

2.25

3.21

1.5

2.2

0.62

0.75

g/l

0.09

Benign neoplasm: Skin of eyelid, including canthus

240

1902

1.27

3.20

3.3

2.4

0.85

0.90

g/l

0.10

201

1623

Retinal breaks without detachment

241

1911

1.27

3.20

2.6

2.4

0.64

0.87

g/l

0.73

204

1650

Other symptoms and signs involving the digestive system and abdomen

225

1769

1.28

3.18

1.9

2.4

0.55

0.94

g/l

1.64

184

1514

Benign neoplasm: Skin of ear and external auricular canal

437

1.58

3.16

2.2

2.7

1.20

1.35

g/l

0.10

383

Dislocation, sprain and strain of joints and ligaments at neck level

166

1254

1.33

3.16

2.7

2.3

0.51

0.89

g/l

0.88

146

1121

Cluster headache, wide,, including avohilmo

397

1.61

3.15

1.8

2.5

0.40

0.86

g/l

0.92

360

Malignant neoplasm of bronchus and lung

208

2479

0.78

3.15

2.2

2.3

0.97

1.21

g/l

0.39

175

2061

Focal epilepsy, strict definition

270

2173

1.25

3.13

2.1

2.3

0.73

0.88

g/l

0.27

221

1864

Meralgia paraesthetica

298

1.71

3.13

1.5

2.5

0.97

1.22

g/l

0.19

257

Noninflammatory disorders of female genital tract

546

2341

1.18

3.13

2.1

2.2

0.52

0.73

g/l

0.98

475

2015

Other keratitis

139

1025

1.37

3.12

2.0

2.3

0.46

0.97

g/l

1.74

124

902

Dislocation, sprain and strain of joints and ligaments of thorax

268

1.74

3.12

1.5

2.6

0.13

1.04

g/l

3.48

239

Diseases of appendix

1077

8808

1.12

3.11

2.6

2.4

0.75

0.81

g/l

0.25

937

7624

Appendectomy

881

7532

1.13

3.11

2.4

2.3

0.70

0.75

g/l

0.17

769

6556

Abnormal blood-pressure reading, without diagnosis

391

1.61

3.11

2.5

2.6

0.36

0.96

g/l

1.69

343

Other disorders of pigmentation

439

1.57

3.10

2.5

2.3

1.05

0.92

g/l

0.08

388

Other puerperal infections

367

1.62

3.10

1.4

1.7

0.97

0.30

g/l

0.48

344

Unspecified misadventure during surgical and medical care

544

1.51

3.08

1.8

2.7

0.64

1.33

g/l

1.28

480

Contact with sharp object, undetermined intent

153

2.00

3.08

1.7

2.2

0.38

1.14

g/l

1.02

140

Alzheimer’s disease (Atypical or mixed)

1111

0.67

3.08

1.8

2.2

2.03

1.23

g/l

0.45

898

Single spontaneous delivery

454

2857

0.84

3.07

2.4

2.2

0.66

0.70

g/l

0.10

402

2426

Alzheimer disease

383

3448

0.83

3.07

1.8

2.3

1.40

1.20

g/l

0.28

274

2837

Malignant neoplasm of digestive organs

490

5630

0.85

3.05

2.1

2.5

0.78

1.10

g/l

1.26

416

4698

Viral and other specified intestinal infections

191

1443

1.30

3.05

1.9

2.0

0.77

0.75

g/l

0.02

171

1268

Other disorders of the genitourinary system

201

1570

1.29

3.04

2.4

0.99

0.93

g/l

0.11

179

1332

Clear cell adenocarcinoma of kidney

514

1.52

3.04

1.8

2.8

1.08

1.35

g/l

0.18

449

Crohn's disease of small intestine

545

1.50

3.04

1.7

2.4

0.24

0.91

g/l

2.96

487

Other obstructive and reflux uropathy

331

1.65

3.03

1.6

2.2

0.60

1.12

g/l

0.77

296

Acute appendicitis

988

8343

1.12

3.03

2.6

2.4

0.77

0.78

g/l

0.03

863

7240

Other and unspecified mononeuropathies of lower limb

256

1.75

3.02

1.8

2.3

0.74

1.17

g/l

0.37

218

Ulcer of oesophagus

112

804

1.41

3.01

2.0

2.8

0.55

1.28

g/l

2.09

694

Organic, including symptomatic, mental disorders

876

5617

1.13

3.00

2.1

2.5

1.11

1.05

g/l

0.18

680

4736

Central retinal artery occlusion

242

1.78

3.00

3.7

2.7

0.73

1.24

g/l

0.46

206

Hereditary angioödema type 1

7.72

2.99

9.3

1.0

8.12

1.22

g/l

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

295

1.69

2.98

2.6

1.4

0.81

0.41

g/l

0.46

254

Other disorders of iris and ciliary body

250

1.75

2.97

2.5

3.0

0.94

1.12

g/l

0.12

220

Other diseases of spinal cord

265

1.73

2.96

5.5

3.0

0.54

1.36

g/l

1.13

240

Short Achilles tendon (acquired)

209

0.33

2.95

5.9

2.4

3.93

1.43

g/l

—

185

Otitis media, unspecified

104

678

1.42

2.94

2.6

2.2

1.06

0.84

g/l

0.16

607

Graves ophthalmopathy, strict

199

1.85

2.94

1.2

2.0

0.97

0.53

g/l

0.19

180

Asthma mixed form (mode), excluding more controls

420

1.56

2.94

2.0

1.8

0.48

0.78

g/l

0.47

357

Aortic valve malfunction, age under 60 years

123

900

1.38

2.94

1.9

2.4

0.68

1.03

g/l

0.45

107

800

Degenerative macular diseases

201

1579

1.28

2.93

2.2

2.4

0.93

0.95

g/l

0.02

166

1333

Delivery

460

2860

0.85

2.92

2.3

2.2

0.62

0.70

g/l

0.24

408

2429

Other sexually transmitted chlamydial diseases

250

1.73

2.92

1.4

0.00

0.46

g/l

2.48

234

Mental and behavioural disorders due to tobacco

116

842

1.39

2.92

1.9

2.6

0.82

0.94

g/l

0.12

747

UC patients in KELA-register (code 208), prior to 1994

462

1.54

2.91

2.3

2.8

0.61

1.12

g/l

0.96

414

Spontaneous rupture of synovium and tendon

116

842

1.39

2.91

2.5

2.2

1.04

1.07

g/l

0.03

721

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

259

1.73

2.91

3.0

1.4

0.99

0.50

g/l

0.40

215

Lichen ruber planus, wide definition including periferal and oral lichen planus

308

2539

1.22

2.89

2.3

2.4

1.02

0.84

g/l

0.34

269

2171

Benign neoplasm: Cerebral meninges

127

937

1.37

2.89

2.2

1.4

0.58

0.41

g/l

0.42

112

789

Other epidermal thickening

415

1.56

2.88

2.3

2.8

0.38

1.24

g/l

2.08

367

Viral warts

119

869

1.38

2.88

2.2

2.4

0.70

0.85

g/l

0.21

103

772

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

659

4500

1.15

2.87

2.2

1.5

0.82

0.48

g/l

2.01

558

3796

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

169

1301

1.31

2.87

2.9

1.5

1.34

0.45

g/l

2.50

141

1117

Later onset COPD

519

3512

1.17

2.86

1.7

2.5

0.92

1.20

g/l

0.76

433

2898

Encephalopathy

2.30

2.86

2.2

2.9

1.21

0.70

g/l

0.30

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.74

2.86

9.3

1.0

3.13

0.71

g/l

—

Acute appendicitis, no complications

731

6439

1.14

2.85

2.6

2.3

0.79

0.74

g/l

0.15

642

5637

Left ventricular outflow tract obstruction (LVOTO), broad definition

128

948

1.36

2.84

1.8

2.4

0.67

1.00

g/l

0.47

112

843

Haemangioma, any site

104

745

1.41

2.83

2.9

1.4

1.17

0.36

g/l

1.03

648

Brachial plexus disorders

103

737

1.41

2.81

2.2

2.3

1.02

0.78

g/l

0.17

662

Corneal ulcer

231

1854

1.25

2.80

2.4

2.2

0.64

0.86

g/l

0.64

202

1618

Smoking dependency

116

849

1.38

2.79

1.9

2.6

0.82

0.94

g/l

0.12

753

Other, unspecified and serous retinal detachments

309

1.65

2.78

2.0

2.9

1.11

1.12

g/l

0.00

272

Colitis, primary sclerosing

2.25

2.77

2.1

2.2

0.00

1.03

g/l

2.09

Nasal polyp

285

2343

1.22

2.77

2.8

2.4

1.27

0.96

g/l

0.38

254

2012

Cysts of oral region, not elsewhere classified

372

1.58

2.75

2.4

2.2

0.40

1.09

g/l

1.86

327

Appendicitis, broad definition

1059

8753

1.11

2.73

2.6

2.4

0.75

0.81

g/l

0.20

923

7577

Disturbance of activity and attention

351

1.58

2.73

1.4

1.5

0.66

0.35

g/l

0.37

328

Crohn's disease of large intestine

421

1.54

2.71

1.4

2.5

0.28

0.78

g/l

1.64

378

Haemangioma and lymphangioma, any site

109

794

1.38

2.70

2.9

1.4

1.12

0.34

g/l

1.04

687

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.92

2.70

1.5

1.2

1.33

0.04

g/l

0.62

Strabismus

328

2735

1.20

2.69

2.3

2.2

0.91

0.81

g/l

0.21

285

2370

Allergic contact dermatitis

159

1226

1.30

2.68

1.5

2.4

0.54

0.79

g/l

0.49

136

1077

Complications of labour and delivery

626

3981

0.87

2.68

2.7

2.3

0.73

0.62

g/l

0.38

554

3448

Hyperkinetic disorders

384

1.55

2.68

1.4

1.6

0.61

0.32

g/l

0.37

358

Ill-defined and unknown causes of mortality

794

0.64

2.68

2.1

2.5

0.93

1.29

g/l

0.42

665

Mouth breathing

572

4994

1.15

2.67

2.5

1.04

0.83

g/l

0.64

493

4362

Corneal scars and opacities

243

1.72

2.67

1.8

3.0

1.09

1.19

g/l

0.05

214

Other and unspecified mononeuropathies, also in other diseases

289

1.65

2.67

2.3

2.5

1.82

1.17

g/l

0.28

248

Tonsillectomy and adenotomy

447

3630

0.86

2.67

1.8

2.1

0.88

0.57

g/l

0.73

399

3252

Hyperfunction of pituitary gland

343

1.59

2.67

4.0

2.1

0.73

0.77

g/l

0.04

315

Burns and corrosions of multiple and unspecified body regions

169

1.87

2.66

2.2

2.5

1.15

1.32

g/l

0.05

155

Right side

0.00

2.65

0.0

2.2

—

0.30

—

Alzheimer disease, including avohilmo

470

3932

0.86

2.65

1.9

2.4

1.41

1.21

g/l

0.33

353

3238

Other papulosquamous disorders

100

2.16

2.64

5.2

2.3

0.78

1.04

g/l

0.17

Contusion of toe(s) without damage to nail

155

1.90

2.64

1.2

2.8

0.00

0.89

g/l

2.46

146

Melanocytic naevi of upper limb, including shoulder

177

1.84

2.63

2.3

1.3

1.24

0.29

g/l

0.66

161

Benign neoplasm of middle ear and respiratory system

106

773

1.38

2.63

3.1

1.5

1.02

0.51

g/l

1.09

664

Scabies

321

1.61

2.62

2.9

2.0

0.93

0.74

g/l

0.17

292

Delivery, wide proxy

383

2405

0.84

2.62

2.3

2.2

0.74

0.69

g/l

0.12

333

2008

Other other unspecified disorders of the circulatory system

378

1.56

2.60

2.0

2.8

1.36

1.24

g/l

0.06

327

Benign neoplasm of male genital organs

193

1.80

2.59

1.8

1.4

0.55

0.52

g/l

0.03

167

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

114

2.05

2.58

3.2

2.3

0.41

0.58

g/l

0.16

106

Perichondritis of external ear

186

1.82

2.58

1.6

2.6

0.78

0.87

g/l

0.09

160

Disorders of lacrimal system and orbit in diseases classified elsewhere

223

1.73

2.58

1.2

1.9

0.91

0.86

g/l

0.02

203

Other retinal artery occlusion

254

1.69

2.57

1.5

3.2

0.27

1.59

g/l

3.09

224

Arterial embolism and thrombosis of lower extremity artery

387

1.55

2.57

1.8

2.9

0.57

1.55

g/l

1.69

330

Complications of genitourinary prosthetic devices, implants and grafts

231

1.72

2.56

2.2

2.1

0.07

0.72

g/l

1.88

201

Ingrowing nail

427

1.51

2.56

1.8

2.6

0.66

0.94

g/l

0.38

381

Ulcer of vagina/vulva

201

1.77

2.55

2.4

0.37

0.67

g/l

0.41

179

Viral encephalitis, not elsewhere classified/unspecified

179

1.82

2.55

4.4

2.7

2.02

0.93

g/l

0.55

161

Unspecified urinary incontinence

130

984

1.33

2.55

1.4

2.3

0.85

0.93

g/l

0.09

832

Other specified disorders of external ear

397

1.54

2.52

2.1

2.8

1.10

1.32

g/l

0.15

353

Assault by bodily force

477

1.48

2.52

1.7

2.2

0.48

0.62

g/l

0.15

439

Scar conditions and fibrosis of skin

325

1.59

2.51

2.7

2.3

0.20

0.70

g/l

1.29

290

Use of disulfiram, acamprosate or naltrexone

108

797

1.37

2.50

1.4

2.4

0.44

0.99

g/l

1.44

712

Crohn disease (strict definition, require KELA, min 2 HDR)

462

1.48

2.49

1.8

2.3

0.17

0.83

g/l

3.25

420

Benign neoplasm: Choroid

587

1.43

2.49

2.1

1.4

1.50

0.38

g/l

1.26

501

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

520

1.45

2.48

2.0

2.4

0.20

0.83

g/l

3.15

464

Other arterial embolism and thrombosis

303

1.61

2.48

1.5

2.9

0.36

1.52

g/l

2.30

259

Sequelae of injuries of head

463

1.48

2.48

3.2

2.7

0.04

1.16

g/l

6.32

414

Crohn disease (strict definition, require KELA)

471

1.48

2.47

1.8

2.3

0.17

0.82

g/l

3.28

427

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

573

3279

1.15

2.47

2.1

1.5

0.62

0.41

g/l

0.83

478

2789

Graves ophthalmopathy

226

1.71

2.47

1.2

2.0

0.91

0.77

g/l

0.06

206

Achilles tendinitis

135

1032

1.32

2.47

2.8

2.2

0.84

0.92

g/l

0.10

119

902

Occupational exposure to risk-factors

337

0.47

2.46

2.8

2.9

1.51

1.39

g/l

0.04

301

Other renal tubulo-interstitial diseases

181

1.80

2.46

1.9

2.1

0.63

0.67

g/l

0.04

163

Schizophrenia

121

1594

0.76

2.46

2.6

2.3

0.43

0.84

g/l

1.52

1409

All dysplastic lesions of the cervix uteri

221

1790

1.24

2.45

2.3

2.1

0.63

0.49

g/l

0.32

199

1591

Anorexia (incl.atypical)

367

1.54

2.43

2.6

1.8

0.14

0.73

g/l

2.81

335

Flat foot [pes planus] (acquired)

114

853

1.35

2.42

2.0

2.5

1.06

1.03

g/l

0.02

738

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

572

3279

1.14

2.41

2.1

1.5

0.62

0.41

g/l

0.83

477

2789

Benign neoplasm of eye and adnexa

148

1151

1.30

2.40

2.2

2.4

1.34

0.95

g/l

0.44

122

1003

Other strabismus

247

2028

1.22

2.40

2.3

0.97

0.79

g/l

0.30

218

1781

Ulcerative proctitis

516

1.45

2.39

1.4

2.3

0.44

0.88

g/l

0.84

460

Personal history of malignant neoplasm

378

1.53

2.38

4.8

2.0

0.09

0.64

g/l

3.99

336

Leisure time condition

234

1919

1.23

2.38

1.9

2.3

1.13

0.91

g/l

0.30

176

1663

Focal epilepsy

281

2346

1.20

2.37

2.1

2.3

0.70

0.89

g/l

0.39

230

2015

Carcinoma in situ of skin, other sites/unspecified

105

2.06

2.35

2.4

1.2

0.98

0.26

g/l

0.84

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.37

2.35

1.5

0.00

1.57

g/l

1.85

Burns and corrosions of external body surface, specified by site

128

979

1.32

2.35

2.1

2.4

0.77

1.07

g/l

0.35

106

873

Open wound of wrist and hand

557

4860

1.14

2.34

2.5

2.3

0.78

0.79

g/l

0.03

490

4242

Suppurative and unspecified otitis media

367

2780

1.17

2.32

2.6

2.1

0.83

0.67

g/l

0.33

327

2443

Schizophrenia or delusion, excluding more controls

341

2881

1.18

2.30

2.0

2.3

0.71

0.75

g/l

0.05

284

2533

Secondary parkinsonism, excluding more controls

208

1.71

2.29

3.2

2.1

0.51

1.35

g/l

1.00

171

Malignant neoplasm of respiratory system and intrathoracic organs

255

2814

0.83

2.29

2.3

0.93

1.14

g/l

0.43

217

2341

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1243

0.73

2.28

3.1

2.5

0.63

1.16

g/l

1.45

1062

Retrobulbar neuritis in diseases classified elsewhere

4.04

2.28

5.4

1.1

0.59

1.72

g/l

—

Parkinson's disease, including avohilmo

256

2131

1.21

2.28

2.0

2.4

0.33

1.07

g/l

6.49

208

1780

Other blood glucose lowering drugs, excl. Insulins

271

2268

1.20

2.27

1.9

2.4

0.51

1.04

g/l

3.04

229

1906

Autonomic disorders

194

1.73

2.26

2.3

2.6

0.22

1.25

g/l

1.99

173

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

514

1.43

2.26

1.7

2.4

0.16

0.82

g/l

3.68

465

Fasciculation

100

2.05

2.24

1.3

2.2

0.07

0.96

g/l

1.83

Acute alcohol intoxication, ICD10

248

2061

1.21

2.23

1.4

2.4

0.34

0.87

g/l

3.24

212

1819

Campylobacter enteritis

233

1.66

2.23

2.1

2.6

2.00

1.22

g/l

0.26

206

Maternal care for other known or suspected fetal problems

104

889

0.75

2.22

1.7

1.8

0.05

0.31

g/l

3.26

823

Other ill-defined and unspecified causes of mortality

699

0.65

2.22

1.6

2.5

1.01

1.37

g/l

0.37

586

Hydrocele

175

1405

1.25

2.21

2.5

2.6

1.03

1.26

g/l

0.44

157

1181

Open wound of shoulder and upper arm

158

1.80

2.20

1.6

2.3

0.39

1.05

g/l

0.75

140

Focal epilepsy, mode (most common among epilepsy diagnosis)

244

2029

1.21

2.19

2.2

2.3

0.80

0.90

g/l

0.16

199

1742

Medial epicondylitis

297

1.57

2.18

2.1

0.91

1.15

g/l

0.21

264

Leiomyoma of uterus

865

4450

1.11

2.17

2.2

2.3

0.61

0.75

g/l

0.68

714

3824

Fibrosis of liver

2.45

2.16

1.9

2.3

0.60

0.95

g/l

0.18

Procedures for purposes other than remedying health state

212

1.68

2.16

2.3

1.6

0.33

0.50

g/l

0.28

195

Benign lipomatous neoplasm

378

3266

1.16

2.15

2.8

1.5

0.95

0.45

g/l

2.50

326

2788

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

420

2962

1.15

2.15

2.0

1.5

0.66

0.44

g/l

0.64

348

2499

Type 1 diabetes, strict definition, subgroup 1

329

1.52

2.14

1.4

1.5

0.23

0.58

g/l

0.69

311

Benign neoplasm: Prostate

2.22

2.14

1.3

3.2

1.25

0.48

g/l

0.45

Asthma mixed form (mode)

453

1.45

2.14

2.0

1.8

0.48

0.83

g/l

0.59

382

Corns and callosities

699

1.36

2.13

1.9

2.5

0.63

0.92

g/l

0.49

614

Arthropathy in ulcerative colitis

102

2.00

2.13

1.6

2.1

0.45

1.14

g/l

0.68

Hordeolum and other deep inflammation of eyelid

479

1.43

2.13

2.7

2.6

0.20

1.20

g/l

4.45

433

Cerebral aneurysm, nonruptured

120

925

1.31

2.13

1.6

2.4

0.52

1.03

g/l

1.23

101

804

Malignant neoplasm of rectum

1193

0.74

2.12

2.7

2.5

0.67

1.20

g/l

1.51

1016

Combinations of oral blood glucose lowering drugs

440

3850

1.15

2.12

1.8

2.6

0.63

1.01

g/l

2.47

386

3292

Benign leiomyoma with endometriosis

203

1665

1.23

2.11

2.3

1.5

0.63

0.44

g/l

0.53

165

1396

Colorectal adenocarcinoma

227

2725

0.83

2.11

2.5

2.4

0.83

1.02

g/l

0.33

183

2284

Adenocarcinoma and papilloma adenocarcinoma of rectum

1191

0.74

2.10

3.1

2.5

0.66

1.18

g/l

1.33

1015

Pre-eclampsia or eclampsia

223

1846

1.21

2.10

2.2

0.50

0.56

g/l

0.16

198

1619

Contact with heat and hot substances

422

1.46

2.10

1.7

2.5

0.72

0.85

g/l

0.08

382

Other acute skin changes due to ultraviolet radiation

357

1.50

2.10

1.9

2.5

0.57

1.11

g/l

0.55

314

Contusion of other and unspecified parts of foot

316

1.53

2.09

2.6

2.4

0.63

0.86

g/l

0.23

291

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

367

1.49

2.05

3.5

1.4

0.96

0.42

g/l

1.00

319

Secondary malignant neoplasm of other and unspecified sites

147

0.33

2.04

1.2

2.8

0.00

0.94

g/l

—

131

Oesophageal obstruction

368

1.49

2.03

3.1

0.64

1.60

g/l

1.27

321

Burn and corrosion of wrist and hand

263

1.58

2.02

1.2

2.4

0.27

0.96

g/l

1.49

238

Graves disease, strict definition

112

862

1.31

2.01

2.3

0.13

0.69

g/l

4.08

100

766

Tobacco use

443

1.44

2.01

1.5

2.7

1.67

0.92

g/l

0.35

402

HSIL lesion of the cervix uteri, vagina or vulva

175

1421

1.24

2.01

2.2

2.0

0.59

0.49

g/l

0.18

154

1254

Coronary angioplasty

660

4555

1.12

2.00

2.1

2.5

0.94

1.10

g/l

0.54

570

3786

Melanocytic naevi of upper limb, including shoulder

194

1.68

1.99

2.3

2.8

1.24

0.81

g/l

0.23

176

Carcinoma in situ of skin of lip

2.90

1.99

1.1

0.74

0.02

g/l

—

Complications of other internal prosthetic devices, implants and grafts

403

1.46

1.98

2.5

2.3

0.61

1.17

g/l

0.75

348

Laparoscopic right hemicolectomy

658

1.35

1.97

2.1

2.8

0.44

1.36

g/l

3.09

567

Other secondary coxarthrosis

346

1.49

1.97

1.7

2.6

0.35

1.25

g/l

1.85

308

Optic neuritis

321

1.51

1.97

1.5

2.3

0.32

0.68

g/l

0.61

295

Degeneration of the brain due to alcohol

226

1.62

1.97

1.5

3.1

1.41

1.35

g/l

0.02

202

Cholangitis (primary sclerosing, PSC)

606

1.37

1.96

1.8

2.5

0.43

1.26

g/l

2.95

527

Other and unspecified disorders of adult personality and behaviour

2.80

1.95

1.4

1.3

0.00

0.95

g/l

—

Other specified/unspecified dorsopathies

322

1.51

1.95

5.2

2.3

0.94

1.25

g/l

0.24

283

Myocardial infarction, with ST-elevation

281

2396

1.18

1.95

1.8

2.4

0.69

1.15

g/l

1.20

237

2009

Vascular dementia (subcortical)

339

1.50

1.95

2.4

2.5

1.45

1.13

g/l

0.19

276

Tracheo-bronchomalasia

3.84

1.95

1.7

3.9

0.00

2.71

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

572

1.37

1.95

2.9

2.3

0.40

0.54

g/l

0.24

513

Pilonidal cyst

589

1.37

1.95

2.0

2.2

0.31

0.81

g/l

1.10

541

Lichen planus, including avohilmo

258

2185

1.19

1.94

2.4

1.09

0.87

g/l

0.35

225

1871

Other and unspecified injuries of wrist and hand

290

1.53

1.94

1.5

2.1

0.07

0.70

g/l

2.36

259

Degeneration of nervous system due to alcohol

227

1.61

1.94

1.5

3.1

1.41

1.32

g/l

0.02

201

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

102

779

1.32

1.94

2.5

0.76

1.28

g/l

0.88

661

Benign neoplasm of brain and other parts of central nervous system

668

1.34

1.93

2.8

2.6

1.39

1.05

g/l

0.31

588

Other maternal disorders predominantly related to pregnancy

521

3685

0.89

1.93

2.3

0.55

0.59

g/l

0.15

453

3248

Episcleritis

455

1.42

1.93

2.0

2.3

0.24

0.95

g/l

2.62

418

Alzheimer’s disease, wide definition

302

2936

0.86

1.92

1.8

2.4

1.33

1.25

g/l

0.09

222

2402

Injury of nerves and spinal cord at neck level

220

1.62

1.91

3.1

3.3

0.86

1.06

g/l

0.14

196

Other noninflammatory disorders of uterus, except cervix

329

1935

1.17

1.90

2.5

2.3

0.94

0.84

g/l

0.19

272

1636

Meningitis

440

1.42

1.89

3.2

2.6

1.21

0.87

g/l

0.21

396

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

2.09

1.89

3.8

1.4

1.82

0.35

g/l

0.80

Pre-eclampsia or poor fetal growth

277

2357

1.18

1.89

2.2

2.1

0.44

0.51

g/l

0.23

247

2088

Injuries involving multiple body regions

300

1.52

1.89

2.8

2.6

0.27

1.02

g/l

1.91

266

Other predominantly sexually transmitted diseases, not elsewhere classified

151

1216

1.25

1.89

1.8

2.0

0.59

g/l

0.01

133

1095

Acquired coagulation factor deficiency

3.81

1.89

2.7

1.0

1.15

0.06

g/l

—

Vascular dementia (mixed)

159

1.73

1.89

2.7

2.5

1.91

0.87

g/l

0.39

132

Benign neoplasm of male genital organs

213

1.63

1.88

1.8

2.8

0.55

1.62

g/l

1.37

189

Corneal degeneration

144

1.77

1.88

1.1

2.2

0.07

0.95

g/l

1.71

126

Thyroiditis, unspecified

144

1.77

1.88

1.3

1.8

0.00

0.95

g/l

1.82

131

Inguinal hernia, bilateral

160

1300

1.24

1.88

2.6

2.3

1.39

1.04

g/l

0.38

136

1107

Postpartum haemorrhage

136

1480

0.80

1.88

2.4

2.1

0.63

0.47

g/l

0.33

120

1341

Other and unspecified acute skin changes due to ultraviolet radiation

269

1.55

1.87

2.0

2.8

0.22

1.26

g/l

2.18

234

Sudden idiopathic hearing loss

150

1211

1.25

1.87

2.6

2.3

1.50

0.92

g/l

0.84

115

1050

Abnormal findings in secretions and smears from cervix uteri vagina vulva

512

3580

1.13

1.86

2.3

2.2

0.49

0.60

g/l

0.38

452

3121

Inguinal or femoral hernia, bilateral

163

1329

1.24

1.85

2.6

2.2

1.38

1.07

g/l

0.34

138

1133

Conductive hearing loss, unspecified

112

875

1.29

1.84

3.1

2.3

1.44

0.94

g/l

0.41

769

Ulcerative rectosigmoiditis

736

1.31

1.81

2.3

1.23

1.01

g/l

0.15

658

Paralytic strabismus

763

1.31

1.81

2.2

2.6

1.22

1.23

g/l

0.00

671

HSIL lesion of the cervix uteri

151

1223

1.24

1.81

2.2

2.1

0.59

0.48

g/l

0.18

136

1089

Redundant prepuce, phimosis and paraphimosis

239

2015

1.19

1.81

2.3

2.6

0.35

0.96

g/l

5.48

214

1750

Outcome of delivery

129

631

1.27

1.80

1.8

2.0

0.13

0.37

g/l

1.34

121

582

Polypectomy (DHB20)

729

1.31

1.80

2.8

2.5

1.94

1.09

g/l

0.48

643

Use of levodopa decarboxylase inhibitor

212

1781

1.20

1.79

2.1

2.4

0.59

1.10

g/l

2.10

173

1491

Varicose veins of other sites

634

1.34

1.78

2.4

2.6

1.26

1.05

g/l

0.14

560

Drug-induced thyroiditis

3.51

1.78

1.0

1.3

0.00

0.81

g/l

—

Status epilepticus

321

1.48

1.78

1.4

2.7

0.56

1.13

g/l

0.63

275

Other mental disorders due to brain damage and dysfunction and to physical disease

170

1401

1.22

1.76

2.8

2.4

0.67

1.09

g/l

1.08

131

1196

Cytomegaloviral hepatitis

3.07

1.76

1.7

2.2

0.00

0.65

g/l

—

Erectile dysfunction

131

1052

1.26

1.74

2.5

1.16

1.26

g/l

0.10

114

889

Congenital iodine-deficiency syndrome/hypothyroidism

323

1.47

1.74

2.8

2.3

0.70

0.92

g/l

0.14

277

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

103

1.88

1.74

3.7

1.4

2.29

0.44

g/l

0.65

Degenerative diseases of the nervous system

461

3892

0.89

1.73

1.8

2.3

1.28

1.18

g/l

0.15

334

3223

Other diseases of gallbladder

500

1.37

1.73

3.1

2.6

1.27

1.21

g/l

0.04

434

Pregnancy with abortive outcome

876

4200

1.09

1.72

2.0

2.4

0.53

0.79

g/l

1.87

751

3579

267

1.52

1.72

2.3

3.0

0.76

1.59

g/l

0.98

224

Unstable angina pectoris

671

5055

1.10

1.71

2.5

1.02

1.10

g/l

0.19

570

4196

Retinal haemorrhage

259

1.53

1.71

4.8

3.1

2.25

1.11

g/l

0.64

225

Other specified disorders of kidney and ureter

316

1.47

1.71

3.1

1.10

1.15

g/l

0.03

280

Other intracranial haemorrhages

333

1.46

1.70

2.3

2.5

0.58

1.46

g/l

1.78

278

Dronedarone medication

317

1.47

1.69

1.6

2.6

1.08

1.65

g/l

0.44

272

Other drug-induced secondary parkinsonism

1.94

1.68

2.4

2.5

0.21

0.60

g/l

—

Lung diseases due to external agents

202

1700

1.19

1.68

2.6

2.3

1.08

1.09

g/l

0.01

158

1432

Alcohol withdrawal state with delirium

737

1.30

1.68

1.3

2.5

0.65

1.14

g/l

0.57

651

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

2.34

1.67

2.1

1.1

2.78

0.04

g/l

0.66

Moderate visual impairment, binocular

293

1.49

1.67

1.9

2.2

0.44

0.91

g/l

0.71

244

Myopia

118

940

1.26

1.67

2.1

2.4

0.83

0.84

g/l

0.01

105

843

Juvenile osteochondrosis

204

1.58

1.66

1.7

2.4

0.00

0.68

g/l

3.32

188

Acute alcohol intoxication

346

3038

1.14

1.66

1.6

2.5

0.61

0.97

g/l

0.73

293

2629

malignant neoplasm of female genital organs

155

1877

0.82

1.66

2.0

2.3

0.48

0.80

g/l

1.11

128

1562

Crohn disease (strict definition, all UC cases excluded)

376

1.42

1.66

1.5

2.5

0.31

0.78

g/l

1.26

342

Sixth [abducent] nerve palsy

335

1.45

1.65

2.8

3.0

1.82

1.36

g/l

0.21

288

Other and unspecified disease of Bartholin gland

302

1.48

1.65

1.3

2.6

0.17

0.84

g/l

2.38

268

Benign neoplasm: Lip

181

1.63

1.65

3.0

1.4

2.84

0.37

g/l

0.87

156

Familial hypercholesterolemia, with ischemic heart disease

157

1294

1.22

1.65

2.0

2.4

0.85

1.18

g/l

0.45

132

1065

Deep endometriosis

943

0.75

1.65

1.4

2.3

0.49

0.71

g/l

0.29

816

Respiratory tuberculosis, confirmed

189

1.61

1.65

1.4

2.9

0.39

1.03

g/l

0.68

161

Prepatellar bursitis

419

1.40

1.65

1.6

2.2

0.54

1.27

g/l

1.18

355

Dysplasia of cervi uteri

241

1591

1.17

1.64

2.3

2.0

0.76

0.61

g/l

0.31

213

1385

Colorectal cancer

286

3286

0.87

1.63

2.5

2.3

0.89

1.00

g/l

0.19

238

2749

Benign neoplasm of ovary

213

1807

1.18

1.63

2.4

1.5

1.06

0.38

g/l

1.88

184

1505

Alzheimer’s disease (Late onset), excluding more controls

242

1379

1.18

1.62

1.9

2.4

1.33

1.40

g/l

0.07

174

1144

Tongue abnormality

689

1.30

1.61

2.6

0.88

1.15

g/l

0.31

601

Other facial nerve disorders

238

1.53

1.61

2.3

2.4

0.81

1.08

g/l

0.17

207

Other acquired deformities of musculoskeletal system and connective tissue

455

1.38

1.61

2.6

0.86

1.03

g/l

0.16

403

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

357

2638

1.14

1.61

2.3

1.5

1.06

0.53

g/l

1.73

306

2221

Other benign neoplasms of connective and other soft tissue

115

920

1.26

1.59

3.0

1.5

0.99

0.50

g/l

0.55

794

Viral haemorrhagic fevers, not elsewhere classified/unspecified

822

0.74

1.59

3.4

2.4

1.39

0.99

g/l

0.21

727

Pedal cyclist injured in noncollision transport accidents

129

1046

1.24

1.58

1.8

2.3

0.33

0.95

g/l

2.58

110

927

Maternal care related to the fetus and amniotic cavity and possible delivery problems

346

2316

0.88

1.58

2.8

2.1

0.58

0.51

g/l

0.22

311

2069

Disorders of eyelid in diseases classified elsewhere

305

1.46

1.58

1.2

2.7

0.00

1.11

g/l

4.77

267

Trigeminal neuralgia

587

1.32

1.56

2.6

2.5

0.81

1.07

g/l

0.31

513

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

104

825

1.27

1.56

2.3

2.6

0.50

1.12

g/l

2.11

720

Lateral epicondylitis

149

1229

1.22

1.55

2.2

0.76

0.97

g/l

0.36

131

1077

Any dementia

547

4255

0.90

1.55

1.9

2.4

1.15

g/l

0.01

410

3528

Other disorders of skin and subcutaneous tissue related to radiation

3.54

1.55

1.2

1.1

0.14

0.00

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

1045

0.77

1.55

3.6

2.4

1.26

1.04

g/l

0.14

919

Lichen sclerosus et atrophicus

133

1086

1.23

1.55

1.9

2.2

0.34

0.72

g/l

1.62

115

919

Contraceptive management

355

2824

0.88

1.55

2.3

2.2

0.74

0.61

g/l

0.23

312

2542

Hypertrophic disorders of skin

441

1.37

1.54

2.9

2.4

0.37

0.75

g/l

0.94

402

Non-invasive ventilation

230

1853

1.17

1.53

3.2

2.5

2.33

0.88

g/l

2.86

187

1601

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.14

1.53

1.5

2.7

1.33

0.79

g/l

0.19

Blindness, monocular

1.94

1.52

5.9

2.3

0.69

0.91

g/l

—

Use of galantamine

883

0.75

1.52

1.3

2.4

0.70

1.23

g/l

0.49

718

Vascular dementia (sudden onset)

0.00

1.52

0.0

2.5

—

1.01

—

Pedestrian injured in transport accident

660

1.30

1.52

1.7

2.4

0.87

1.10

g/l

0.24

583

Other or unspecified paralytic strabismus

2.12

1.51

1.0

3.0

0.00

0.76

g/l

1.03

Personal history of certain other diseases

1.88

1.51

1.3

1.8

0.60

0.31

g/l

0.36

Alzheimer’s disease, wide definition, excluding more controls

251

1472

1.16

1.51

1.9

2.4

1.09

1.32

g/l

0.33

184

1226

Endometriosis of rectovaginal septum and vagina

815

0.74

1.51

1.5

2.1

0.57

0.72

g/l

0.15

700

Other and unspecified nerve root and plexus disorders, also in other diseases

234

2016

1.17

1.50

3.1

2.2

1.06

0.91

g/l

0.26

196

1756

Dementia in other diseases classified elsewhere

522

1.34

1.50

1.8

2.7

0.66

1.50

g/l

1.19

442

Chronic iridocyclitis

470

1.35

1.49

2.4

2.6

0.58

1.07

g/l

0.88

416

Other and unspecified abdominal hernia

428

1.37

1.48

1.5

2.0

0.21

1.16

g/l

2.85

371

Benign neoplasm of meninges

145

1201

1.22

1.48

2.1

2.5

0.52

0.97

g/l

1.58

125

1025

Malignant melanoma of skin

166

1393

1.20

1.48

2.0

2.5

0.87

1.09

g/l

0.28

137

1195

Antepartum haemorrhage, not elsewhere classified

496

1.34

1.48

2.4

1.8

0.72

0.39

g/l

0.30

456

Congenital malformations of genital organs

597

1.30

1.47

2.0

0.44

g/l

0.00

542

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

285

1.45

1.47

1.6

2.5

0.56

0.89

g/l

0.35

261

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

261

2273

1.15

1.46

2.5

1.5

1.09

0.48

g/l

1.54

214

1895

Other diseases of biliary tract

121

986

1.24

1.46

2.7

2.4

0.48

0.98

g/l

1.53

100

840

Parkinson's disease, strict definition

220

1894

1.17

1.45

2.0

2.4

0.36

1.10

g/l

5.32

181

1590

Bitten or struck by other mammals

111

896

1.24

1.45

2.4

2.6

0.58

0.98

g/l

0.67

102

803

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

464

1.35

1.44

2.9

1.4

1.74

0.50

g/l

1.46

386

Nonsuppurative otitis media

209

1545

1.17

1.44

2.2

2.0

0.87

0.76

g/l

0.12

181

1358

Parkinson's disease

236

2046

1.16

1.42

2.0

2.4

0.36

1.08

g/l

5.67

193

1716

Pre-eclampsia

195

1665

1.17

1.41

2.4

2.2

0.51

0.58

g/l

0.16

173

1465

Diseases of middle ear and mastoid

679

5110

1.09

1.41

2.6

2.2

0.79

0.77

g/l

0.03

596

4431

Other abnormal findings in urine

150

1.63

1.40

7.3

2.6

1.01

0.82

g/l

0.10

131

Peritonsillar abscess

224

1936

1.16

1.39

2.8

2.2

0.91

0.76

g/l

0.25

199

1692

Other noninflammatory disorders of vagina

722

1.27

1.39

2.6

2.0

0.46

0.69

g/l

0.39

616

Acute lymphadenitis

450

1.34

1.39

3.0

2.6

1.05

0.90

g/l

0.09

402

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

785

1.26

1.38

3.2

1.4

0.58

0.39

g/l

0.17

671

Infective dermatitis

145

1210

1.20

1.38

2.2

2.5

0.78

0.99

g/l

0.27

120

1044

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

331

1.40

1.38

1.9

1.5

1.49

0.55

g/l

0.74

276

Hereditary corneal dystrophies

357

1.39

1.38

1.5

2.9

0.55

1.25

g/l

0.79

315

Respiratory conditions due to other external agents

215

1.51

1.38

7.5

2.2

1.44

0.87

g/l

0.32

187

Benign neoplasm: Skin of trunk

365

1.38

3.5

1.4

0.63

0.46

g/l

0.20

320

Erythema intertrigo

207

1.52

1.37

1.9

3.5

0.20

1.21

g/l

2.12

184

Respiratory tuberculosis, bacteriologically and histologically confirmed

199

1.53

1.37

1.4

2.8

0.39

1.31

g/l

1.01

170

Glaucoma-related operations

672

1.28

1.36

3.0

2.6

1.58

1.30

g/l

0.19

575

Macular hole

699

1.27

1.36

2.7

2.6

0.62

1.11

g/l

0.72

600

LSIL lesion of the cervix uteri, vagina or vulva

126

1039

1.22

1.36

2.4

2.1

0.43

0.57

g/l

0.32

113

918

Foreign body entering into or through eye or natural orifice

743

1.26

1.35

3.1

2.4

0.66

1.16

g/l

1.11

664

Ménière disease

136

1132

1.21

1.35

1.7

2.6

0.76

1.07

g/l

0.52

115

980

Bacterial meningitis

316

1.41

1.34

4.0

2.9

1.73

0.88

g/l

0.41

284

Nontoxic single thyroid nodule

780

1.25

1.34

2.6

2.4

0.86

0.92

g/l

0.06

687

Oral lichen ruber planus, including avohilmo

629

1.28

1.34

2.1

2.7

1.27

0.95

g/l

0.23

553

Pneumonitis due to solids and liquids

109

889

1.23

1.33

1.5

2.3

0.45

1.16

g/l

1.70

753

Haemangioma, any site

104

844

1.24

1.32

2.9

2.5

1.17

1.01

g/l

0.12

744

Frontotemporal dementia

2.00

1.31

2.4

2.6

1.33

0.62

g/l

—

Chromophobe cell carcinoma of kidney

2.07

1.30

2.1

1.8

2.78

0.24

g/l

0.59

Lichen planus

179

1532

1.17

1.30

2.6

2.4

1.13

0.91

g/l

0.29

155

1328

Pregnancy, childbirth and the puerperium

351

2056

0.89

1.30

1.9

2.2

0.59

0.81

g/l

0.76

302

1697

All dysplastic lesions of the vulva

396

1.35

1.28

1.3

2.5

0.26

0.75

g/l

0.96

353

Lesion of radial nerve

336

1.38

1.28

2.2

2.4

2.16

1.38

g/l

0.34

292

Benign neoplasm of other and unspecified female genital organs

471

0.69

1.28

1.8

2.3

0.65

0.77

g/l

0.08

409

Benign neoplasm of bone and articular cartilage

768

1.24

1.26

1.8

2.5

0.37

0.94

g/l

1.77

684

Aneurysms, operations, SAH

227

1983

1.15

1.26

2.1

2.3

0.53

0.92

g/l

1.54

188

1689

Abnormalities of forces of labour

714

1.25

1.26

1.6

2.1

0.07

0.52

g/l

4.14

661

Unspecified jaundice

529

1.30

1.25

2.2

2.3

1.03

1.32

g/l

0.20

452

Systemic sclerosis,strict definition

1.80

1.25

1.3

2.0

1.23

0.76

g/l

0.15

Colorectal cancer, excluding all cancers (controls excluding all cancers)

383

3343

1.11

1.24

2.4

1.5

0.96

0.52

g/l

1.54

317

2804

Other lesions of median nerve

279

1.41

1.24

1.2

2.5

0.05

0.98

g/l

3.31

231

Other disorders of bone density and structure

196

1.49

1.23

1.6

2.4

0.72

0.90

g/l

0.14

179

Presence of other devices

284

3189

0.89

1.22

2.4

1.20

1.06

g/l

0.19

244

2680

Glaucoma secondary to other eye disorders

417

1.33

1.22

2.8

0.81

1.31

g/l

0.39

362

Other peripheral vertigo

127

1063

1.20

1.22

2.0

2.6

0.95

1.04

g/l

0.06

928

Haemangioma and lymphangioma, any site

109

899

1.22

1.21

2.9

2.4

1.12

0.99

g/l

0.10

793

Car occupant injured in other and unspecified transport accidents

200

1737

1.15

1.21

2.4

2.2

0.94

0.86

g/l

0.08

172

1527

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

656

1.26

1.21

2.6

1.4

0.95

0.52

g/l

0.63

567

Changes in corneal membranes

2.40

1.21

1.5

2.6

0.00

1.47

g/l

—

Benign neoplasm: Choroid

666

1.26

1.20

2.1

2.6

1.50

1.24

g/l

0.18

583

Impotence

559

1.28

1.20

2.4

2.5

1.16

1.32

g/l

0.16

472

Other problems related to primary support group, including family circumstances

692

1.24

1.19

2.0

2.2

0.49

0.63

g/l

0.25

626

Presbycusis

226

1974

1.14

1.19

3.0

2.3

1.46

1.10

g/l

0.42

171

1630

Malignant neoplasm of mesothelium and soft tissue

472

1.30

1.19

3.3

2.9

2.69

1.40

g/l

0.56

413

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

411

1.33

1.18

3.5

2.7

0.96

1.34

g/l

0.48

364

Dementia

627

4677

0.92

1.18

1.9

2.5

1.15

1.09

g/l

0.13

468

3916

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

596

1.27

1.18

3.5

1.4

0.75

0.39

g/l

0.26

517

Pleural plaque

154

1317

1.18

1.17

2.2

2.4

1.28

1.31

g/l

0.02

124

1099

Dental caries 2 and operation codes, only avohilmo

963

5608

1.07

1.17

2.5

0.74

0.84

g/l

0.29

825

4853

Benign neoplasm of other and unspecified sites

291

1.39

1.16

2.8

1.4

0.53

0.43

g/l

0.11

252

Acute nasopharyngitis (common cold)

126

1053

1.19

1.15

2.0

2.1

0.61

0.66

g/l

0.07

112

949

Postpartum care and examination

500

0.78

1.15

1.7

1.8

0.12

0.29

g/l

0.84

460

Neovascular glaucoma

422

1.31

1.14

2.8

2.7

0.81

1.40

g/l

0.47

365

Benign neoplasm: Endocrine pancreas

1.95

1.14

1.9

1.2

1.13

0.49

g/l

0.42

Other benign neoplasm of uterus: Other parts/unspecified

493

1.29

1.14

3.1

1.4

1.12

0.39

g/l

0.70

400

Gonococcal infection

284

1.39

1.13

2.4

2.0

1.09

0.75

g/l

0.15

259

Embedded teeth, including avohilmo

501

1.28

1.13

3.1

2.0

0.66

g/l

0.00

458

Other vitreous opacities

397

1.32

1.12

3.4

2.9

1.79

1.24

g/l

0.27

351

Benign neoplasm: Scrotum

2.32

1.12

1.3

0.00

0.21

g/l

—

Alzheimer disease, excluding more controls

272

1616

1.13

1.12

2.0

2.4

1.21

1.29

g/l

0.10

193

1359

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

897

0.80

1.11

2.3

1.5

0.86

0.56

g/l

0.54

758

TMD related pain

251

1.41

1.11

1.9

2.4

0.27

0.61

g/l

0.50

229

Carcinoma in situ of skin, other sites/unspecified

136

1.57

1.11

2.4

2.3

0.98

0.90

g/l

0.05

112

Other factor of the environment

104

1.66

1.11

4.2

1.6

1.95

0.89

g/l

0.52

Other specific arthropathies, wide

168

1.50

1.11

1.5

2.6

0.55

1.69

g/l

1.01

151

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

628

1.25

1.10

2.9

2.2

0.40

0.55

g/l

0.26

566

Other operation for atrial fibrillation

1.92

1.10

1.4

2.2

0.29

0.77

g/l

0.53

Use of peginterferon beta-1a

2.43

1.10

2.6

1.0

2.42

1.48

g/l

—

Disturbances of smell and taste

425

1.30

1.10

3.0

3.2

0.62

1.18

g/l

0.90

375

malignant neoplasm of male genital organs

683

4035

1.08

1.10

2.4

2.6

1.35

1.13

g/l

0.52

560

3439

Postpartum hemorraghe, all women as controls

136

1584

0.85

1.08

2.4

2.0

0.63

0.38

g/l

0.59

120

1436

342

2933

1.11

1.07

2.3

1.16

1.15

g/l

0.02

263

2405

Benign lipomatous neoplasm of other sites/unspecified

111

932

1.20

1.06

3.2

1.4

0.71

0.50

g/l

0.37

101

789

Contact with other hot fluids

203

1.44

1.06

1.3

2.6

0.00

1.07

g/l

3.97

188

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

212

1763

1.14

1.06

2.2

1.5

1.27

0.51

g/l

1.47

178

1466

Endometriosis of pelvic peritoneum

155

1320

1.16

1.06

1.7

2.2

0.71

0.69

g/l

0.03

131

1149

Felty syndrome

1.88

1.05

1.4

2.6

0.86

0.44

g/l

0.30

Dislocation of lens

146

1.53

1.05

4.5

2.8

2.14

0.98

g/l

0.35

129

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

652

1.23

1.04

2.3

1.5

0.63

0.50

g/l

0.17

544

Spermatocele

106

890

1.20

1.03

2.7

2.5

1.51

1.20

g/l

0.27

754

Alzheimer’s disease (Late onset)

285

2710

0.90

1.03

1.8

2.4

1.37

1.29

g/l

0.08

206

2209

Malignant neoplasm of breast, HER-negative

229

2568

0.89

1.02

2.2

2.5

0.66

0.83

g/l

0.39

186

2151

Use of rivastigmine

163

1865

0.87

1.02

2.0

2.4

1.24

1.15

g/l

0.08

120

1508

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

308

2786

1.11

1.02

3.2

1.5

0.97

0.50

g/l

1.19

263

2361

Chorioretinal scars

2.06

1.02

1.9

2.4

0.00

0.55

g/l

—

Presbyopia

573

1.25

1.01

1.5

2.4

0.90

0.94

g/l

0.03

515

Other abnormal products of conception

247

1466

1.12

1.01

1.9

2.2

0.30

0.42

g/l

0.48

227

1325

Single delivery by caesarean section

115

787

0.84

1.01

2.1

1.6

0.35

0.27

g/l

0.13

104

727

Conductive and sensorineural hearing loss

1292

8518

1.05

1.00

2.7

2.4

1.24

0.89

g/l

1.55

1040

7318

Embolic stroke with flimmer

274

1.36

1.00

2.2

1.9

1.52

1.39

g/l

0.04

226

Glaucoma

906

7509

1.06

0.99

2.4

2.5

1.26

1.00

g/l

1.09

734

6341

Postprocedural musculoskeletal disorders, not elsewhere classified

793

1.21

0.99

2.6

0.50

1.07

g/l

1.30

690

Carcinoma in situ of breast, intraductal

811

1.20

0.99

1.9

1.5

0.53

0.37

g/l

0.32

689

Benign neoplasm: Cerebral meninges

127

1088

1.17

0.98

2.2

2.5

0.58

0.95

g/l

1.02

112

937

Respiratory tuberculosis, not confirmed

492

0.75

0.98

2.6

2.8

1.11

1.30

g/l

0.14

414

Polyhydramnios

235

0.64

0.96

1.5

2.0

0.00

0.31

g/l

1.90

216

Use of rasagiline

294

1.34

0.96

1.4

3.3

0.02

1.30

g/l

4.98

258

Alzheimer’s disease (Atypical or mixed), excluding more controls

761

0.81

0.96

1.9

2.2

2.11

1.71

g/l

0.18

623

Radial styloid tenosynovitis [de Quervain]

434

1.27

0.96

2.7

2.2

0.73

0.95

g/l

0.17

390

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

2.30

0.95

1.8

1.9

0.00

0.87

g/l

—

Unknown and unspecified causes of morbidity

605

1.23

0.95

2.2

2.3

0.39

0.94

g/l

1.77

513

Blood alcohol or alcohol intoxication level

166

1.46

0.95

1.3

2.3

0.00

1.12

g/l

3.28

157

Right hemicolectomy

706

1.21

0.95

3.2

2.6

1.18

1.29

g/l

0.09

608

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

150

1.49

0.94

2.2

2.0

1.37

0.82

g/l

0.39

129

Intermittent heterotropia

364

1.30

0.94

2.2

0.33

0.76

g/l

1.15

327

Vascular dementia

126

1047

1.17

0.94

2.2

2.3

1.32

1.38

g/l

0.04

851

Chalazion

133

1149

1.16

0.93

3.1

2.4

0.87

1.02

g/l

0.20

112

1011

Benign neoplasm of middle ear and respiratory system

106

900

1.18

0.93

3.1

2.5

1.02

1.19

g/l

0.24

778

Malignant neoplasm of prostate

673

3982

1.07

0.93

2.4

2.6

1.36

1.14

g/l

0.51

551

3389

Colorectal neuroendocrine tumor and carcinoma

126

1.53

0.92

3.7

2.6

2.29

1.02

g/l

0.39

116

Benign neoplasm: Endocrine pancreas

1.79

0.92

1.9

2.2

1.13

0.99

g/l

0.07

Pathological resorption of teeth

227

1.38

0.91

1.2

2.1

0.26

0.92

g/l

1.68

208

Pyoderma

168

1.44

0.90

2.1

2.6

0.28

1.25

g/l

1.31

151

Other diseases of peritoneum

465

1.26

0.90

1.6

2.5

0.77

1.06

g/l

0.29

404

Infections of genitourinary tract in pregnancy

807

0.81

0.90

2.7

2.2

0.41

0.58

g/l

0.42

712

Foreign body on external eye

127

1466

0.86

0.90

2.3

2.4

1.00

0.92

g/l

0.09

112

1305

Postpartum hemorraghe, parous women as controls

136

1369

0.87

0.89

2.4

2.1

0.63

0.45

g/l

0.38

120

1234

Brain meningioma, excluding all cancers (controls excluding all cancers)

520

1.24

0.89

2.4

1.4

0.84

0.41

g/l

0.74

441

Orthopaedic devices associated with adverse incidents

186

1.42

0.89

1.1

2.9

1.36

0.74

g/l

0.23

160

Benign neoplasm: Cranial nerves

263

1.34

0.89

4.4

1.3

0.98

0.33

g/l

0.65

231

Inflammatory disorders of breast

457

1.25

0.89

1.7

2.4

0.68

0.67

g/l

0.01

412

Other and unspecified disorders of orbit

1.90

0.88

1.4

1.7

0.82

0.78

g/l

—

Lack of expected normal physiological development

2.01

0.87

1.0

0.00

0.04

g/l

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

127

1101

1.16

0.87

3.1

1.5

0.83

0.57

g/l

0.53

111

930

Tooth eruption problems

678

1.20

0.86

2.6

1.8

0.51

0.56

g/l

0.07

625

Benign neoplasm: Parathyroid gland

1.59

0.85

1.3

0.68

0.41

g/l

—

Contact with machinery

103

1201

0.85

2.3

2.4

1.63

1.06

g/l

0.42

1053

Amblyopia ex anopsia

291

1.31

0.85

1.2

2.3

0.02

0.89

g/l

4.29

261

Obstructed labour due to malposition and malpresentation of fetus

132

1425

0.87

0.85

1.7

2.0

0.35

0.40

g/l

0.09

121

1300

Maternal care for known or suspected malpresentation of fetus

761

0.84

2.2

1.8

0.50

0.34

g/l

0.30

698

Carcinoma in situ, bladder

328

1.29

0.83

4.3

1.4

1.35

0.49

g/l

0.82

282

Myocardial infarction, unclassifiable

303

2948

0.91

0.82

1.8

2.3

0.37

1.25

g/l

10.67

258

2431

Mild mental retardation

165

0.60

0.82

2.3

0.62

1.01

g/l

—

155

Dystonia

544

1.22

0.82

1.3

2.5

0.27

0.92

g/l

1.95

483

Carcinoma in situ of middle ear and respiratory system

1.74

0.82

2.1

1.2

1.26

0.34

g/l

—

conjunctival haemorrhage

100

857

1.17

0.81

2.5

2.4

0.42

1.05

g/l

2.03

747

Other benign neoplasms of uterus

627

1.20

0.81

3.0

1.5

1.13

0.40

g/l

0.85

520

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

169

1503

1.13

0.81

2.9

2.4

1.34

0.97

g/l

0.65

141

1313

Other ulcerative colitis

472

1.23

0.81

1.3

2.6

0.96

0.98

g/l

0.01

421

Laparoscopic left hemicolectomy

181

1.40

0.81

2.7

2.8

2.51

1.06

g/l

0.38

159

Vertigo of central origin

164

1.42

0.81

1.7

2.8

1.15

0.86

g/l

0.11

139

Benign neoplasm: Larynx

285

1.31

0.81

3.2

1.3

1.11

0.44

g/l

0.60

247

Frontotemporal dementia, wide, incl. Pick's disease

1.66

0.80

2.4

1.33

0.55

g/l

—

Evidence of alcohol involvement determined by blood alcohol level

106

1.52

0.79

1.3

1.9

0.00

1.21

g/l

2.10

101

L01XE Protein kinase inhibitors

666

1.19

0.79

3.6

2.7

0.98

1.27

g/l

0.33

585

Convalescence

492

1.23

0.79

2.3

2.2

1.16

0.89

g/l

0.14

437

Burns and corrosions confined to eye and internal organs

199

1.37

0.78

1.6

2.4

0.51

0.98

g/l

0.58

186

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.78

0.0

1.1

—

0.44

—

Dislocation, sprain and strain of joints and ligaments of elbow

465

1.23

0.78

2.2

1.9

0.15

0.85

g/l

2.87

419

Transient global amnesia

102

1180

0.86

0.78

2.6

2.4

1.32

1.05

g/l

0.21

1025

Other female pelvic inflammatory diseases

188

1687

1.12

0.78

1.7

2.4

0.57

0.67

g/l

0.24

140

1445

Sequelae of injuries of upper limb

110

954

1.16

0.77

2.8

2.5

1.79

1.00

g/l

0.61

840

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

713

1.18

0.77

3.3

1.4

0.66

0.41

g/l

0.20

613

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

1136

0.86

0.77

2.9

1.5

0.58

0.52

g/l

0.11

963

Schizoaffective disorder

621

1.20

0.77

2.0

2.4

0.52

0.69

g/l

0.26

562

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

649

0.81

0.77

3.4

1.4

0.72

0.31

g/l

0.60

542

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

466

1.23

0.77

1.7

2.1

0.24

0.50

g/l

0.52

430

Fall on and from ladder

853

1.17

0.77

4.1

2.7

0.82

1.33

g/l

0.82

747

Other disorders of conjunctiva

191

1720

1.11

0.76

2.7

2.3

1.04

0.95

g/l

0.09

167

1471

Nonspecific lymphadenitis

504

1.22

0.75

2.2

2.3

0.63

0.65

g/l

0.02

456

Benign mammary dysplasia

187

1683

1.11

0.75

2.7

2.3

0.58

0.68

g/l

0.23

159

1430

Benign neoplasm: Scrotum

1.88

0.75

1.3

1.5

0.00

0.96

g/l

—

Benign neoplasm of other and unspecified sites

316

1.28

0.74

2.8

2.4

0.53

0.98

g/l

0.58

279

Burn and corrosion confined to eye and adnexa

167

1.39

0.74

1.7

2.5

0.43

1.06

g/l

0.78

158

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

732

0.83

0.73

3.7

2.6

0.41

1.12

g/l

2.12

641

Calcaneal spur

100

1.52

0.73

1.3

2.0

0.24

1.42

g/l

—

Dementia, including avohilmo

689

5013

0.95

0.73

1.9

2.5

1.17

1.09

g/l

0.19

517

4202

Dislocation, sprain and strain of joints and ligaments of knee

726

6400

1.05

0.73

2.0

2.4

0.47

0.78

g/l

2.83

623

5625

Other disorders of breast

139

1232

1.13

0.73

2.2

0.36

0.58

g/l

0.78

113

1066

L02BA Anti-estrogens

200

1813

1.11

0.71

2.1

2.3

0.76

0.72

g/l

0.04

173

1550

Unspecified mental disorder

483

4537

1.07

0.71

2.1

2.3

0.48

0.79

g/l

1.73

411

3948

Other disorders of Eustachian tube

265

1.29

0.70

1.8

2.4

0.89

0.93

g/l

0.02

237

Chondromalacia

265

1.29

0.70

1.6

2.3

1.41

0.88

g/l

0.22

248

Foreign body in alimentary tract

518

1.20

0.70

1.5

2.6

0.50

1.33

g/l

1.77

460

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

195

1.34

0.70

4.2

1.3

0.89

0.39

g/l

0.25

169

Carcinoma in situ of other and unspecified sites

364

1.25

0.70

4.1

1.5

1.23

0.48

g/l

0.76

313

Oesophagitis, drug-induced

1.91

0.69

1.0

0.00

0.04

g/l

—

Specific developmental disorder of motor function

1.89

0.69

1.0

2.2

0.00

0.17

g/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

1092

0.87

0.69

3.0

1.5

0.61

0.52

g/l

0.15

925

Carcinoma in situ of breast, lobular

1.62

0.69

4.9

1.4

1.49

0.32

g/l

0.45

Perforation of tympanic membrane

117

1030

1.14

0.69

2.2

2.3

0.80

0.88

g/l

0.10

104

897

Acute appendicitis, with complications

257

2362

1.09

0.69

2.8

2.3

0.71

0.91

g/l

0.61

221

2047

Benign neoplasm: Lip

222

1.32

0.69

3.0

2.5

2.84

0.87

g/l

0.64

194

Secondary parkinsonism+Parkinsonism in other disease

284

1.28

0.69

3.2

2.8

0.51

1.59

g/l

1.70

247

Toxic effects of substances chiefly nonmedicinal as to source

1038

0.86

0.68

1.9

2.4

0.18

1.00

g/l

3.60

916

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

612

1.18

0.68

1.2

1.5

0.34

0.52

g/l

0.45

518

Multiple delivery

745

0.84

0.66

2.2

2.0

0.58

0.49

g/l

0.11

661

Postmenopausal atrophic vaginitis

351

1966

1.08

0.66

2.6

2.3

0.82

0.83

g/l

0.01

305

1675

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

698

1.17

0.66

1.8

1.5

0.89

0.59

g/l

0.46

588

Secondary parkinsonism

278

1.27

0.64

3.2

2.8

0.51

1.53

g/l

1.53

242

Other menopausal disorders

352

1890

1.08

0.64

2.1

2.3

0.54

0.74

g/l

0.72

310

1631

Benign neoplasm of other and unspecified female genital organs

415

0.79

0.64

1.8

1.4

0.65

0.32

g/l

0.23

355

Communicating hydrocephalus

216

1.31

0.64

2.4

3.1

0.45

1.36

g/l

1.53

189

Scarlet fever

1.74

0.64

1.0

2.5

0.00

1.52

g/l

—

Non-allergic asthma

102

896

1.14

0.64

2.1

2.5

0.75

1.01

g/l

0.24

773

Other melanin hyperpigmentation

234

1.29

0.64

1.7

2.5

0.33

1.23

g/l

1.72

207

Motor disorders

1.72

0.63

1.0

2.1

0.00

0.16

g/l

—

Colon adenocarcinoma

141

1569

0.90

0.63

2.5

1.01

1.14

g/l

0.12

114

1327

Recurrent and persistent haematuria

1.54

0.63

1.6

2.4

0.13

0.75

g/l

1.40

Endometriosis of ovary

183

1660

1.10

0.63

1.8

2.3

0.77

0.72

g/l

0.07

154

1432

Macular cyst

297

1.26

0.63

1.3

3.2

0.09

1.48

g/l

3.95

261

Residual foreign body in soft tissue

387

1.22

0.63

2.3

2.1

0.42

1.42

g/l

2.10

334

Motorcycle rider injured in noncollision transport accidents

190

1.32

0.63

1.9

1.8

0.98

0.90

g/l

0.04

179

Universal erythroderma, KELA reimbursement

130

1.40

0.62

1.4

2.6

1.74

1.25

g/l

0.13

117

Other helminthiases

0.00

0.62

0.0

2.6

—

0.00

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

434

1.20

0.61

2.6

1.4

0.95

0.44

g/l

0.70

369

Obstructed labour due to maternal pelvic abnormality

136

1513

0.90

0.61

3.0

2.3

0.74

0.76

g/l

0.01

116

1329

Seminoma of testis, excluding all cancers (controls excluding all cancers)

1.58

0.61

1.8

1.3

0.14

0.43

g/l

—

Congenital hydrocephalus

0.00

0.60

0.0

4.5

—

1.80

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

296

2298

1.08

0.60

2.2

1.5

1.13

0.51

g/l

1.67

250

1927

Separation of retinal layers (serosa)

381

1.21

0.59

2.0

2.7

0.64

1.17

g/l

0.70

344

Maltreatment syndromes

299

1.24

0.59

2.1

1.9

1.12

0.63

g/l

0.28

280

Hepatocellular carcinoma

219

1.29

0.59

1.9

2.8

1.21

1.20

g/l

0.00

190

Other and unspecified injuries of thorax

140

1.37

0.59

1.6

2.5

1.94

1.16

g/l

0.19

123

Other infective (teno)synovitis

1.74

0.58

1.0

1.4

1.35

1.22

g/l

—

Accidental poisoning by and exposure to alcohol

113

0.62

0.58

1.3

3.3

0.00

0.79

g/l

—

103

Heterophoria

669

1.15

0.58

3.0

2.5

1.21

0.94

g/l

0.17

596

Uterine polyps

109

970

1.13

0.58

2.3

2.2

0.92

0.78

g/l

0.17

838

Other appendicitis

839

1.14

0.57

2.8

2.5

0.50

1.06

g/l

1.52

743

Vertical strabismus

292

1.24

0.57

2.0

2.8

0.65

0.96

g/l

0.38

261

Embolic stroke

521

1.18

0.57

1.8

2.6

0.99

1.56

g/l

0.35

430

Von Willebrand disease

1.44

0.57

2.7

2.3

1.06

0.71

g/l

0.22

Struck by thrown, projected or falling objec

374

1.21

0.57

3.1

2.7

0.35

0.87

g/l

0.72

339

Medical treatment for female infertility

110

1229

0.89

0.57

1.7

1.9

0.40

0.36

g/l

0.08

100

1118

Ovarian dysfunction, other/unspecified

1.64

0.56

2.7

2.4

4.05

1.06

g/l

—

Persistent delusional disorders

784

0.86

0.55

2.0

2.4

0.87

0.91

g/l

0.03

682

FESS (DNB20)

114

1271

0.89

0.55

2.3

2.4

1.35

0.89

g/l

0.25

1122

Open wound of thorax

116

1.39

0.55

2.2

2.4

1.61

1.38

g/l

—

107

Benign neoplasm: Skin of trunk

422

1.19

0.55

3.5

2.7

0.63

1.15

g/l

0.69

377

Glaucoma suspect

481

5063

0.95

0.54

2.4

1.31

0.93

g/l

1.06

388

4281

Examination and encounter for administrative purposes

367

1.20

0.54

3.4

2.6

0.82

1.15

g/l

0.29

314

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

1.49

0.54

1.6

1.1

1.22

0.05

g/l

—

Other and unspecified injuries of shoulder and upper arm

249

1.25

0.54

2.8

2.6

0.53

0.95

g/l

0.52

219

Other fall from one level to another

249

2317

1.08

0.53

2.2

2.3

0.80

0.90

g/l

0.18

213

2022

Bicuspidal aortic valve syndrome

295

1.23

0.53

1.7

2.7

0.32

1.17

g/l

1.97

270

Superficial injuries involving multiple body regions

205

1.28

0.53

4.0

2.7

0.29

0.83

g/l

0.94

187

Labour and delivery complicated by fetal stress [distress]

122

903

0.90

0.52

1.8

0.19

0.27

g/l

0.36

112

828

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

1.52

0.52

1.8

1.4

0.87

0.03

g/l

—

Malignant neoplasm, without specification of site

333

1.21

0.51

2.6

2.12

1.44

g/l

0.33

277

Gender identity disorders

1.47

0.50

1.0

1.8

0.00

0.78

g/l

—

Oligomenorrhoea

252

1.23

0.50

1.7

2.3

0.28

0.88

g/l

1.07

220

Benign neoplasm: Parathyroid gland

110

1.38

0.49

1.3

2.2

0.68

0.76

g/l

—

LSIL lesion of the cervix uteri

745

1.13

0.49

3.0

2.2

0.64

0.51

g/l

0.21

673

Oral leukoplakia, including avohilmo

280

1.22

0.49

1.2

2.2

0.62

1.09

g/l

0.40

252

Other obstructed labour

626

0.86

0.49

2.7

2.2

0.39

0.53

g/l

0.22

568

Maternal care for known or suspected abnormality of pelvic organs

164

1230

0.92

0.48

3.0

2.1

0.53

0.49

g/l

0.08

145

1115

Lifestyle-related condition

102

1.39

0.48

4.6

1.7

1.85

0.51

g/l

0.66

Other complications of labour and delivery, not elsewhere classified

478

0.85

0.48

1.5

1.6

0.27

0.21

g/l

0.11

439

Use of selegiline

541

1.15

0.47

2.2

2.6

0.11

1.46

g/l

7.20

467

Pterygium

318

1.20

0.47

2.2

2.7

0.48

1.48

g/l

1.72

280

Other rupture of muscle

1.47

0.47

1.0

2.3

0.00

2.40

g/l

—

Injury of muscle and tendon at wrist and hand level

157

1445

1.09

0.47

2.1

2.5

1.01

0.96

g/l

0.05

140

1274

Correction of physiology of bite - demanding therapy visit

548

0.86

0.47

4.4

2.5

1.12

0.80

g/l

0.19

500

Congenital malformations of aortic and mitral valves

328

1.19

0.46

1.7

2.6

0.29

1.15

g/l

2.31

300

Benign neoplasm of thyroid gland

342

0.81

0.46

1.4

2.4

0.25

1.07

g/l

1.67

304

Other and unspecified degenerative diseases of nervous system

255

1.22

0.46

1.7

2.7

1.39

g/l

0.00

218

Normotensive glaucoma

121

1103

1.10

0.46

2.6

2.5

1.72

1.08

g/l

0.73

942

Benign neoplasm: Skin of other and unspecified parts of face

119

1305

0.91

0.45

4.2

2.4

0.94

0.95

g/l

0.01

1120

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

1.42

0.45

2.3

1.1

0.80

0.48

g/l

—

Palindromic rheumatism

1.41

0.45

1.5

1.6

0.08

1.19

g/l

2.13

Other benign neoplasm of uterus: Other parts/unspecified

554

1.14

0.44

3.1

2.3

1.12

1.01

g/l

0.07

451

Carcinoma in situ of breast, lobular

1.43

0.44

4.9

2.7

1.49

0.66

g/l

0.29

Lesion of sciatic nerve

543

0.86

0.43

1.6

2.5

2.73

1.31

g/l

0.50

450

Exposure to excessive natural cold

0.65

0.43

1.2

2.6

0.00

0.93

g/l

—

Carcinoma in situ of middle ear and respiratory system

1.42

0.43

2.1

3.3

1.26

0.25

g/l

—

Malignant neoplasm of bladder

888

1.11

0.42

1.8

2.6

0.68

1.30

g/l

1.00

743

Follow-up care involving plastic surgery

350

1.18

0.42

1.5

2.0

0.29

0.68

g/l

0.66

308

Congenital malformations of spine and bony thorax

1.58

0.42

1.0

2.3

0.00

0.23

g/l

—

Malignant neoplasm of corpus uteri

1016

0.90

0.42

1.6

2.2

0.41

0.80

g/l

1.10

848

Obstetric embolism

0.00

0.42

0.0

1.1

—

0.00

—

Cyst of spleen

0.00

0.41

0.0

3.8

—

0.99

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.41

0.0

3.0

—

1.03

—

Benign neoplasm: Pineal gland

0.00

0.41

0.0

1.1

—

0.91

—

Injury of muscle and tendon at shoulder and upper arm level

504

4838

1.04

0.41

2.3

2.5

0.72

0.92

g/l

0.69

428

4174

Use of levodopa decarbox-comt-inhibitor

370

1.17

0.41

1.1

3.1

0.16

1.49

g/l

4.25

321

Other specified and unspecified strabismus

1.40

0.41

2.3

2.7

2.71

0.84

g/l

0.31

Other benign neoplasms of connective and other soft tissue

115

1053

1.09

0.41

3.0

2.4

0.99

0.94

g/l

0.04

922

Pedal cyclist injured in transport accident

243

2290

1.06

0.41

2.1

2.3

0.61

0.83

g/l

0.65

208

2003

Pregnancy hypertension

390

3355

1.05

0.40

2.3

2.2

0.63

0.57

g/l

0.10

351

2942

Spinal instabilities

249

0.80

0.40

1.5

2.1

0.57

1.07

g/l

0.58

220

Renal cell carcinoma of kidney

399

1.16

0.40

1.9

2.9

1.49

1.51

g/l

0.01

341

Carcinoma in situ of cervix uteri

521

1.13

0.40

2.8

1.4

0.39

0.28

g/l

0.20

466

Dementia due to Parkinsons disease, excluding more controls

205

1.23

0.39

1.6

2.2

1.60

1.55

g/l

0.02

169

Medicines for HER+ breast cancer

434

4411

0.96

0.39

2.1

2.5

0.67

0.81

g/l

0.37

362

3724

Melanoma in situ, other sites/unspecified

1.41

0.39

1.0

1.1

0.00

0.37

g/l

—

Family history of malignant neoplasm

927

0.90

0.38

3.3

2.1

1.07

0.67

g/l

0.42

817

Malignant neoplasm of breast, HER-positive

416

4279

0.96

0.38

2.1

2.5

0.66

0.82

g/l

0.41

344

3608

Malignant neoplasm of nasal cavity and sinuses

1.34

0.38

7.2

2.0

1.24

0.52

g/l

—

Sequelae of other and unspecified infectious and parasitic diseases

448

1.14

0.38

2.7

2.3

0.33

0.73

g/l

0.82

404

Tuberculosis, IBD comorbidity

876

1.10

0.38

2.1

2.3

0.70

1.15

g/l

0.91

736

Other specified and unspecified disorders of lens

116

1.31

0.37

1.9

2.8

0.00

0.69

g/l

—

100

Complications predominantly related to the puerperium

225

2123

1.06

0.37

2.2

0.53

0.59

g/l

0.12

201

1880

Hydatidiform mole

112

0.71

0.37

2.5

2.1

4.84

0.40

g/l

—

102

Other disorders of male genital organs

299

1.17

0.37

1.7

2.7

0.26

1.14

g/l

1.71

258

Additional codes for the location of defect, injury or illness

553

1.12

0.37

1.5

2.7

0.36

1.28

g/l

3.06

484

Androgenic alopecia

1.29

0.37

1.1

2.5

0.00

0.69

g/l

—

Tuberculosis, wide

100

916

1.09

0.37

2.1

2.5

0.67

1.25

g/l

1.35

772

Vasomotor rhinitis (mode)

754

1.10

0.36

2.2

2.8

0.55

1.09

g/l

1.55

662

Benign neoplasm: Cranial nerves

300

1.17

0.36

4.4

2.7

0.98

1.20

g/l

0.15

262

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

0.65

0.36

4.6

1.2

0.14

0.31

g/l

—

Chronic mastoiditis

291

1.17

0.36

1.9

2.8

0.29

1.62

g/l

2.99

248

Endometriosis ASRM stages 3,4

226

2389

0.94

0.36

1.8

2.2

0.78

0.66

g/l

0.19

188

2041

Endometriosis diagnosis and infertility diagnosis occurring together

745

1.10

0.36

1.4

2.2

0.21

0.52

g/l

1.31

672

Brain meningioma

574

1.12

0.36

2.4

2.7

0.84

0.99

g/l

0.17

499

Malignant neoplasm of hypopharynx

1.41

0.35

1.0

2.5

0.00

0.50

g/l

—

Endometriosis ASRM stages 1,2

160

1497

1.07

0.35

1.7

2.0

0.70

0.52

g/l

0.38

133

1324

Disorders of adrenal gland, other and/or unspecified

1.41

0.35

1.2

2.5

0.00

1.34

g/l

—

Other benign neoplasms of uterus

680

1.11

0.35

3.0

2.3

1.13

0.87

g/l

0.22

561

Fitting and adjustment of other devices

497

4460

1.04

0.34

2.6

2.3

1.66

1.04

g/l

1.49

390

3698

Benign neoplasm of ovary

213

2016

1.06

0.34

2.4

2.3

1.06

0.70

g/l

0.71

184

1714

Benign leiomyoma with endometriosis

203

1919

1.06

0.34

2.3

0.63

0.79

g/l

0.36

165

1635

Melanocytic naevi, other sites/unspecified

740

0.90

0.33

2.5

1.06

1.10

g/l

0.02

659

Acute and transient psychotic disorders

116

1076

1.08

0.33

2.2

2.3

0.96

0.79

g/l

0.11

962

Malignant neoplasm of brain

296

0.84

0.33

1.5

2.6

1.44

1.01

g/l

0.16

263

Inflammatory disease of cervix uteri

718

0.90

0.32

1.4

2.3

0.31

0.76

g/l

1.21

621

Bullous keratopathy

1.34

0.32

1.0

2.7

0.00

0.78

g/l

1.68

Long labour

162

1504

0.94

0.32

2.4

2.1

0.61

0.50

g/l

0.16

148

1361

Left ventricular outflow tract obstruction, narrow definition

379

1.14

0.32

1.6

2.6

0.31

1.16

g/l

2.39

342

Pedestrian injured in collision with car, pick-up truck or van

220

1.19

0.32

1.9

2.6

0.99

0.86

g/l

0.07

193

Burn and corrosion of trunk

248

1.17

0.32

1.8

2.8

0.09

1.13

g/l

3.67

222

Malignant neoplasm of colon

187

1976

0.94

0.31

2.5

2.4

1.03

1.06

g/l

0.03

156

1660

Malignant neoplasm of nasal cavity and middle ear

1.34

0.31

7.7

2.1

0.49

0.46

g/l

—

Antenatal screening

165

874

1.06

0.31

2.0

0.39

0.42

g/l

0.06

158

802

Primary open-angle glaucoma, strict

371

3844

0.96

0.30

2.6

2.3

1.40

0.96

g/l

1.05

294

3191

Drug-induced gout

1.29

0.30

2.4

1.7

1.31

0.39

g/l

—

Lesion of plantar nerve

693

0.91

0.30

2.6

2.4

0.92

0.88

g/l

0.03

590

Benign neoplasm: Bladder

1.32

0.30

2.3

1.2

0.07

0.26

g/l

0.43

Diabetes mellitus in pregnancy

195

1334

0.95

0.30

1.5

1.9

0.15

0.36

g/l

1.83

175

1223

Other osteochondropathies

601

1.10

0.29

2.6

2.3

1.43

0.89

g/l

0.49

536

Pedal cyclist injured in collision with pedestrian or animal

1.26

0.29

2.6

2.4

3.04

1.03

g/l

—

Pedal cyclist injured in other and unspecified transport accidents

1066

0.93

0.29

2.2

2.4

0.75

0.99

g/l

0.37

939

Ethmoidectomy

124

1323

0.94

0.29

2.8

2.4

1.28

0.88

g/l

0.24

104

1167

Tuberculosis of other organs, strict

279

1.15

0.29

2.0

2.8

0.38

1.02

g/l

0.87

238

L02BG Aromatase inhibitors

356

3693

0.96

0.28

2.2

2.5

0.46

0.86

g/l

2.00

296

3112

Anomalies of dental arch relationship, including avohilmo

143

1363

0.94

0.28

2.2

2.3

0.61

0.87

g/l

0.51

116

1216

Torsion of ovary, ovarian pedicle and fallopian tube

158

1.21

0.28

1.4

2.3

0.55

0.28

g/l

0.22

143

Primary angle-closure glaucoma

522

0.90

0.27

2.7

2.8

0.75

1.25

g/l

0.66

444

Mixed conductive and sensorineural hearing loss

166

1574

1.06

0.27

2.5

2.3

1.13

0.92

g/l

0.20

131

1336

Inflammatory diseases of prostate (prostatitis)

161

1526

1.06

0.27

2.2

2.7

0.62

1.16

g/l

1.91

138

1299

Dislocation, sprain and strain of joints and ligaments of head

281

1.14

0.26

1.5

2.0

1.76

0.71

g/l

0.57

257

Benign neoplasm: Uterine tubes and ligaments

0.69

0.26

1.0

3.1

0.00

1.04

g/l

—

Seminoma of testis

1.20

0.26

1.7

2.1

0.14

0.93

g/l

—

Glaucoma, exfoliation

142

1501

0.94

0.26

2.3

2.4

1.41

1.05

g/l

0.43

118

1239

Foreign body or object entering through skin

529

1.10

0.26

3.2

2.5

0.96

1.08

g/l

0.11

475

Failed attempted abortion

0.68

0.26

3.6

1.4

0.76

0.58

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

883

0.93

0.26

2.1

2.5

0.87

1.03

g/l

0.16

772

Benign neoplasm: Skin of upper limb, including shoulder

160

1.19

0.25

4.3

1.5

0.59

0.47

g/l

0.08

143

Anomalies of pupillary function

160

1.19

0.25

3.0

2.3

0.87

1.04

g/l

0.07

144

Mental retardation, excluding more controls

203

1.16

0.25

1.8

2.7

0.82

1.02

g/l

0.11

184

Primary open-angle glaucoma

466

4673

0.97

0.25

2.5

2.4

1.33

1.05

g/l

0.67

374

3884

Vestibular neuronitis

107

1006

1.07

0.24

2.6

2.5

0.56

1.14

g/l

1.34

870

Sequelae of infectious and parasitic diseases

744

1.08

0.24

3.0

2.3

0.98

1.08

g/l

0.07

650

Thyrotoxicosis with toxic single thyroid nodule

0.74

0.24

7.8

2.3

5.15

0.64

g/l

—

Impacted teeth

848

0.93

0.24

1.5

1.8

0.51

0.41

g/l

0.13

781

Benign neoplasm: Skin of other and unspecified parts of face

119

1124

1.06

0.23

4.2

1.5

0.94

0.43

g/l

0.71

951

Poor fetal growth

610

1.08

0.23

1.8

1.9

0.16

0.38

g/l

0.66

558

Caught, crushed, jammed or pinched in or between objects

370

1.11

0.23

1.3

2.4

0.19

0.84

g/l

2.17

332

Divergent concomitant strabismus

678

1.08

0.23

2.1

2.4

0.82

0.96

g/l

0.15

595

Hydrocephalus

908

0.93

0.23

2.8

2.5

0.61

1.22

g/l

2.21

771

Hypertrophy of breast in women and men

193

1849

1.04

0.23

2.1

2.4

0.52

0.80

g/l

0.71

170

1631

Vascular syndromes of brain in cerebrovascular disorders

546

0.91

0.23

2.6

2.7

1.69

1.55

g/l

0.07

470

Other injuries of upper limb, level unspecified

1.26

0.23

2.3

2.5

0.34

1.05

g/l

0.90

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

113

1068

1.06

0.22

1.5

0.44

0.38

g/l

0.15

875

Tuberculosis of other organs

238

1.14

0.22

2.1

2.7

0.46

1.07

g/l

0.65

203

Toxic effect of pesticides

0.00

0.22

0.0

1.0

—

0.00

—

Injury of blood vessels at ankle and foot level

0.00

0.21

0.0

4.4

—

0.50

—

Calcific tendinitis of shoulder

534

0.92

0.21

3.5

2.2

2.59

0.97

g/l

0.70

472

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

1.00

—

Need for immunization against certain single viral diseases

0.00

0.21

0.0

1.5

—

1.67

—

Disorder of visual pathways, unspecified

0.00

0.21

0.0

1.8

—

0.00

—

Hypertrophy of breast

161

1539

1.05

0.21

1.6

2.3

0.51

0.63

g/l

0.21

140

1357

Birth injury to peripheral nervous system

0.00

0.21

0.0

3.5

—

2.91

—

Other congenital malformations of spinal cord

0.00

0.21

0.0

1.2

—

1.21

—

Syndactyly

0.00

0.21

0.0

3.3

—

0.83

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

0.00

—

Tuberculosis

781

0.93

0.21

2.1

2.5

0.63

1.31

g/l

1.40

653

Patellar tendinitis

103

0.77

0.21

1.4

2.1

0.35

0.75

g/l

—

Anxious personality disorder

105

0.76

0.21

5.3

1.9

0.24

1.07

g/l

—

Carcinoma in situ, bladder

383

1.10

0.21

4.3

2.9

1.35

1.54

g/l

0.11

335

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

227

2352

0.96

0.20

2.5

1.5

0.83

0.49

g/l

0.72

183

1968

Benign neoplasm: Pineal gland

0.00

0.20

0.0

1.1

—

2.54

—

Female infertility

283

1692

1.03

0.20

2.0

2.1

0.35

0.61

g/l

1.28

247

1488

Cholesteatoma of middle ear

603

0.93

0.19

1.9

2.6

0.92

1.25

g/l

0.51

519

Retained placenta and membranes, without haemorrhage

103

1086

0.95

0.19

2.3

2.1

1.04

0.59

g/l

0.67

963

Hypermetropia

587

1.07

0.19

2.6

2.4

0.55

0.92

g/l

0.62

519

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

772

1.06

0.19

2.1

1.5

0.87

0.38

g/l

0.71

665

Schizophrenia or delusion

341

3319

1.03

0.19

2.0

2.2

0.71

0.75

g/l

0.06

284

2903

Calculus of lower urinary tract

628

1.07

0.18

2.3

2.5

0.60

1.24

g/l

1.05

539

Other specified/unspecified diseases of inner ear

1.19

0.18

1.9

2.1

0.13

0.43

g/l

—

Supervision of high-risk pregnancy

143

828

1.04

0.18

1.7

2.0

0.31

0.43

g/l

0.38

128

758

Contact with sharp glass

252

1.11

0.18

2.2

0.00

0.76

g/l

3.41

231

Fourth [trochlear] nerve palsy

216

0.88

0.18

1.4

2.9

0.47

1.32

g/l

0.81

188

Benign neoplasm of thyroid gland

310

0.90

0.17

1.4

0.25

0.32

g/l

0.10

273

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

281

1.11

0.17

3.1

1.4

1.11

0.47

g/l

0.59

242

Congenital malformations of breast

1.21

0.17

1.0

1.7

0.00

0.54

g/l

1.21

Erosion and ectropion of cervix uteri

310

1.10

0.17

4.1

2.1

0.74

0.85

g/l

0.07

268

Burn and corrosion of shoulder and upper limb, except wrist and hand

157

1.15

0.17

2.6

3.4

2.81

0.96

g/l

0.40

140

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS